phase,status,disease_id,disease_name,chembl_id,drug_name,gene_symbol,smiles
4.0,,EFO_0000274,atopic eczema,CHEMBL1201109,DESONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000274,atopic eczema,CHEMBL131,PREDNISOLONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL1473,FLUTICASONE PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL1650,CORTISONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL1683,HYDROCORTISONE BUTYRATE,NR3C1,CCCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000274,atopic eczema,CHEMBL389621,HYDROCORTISONE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL635,PREDNISONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL650,METHYLPREDNISOLONE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)CO)[C@@]2(C)C=CC(=O)C=C12
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1201014,PREDNISOLONE SODIUM PHOSPHATE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1370,BUDESONIDE,NR3C1,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1676,FLUTICASONE FUROATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)SCF
4.0,,EFO_0000274,atopic eczema,CHEMBL2021430,DEXAMETHASONE SODIUM PHOSPHATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0000274,atopic eczema,CHEMBL384467,DEXAMETHASONE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4.0,,EFO_0000274,atopic eczema,CHEMBL989,FLUOCINOLONE ACETONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000544,infection,CHEMBL1200384,BETAMETHASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000546,injury,CHEMBL1504,TRIAMCINOLONE ACETONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000574,lymphoma,CHEMBL1201081,METHYLPREDNISOLONE SODIUM SUCCINATE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)[O-])[C@@]2(C)C=CC(=O)C=C12.[Na+]
4.0,,EFO_0000565,leukemia,CHEMBL1364144,METHYLPREDNISOLONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000676,psoriasis,CHEMBL1766,DESOXIMETASONE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO
4.0,,EFO_0000676,psoriasis,CHEMBL1159650,CLOBETASOL PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,Terminated,EFO_0000676,psoriasis,CHEMBL1200908,HALOBETASOL PROPIONATE,NR3C1,CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1091,HYDROCORTISONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200386,PREDNICARBATE,NR3C1,CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200545,DIFLORASONE DIACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200953,HYDROCORTISONE PROBUTATE,NR3C1,CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1200989,ALCLOMETASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)C[C@H]2[C@H]3[C@H]([C@@H](O)C[C@@]21C)[C@@]1(C)C=CC(=O)C=C1C[C@H]3Cl
4.0,,EFO_0000701,skin disease,CHEMBL1497,BETAMETHASONE VALERATE,NR3C1,CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000701,skin disease,CHEMBL1501,FLUOCINONIDE,NR3C1,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
4.0,,EFO_0000701,skin disease,CHEMBL1161,MOMETASONE FUROATE,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl
4.0,,EFO_0000701,skin disease,CHEMBL1200845,HALCINONIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1
4.0,,EFO_0000701,skin disease,CHEMBL1201012,FLURANDRENOLIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,EFO_0000701,skin disease,CHEMBL1451,TRIAMCINOLONE,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@H]1[C@@H]3C[C@@H](O)[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@]12F
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200538,BETAMETHASONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200762,BETAMETHASONE SODIUM PHOSPHATE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]
4.0,,EFO_0003099,Cushing syndrome,CHEMBL1276308,MIFEPRISTONE,NR3C1,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C
4.0,,EFO_0003894,acne,CHEMBL1200600,FLUOROMETHOLONE,NR3C1,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0005752,eye inflammation,CHEMBL1200617,RIMEXOLONE,NR3C1,CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0005752,eye inflammation,CHEMBL1201173,MEDRYSONE,NR3C1,CC(=O)[C@H]1CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C
4.0,,EFO_0005752,eye inflammation,CHEMBL632,BETAMETHASONE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1200865,LOTEPREDNOL ETABONATE,NR3C1,CCOC(=O)O[C@]1(C(=O)OCCl)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,Completed,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200500,BECLOMETHASONE DIPROPIONATE,NR3C1,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2040682,CICLESONIDE,NR3C1,CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
4.0,,EFO_1000811,anterior uveitis,CHEMBL1201749,DIFLUPREDNATE,NR3C1,CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1152,PREDNISOLONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
4.0,,EFO_0008521,rhinitis,CHEMBL1512,FLUNISOLIDE,NR3C1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1
4.0,,MONDO_0004979,asthma,CHEMBL1200495,HYDROCORTISONE SODIUM SUCCINATE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)[O-].[Na+]
4.0,Unknown status,MONDO_0005178,osteoarthritis,CHEMBL1200878,TRIAMCINOLONE HEXACETONIDE,NR3C1,CC(C)(C)CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL1201891,DEFLAZACORT,NR3C1,CC(=O)OCC(=O)[C@@]12N=C(C)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL3707311,VAMOROLONE,NR3C1,
3.0,Terminated,EFO_0000222,acute myeloid leukemia,CHEMBL1201265,METHYLPREDNISOLONE HEMISUCCINATE,NR3C1,C[C@H]1C[C@@H]2[C@H]([C@@H](O)C[C@@]3(C)[C@H]2CC[C@]3(O)C(=O)COC(=O)CCC(=O)O)[C@@]2(C)C=CC(=O)C=C12
3.0,Unknown status,EFO_0000565,leukemia,CHEMBL1530428,DEXAMETHASONE ACETATE,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
3.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL139835,CYPROTERONE ACETATE,NR3C1,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
3.0,Completed,EFO_0003099,Cushing syndrome,CHEMBL4068611,RELACORILANT,NR3C1,Cn1cc(S(=O)(=O)N2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3cc(C(F)(F)F)ccn3)C2)cn1
3.0,Completed,EFO_0006834,septic shock,CHEMBL977,HYDROCORTISONE HEMISUCCINATE ANHYDROUS,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC(=O)O
3.0,Completed,EFO_1000811,anterior uveitis,CHEMBL1201302,DEXAMETHASONE PHOSPHORIC ACID,NR3C1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
3.0,Unknown status,EFO_0007308,Herpes simplex virus keratitis,CHEMBL1201231,PREDNISOLONE PHOSPHORIC ACID,NR3C1,C[C@]12C=CC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COP(=O)(O)O
3.0,Terminated,EFO_1001097,periarthritis,CHEMBL1201207,BETAMETHASONE PHOSPHORIC ACID,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
3.0,Completed,MONDO_0005129,cataract,CHEMBL2103876,MAPRACORAT,NR3C1,Cc1ccc2c(NC[C@](O)(CC(C)(C)c3cc(F)cc4c3OCC4)C(F)(F)F)cccc2n1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4072756,AZD-5423,NR3C1,COc1cccc([C@@H](Oc2ccc3c(cnn3-c3ccc(F)cc3)c2)[C@H](C)NC(=O)C(F)(F)F)c1
2.0,Completed,EFO_0000677,mental or behavioural disorder,CHEMBL3545391,ORG-34517,NR3C1,CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc4c(c3)OCO4)C[C@@]21C
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297572,ABBV-3373,NR3C1,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3137316,FOSDAGROCORAT,NR3C1,Cc1ncccc1NC(=O)c1ccc2c(c1)CC[C@@H]1C[C@@](OP(=O)(O)O)(C(F)(F)F)CC[C@@]21Cc1ccccc1
2.0,Completed,EFO_0000756,melanoma,CHEMBL1201148,MEPREDNISONE,NR3C1,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3C(=O)C[C@]2(C)[C@@]1(O)C(=O)CO
2.0,Completed,EFO_0003843,pain,CHEMBL2105842,CORTIVAZOL,NR3C1,CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
2.0,Completed,MONDO_0004979,asthma,CHEMBL3666807,VELSECORAT,NR3C1,C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2c(cnn2-c2cccc(C(=O)N[C@@H]3CCOC3)c2)c1)c1ccc2c(c1)OCCO2
2.0,Completed,MONDO_0015129,chronic primary adrenal insufficiency,CHEMBL1549,HYDROCORTISONE CYPIONATE,NR3C1,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL6622,ISOSORBIDE DINITRATE,GUCY1B1,O=[N+]([O-])O[C@H]1CO[C@H]2[C@@H]1OC[C@H]2O[N+](=O)[O-]
4.0,,EFO_0000319,cardiovascular disease,CHEMBL730,NITROGLYCERIN,GUCY1B1,O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1311,ISOSORBIDE MONONITRATE,GUCY1B1,O=[N+]([O-])O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL4066936,VERICIGUAT,GUCY1B1,COC(=O)Nc1c(N)nc(-c2nn(Cc3ccccc3F)c3ncc(F)cc23)nc1N
4.0,,EFO_0000319,cardiovascular disease,CHEMBL466659,PENTAERYTHRITOL TETRANITRATE,GUCY1B1,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]
4.0,,EFO_0000373,congestive heart failure,CHEMBL136478,SODIUM NITROPRUSSIDE,GUCY1B1,
4.0,,EFO_0000537,hypertension,CHEMBL2097081,NITROPRUSSIDE,GUCY1B1,
4.0,,EFO_0000537,hypertension,CHEMBL2107834,RIOCIGUAT,GUCY1B1,COC(=O)N(C)c1c(N)nc(-c2nn(Cc3ccccc3F)c3ncccc23)nc1N
4.0,,EFO_0000684,respiratory system disease,CHEMBL1200689,NITRIC OXIDE,GUCY1B1,[N]=O
2.0,Completed,EFO_0000266,aortic stenosis,CHEMBL2107729,ATACIGUAT,GUCY1B1,O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1
2.0,Terminated,EFO_0000373,congestive heart failure,CHEMBL1236936,CINACIGUAT,GUCY1B1,O=C(O)CCCCN(CCc1ccccc1OCc1ccc(CCc2ccccc2)cc1)Cc1ccc(C(=O)O)cc1
2.0,Completed,EFO_0003144,heart failure,CHEMBL4297214,PRALICIGUAT,GUCY1B1,OC(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)(C(F)(F)F)C(F)(F)F
2.0,Completed,EFO_0003770,diabetic retinopathy,CHEMBL4650322,RUNCACIGUAT,GUCY1B1,C[C@H]([C@H](C(=O)Nc1cc([C@@H](CC(=O)O)C2CC2)ccc1Cl)c1ccc(Cl)cc1)C(F)(F)F
2.0,Terminated,HP_0002571,Achalasia,CHEMBL4297616,OLINCIGUAT,GUCY1B1,NC(=O)[C@](O)(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)C(F)(F)F
4.0,,EFO_0000540,immune system disease,CHEMBL1201828,ECULIZUMAB,C5,
4.0,,EFO_0000540,immune system disease,CHEMBL3989986,RAVULIZUMAB,C5,
4.0,,EFO_0004991,Myasthenia gravis,CHEMBL5315048,ZILUCOPLAN SODIUM,C5,
4.0,,HP_0002243,Protein-losing enteropathy,CHEMBL4298086,POZELIMAB,C5,
3.0,Completed,EFO_0001645,coronary artery disease,CHEMBL2107979,PEXELIZUMAB,C5,
3.0,Completed,EFO_0004991,Myasthenia gravis,CHEMBL4298207,ZILUCOPLAN,C5,
3.0,Withdrawn,EFO_0007292,Guillain-Barre syndrome,CHEMBL4594316,CROVALIMAB,C5,
3.0,Recruiting,EFO_0004991,Myasthenia gravis,CHEMBL4297722,CEMDISIRAN,C5,
3.0,Withdrawn,EFO_0007187,bullous pemphigoid,CHEMBL4297928,NOMACOPAN,C5,
3.0,Recruiting,HP_0000999,Pyoderma,CHEMBL2109636,VILOBELIMAB,C5,
2.0,Completed,EFO_0001365,age-related macular degeneration,CHEMBL4298012,TESIDOLUMAB,C5,
2.0,Terminated,EFO_0002689,antiphospholipid syndrome,CHEMBL3990025,OLENDALIZUMAB,C5,
4.0,,EFO_0000540,immune system disease,CHEMBL2108730,SARILUMAB,IL6R,
4.0,,EFO_0000540,immune system disease,CHEMBL3833307,SATRALIZUMAB,IL6R,
4.0,,EFO_0000540,immune system disease,CHEMBL1237022,TOCILIZUMAB,IL6R,
3.0,"Active, not recruiting",EFO_0000685,rheumatoid arthritis,CHEMBL4650406,LEVILIMAB,IL6R,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3833343,VOBARILIZUMAB,IL6R,
4.0,Completed,EFO_0000384,Crohn's disease,CHEMBL1201580,ADALIMUMAB,TNF,
4.0,,EFO_0000384,Crohn's disease,CHEMBL1201581,INFLIXIMAB,TNF,
4.0,,EFO_0000384,Crohn's disease,CHEMBL1201831,CERTOLIZUMAB PEGOL,TNF,
4.0,,EFO_0000540,immune system disease,CHEMBL1201572,ETANERCEPT,TNF,
4.0,,EFO_0000540,immune system disease,CHEMBL1201833,GOLIMUMAB,TNF,
3.0,Terminated,EFO_0003778,psoriatic arthritis,CHEMBL2107911,ONERCEPT,TNF,
2.0,,EFO_0000540,immune system disease,CHEMBL2108887,AFELIMOMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1743057,PEGSUNERCEPT,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297572,ABBV-3373,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1743054,OZORALIZUMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL2108739,PLACULUMAB,TNF,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297863,REMTOLUMAB,TNF,
4.0,,EFO_0000319,cardiovascular disease,CHEMBL521,IBUPROFEN,PTGS2,CC(C)Cc1ccc(C(C)C(=O)O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL6,INDOMETHACIN,PTGS2,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,Completed,EFO_0000612,myocardial infarction,CHEMBL25,ASPIRIN,PTGS2,CC(=O)Oc1ccccc1C(=O)O
4.0,,EFO_0000616,neoplasm,CHEMBL118,CELECOXIB,PTGS2,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1034,DICLOFENAC SODIUM,PTGS2,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1070,NABUMETONE,PTGS2,COc1ccc2cc(CCC(C)=O)ccc2c1
4.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1200804,DICLOFENAC POTASSIUM,PTGS2,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL139,DICLOFENAC,PTGS2,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL154,NAPROXEN,PTGS2,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1562610,MECLOFENAMATE SODIUM,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]
4.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL421,SULFASALAZINE,PTGS2,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL599,MELOXICAM,PTGS2,Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL865,VALDECOXIB,PTGS2,Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200760,BALSALAZIDE DISODIUM,PTGS2,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1201013,OLSALAZINE SODIUM,PTGS2,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1071,OXAPROZIN,PTGS2,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL704,MESALAMINE,PTGS2,Nc1ccc(O)c(C(=O)O)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200613,TOLMETIN SODIUM,PTGS2,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200806,NAPROXEN SODIUM,PTGS2,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL15770,SULINDAC,PTGS2,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103736,FENOPROFEN CALCIUM,PTGS2,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL527,PIROXICAM,PTGS2,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL571,KETOPROFEN,PTGS2,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL622,ETODOLAC,PTGS2,CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL898,DIFLUNISAL,PTGS2,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL93645,ACECLOFENAC,PTGS2,O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
4.0,,EFO_0003843,pain,CHEMBL1021,NEPAFENAC,PTGS2,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N
4.0,,EFO_0003843,pain,CHEMBL112,ACETAMINOPHEN,PTGS2,CC(=O)Nc1ccc(O)cc1
4.0,,EFO_0003843,pain,CHEMBL1201180,DICLOFENAC EPOLAMINE,PTGS2,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1
4.0,,EFO_0003843,pain,CHEMBL146095,GLAFENINE,PTGS2,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
4.0,Completed,EFO_0003843,pain,CHEMBL3989803,DIPYRONE,PTGS2,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
4.0,,EFO_0005752,eye inflammation,CHEMBL1077,BROMFENAC,PTGS2,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1
4.0,,EFO_0005752,eye inflammation,CHEMBL3989676,OXYPHENBUTAZONE,PTGS2,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O
4.0,,EFO_0005752,eye inflammation,CHEMBL469,KETOROLAC,PTGS2,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0005752,eye inflammation,CHEMBL563,FLURBIPROFEN,PTGS2,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL101,PHENYLBUTAZONE,PTGS2,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL122,ROFECOXIB,PTGS2,CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL12610,BENZYDAMINE,PTGS2,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
4.0,,EFO_0005755,rheumatic disease,CHEMBL1297,FENOPROFEN,PTGS2,CC(C(=O)O)c1cccc(Oc2ccccc2)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL15870,INDOPROFEN,PTGS2,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL175,DEXIBUPROFEN,PTGS2,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL189171,ACEMETACIN,PTGS2,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL416146,ETORICOXIB,PTGS2,Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1
4.0,,EFO_0005755,rheumatic disease,CHEMBL686,MEFENAMIC ACID,PTGS2,Cc1cccc(Nc2ccccc2C(=O)O)c1C
4.0,,EFO_0005755,rheumatic disease,CHEMBL75435,DEXKETOPROFEN,PTGS2,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0003843,pain,CHEMBL1201124,KETOROLAC TROMETHAMINE,PTGS2,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0003843,pain,CHEMBL2108222,ALOXIPRIN,PTGS2,
4.0,,EFO_0003843,pain,CHEMBL296913,PARECOXIB SODIUM,PTGS2,CCC(=O)[N-]S(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1.[Na+]
4.0,,EFO_0003843,pain,CHEMBL3181947,BROMFENAC SODIUM,PTGS2,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+]
4.0,,EFO_0005755,rheumatic disease,CHEMBL1020,TOLMETIN,PTGS2,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1206690,PARECOXIB,PTGS2,CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1565476,APAZONE,PTGS2,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL1569487,LORNOXICAM,PTGS2,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL188952,PIRPROFEN,PTGS2,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL404108,LUMIRACOXIB,PTGS2,Cc1ccc(Nc2c(F)cccc2Cl)c(CC(=O)O)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL509,MECLOFENAMIC ACID,PTGS2,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl
4.0,,EFO_0005755,rheumatic disease,CHEMBL956,SUPROFEN,PTGS2,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1
4.0,,HP_0002018,Nausea,CHEMBL1120,BISMUTH SUBSALICYLATE,PTGS2,
4.0,,HP_0001643,Patent ductus arteriosus,CHEMBL1201141,IBUPROFEN LYSINE,PTGS2,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O
3.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL2107455,IGURATIMOD,PTGS2,CS(=O)(=O)Nc1cc2occ(NC=O)c(=O)c2cc1Oc1ccccc1
3.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL364804,GW-406381,PTGS2,CCOc1ccc(-c2nn3ncccc3c2-c2ccc(S(C)(=O)=O)cc2)cc1
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL1201346,BALSALAZIDE,PTGS2,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1
3.0,Completed,EFO_0003843,pain,CHEMBL3989408,IBUPROFEN SODIUM,PTGS2,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]
3.0,Recruiting,EFO_0003843,pain,CHEMBL461522,METAMIZOLE,PTGS2,Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C
3.0,,EFO_0005755,rheumatic disease,CHEMBL2103831,NAPROXCINOD,PTGS2,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1
3.0,Completed,EFO_0003843,pain,CHEMBL19299,LOXOPROFEN,PTGS2,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1
3.0,Completed,EFO_1000786,"osteoarthritis, hip",CHEMBL166863,POLMACOXIB,PTGS2,CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(F)c2)C1=O
3.0,Not yet recruiting,EFO_1001904,oral mucositis,CHEMBL1528134,BENZYDAMINE HYDROCHLORIDE,PTGS2,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl
3.0,Completed,HP_0030839,Knee pain,CHEMBL435298,ESFLURBIPROFEN,PTGS2,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1
2.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL1835207,APRICOXIB,PTGS2,CCOc1ccc(-c2cc(C)cn2-c2ccc(S(N)(=O)=O)cc2)cc1
2.0,Completed,EFO_0003898,ankylosing spondylitis,CHEMBL425,OLSALAZINE,PTGS2,O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O
2.0,Completed,MONDO_0002050,depressive disorder,CHEMBL435381,CIMICOXIB,PTGS2,COc1ccc(-c2c(Cl)ncn2-c2ccc(S(N)(=O)=O)cc2)cc1F
2.0,Completed,MONDO_0005178,osteoarthritis,CHEMBL2105683,NAPROXEN ETEMESIL,PTGS2,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1
1.0,Completed,MP_0001845,inflammation,CHEMBL3989410,INDOMETHACIN SODIUM,PTGS2,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]
4.0,,EFO_0000275,atrial fibrillation,CHEMBL1201657,HEPARIN SODIUM,SERPINC1,
4.0,,EFO_0000612,myocardial infarction,CHEMBL1201476,ENOXAPARIN SODIUM,SERPINC1,
4.0,,EFO_0000612,myocardial infarction,CHEMBL1200644,FONDAPARINUX SODIUM,SERPINC1,CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)[O-])[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)[O-])[C@H]3NS(=O)(=O)[O-])[C@H](O)[C@H]2OS(=O)(=O)[O-])[C@H](O)[C@H]1NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
4.0,Completed,EFO_0003907,deep vein thrombosis,CHEMBL1201414,TINZAPARIN SODIUM,SERPINC1,
4.0,,EFO_0004286,venous thromboembolism,CHEMBL1201460,DALTEPARIN SODIUM,SERPINC1,
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL1201202,FONDAPARINUX,SERPINC1,CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](O)[C@H]5NS(=O)(=O)O)[C@H](O)[C@H]4O)[C@H](OS(=O)(=O)O)[C@H]3NS(=O)(=O)O)[C@H](O)[C@H]2OS(=O)(=O)O)[C@H](O)[C@H]1NS(=O)(=O)O
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL1201534,DANAPAROID SODIUM,SERPINC1,
3.0,Completed,EFO_0000319,cardiovascular disease,CHEMBL4650299,HEPARIN,SERPINC1,
3.0,Terminated,EFO_0000545,infertility,CHEMBL2108080,PARNAPARIN SODIUM,SERPINC1,
3.0,Completed,EFO_0003907,deep vein thrombosis,CHEMBL2108806,BEMIPARIN SODIUM,SERPINC1,
3.0,Completed,EFO_0003907,deep vein thrombosis,CHEMBL2109204,NADROPARIN CALCIUM,SERPINC1,
3.0,Terminated,EFO_0004286,venous thromboembolism,CHEMBL2108718,SEMULOPARIN SODIUM,SERPINC1,
3.0,Completed,MONDO_0010602,hemophilia A,CHEMBL4297754,FITUSIRAN,SERPINC1,
2.0,Completed,EFO_1000954,habitual abortion,CHEMBL1201513,HEPARIN CALCIUM,SERPINC1,
4.0,,EFO_0000224,acute promyelocytic leukemia,CHEMBL38,TRETINOIN,RARG,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1
4.0,,EFO_0000558,Kaposi's sarcoma,CHEMBL705,ALITRETINOIN,RARG,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1
4.0,,EFO_0000676,psoriasis,CHEMBL1657,TAZAROTENE,RARG,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1
4.0,,EFO_0000676,psoriasis,CHEMBL1131,ACITRETIN,RARG,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
4.0,,EFO_0000676,psoriasis,CHEMBL464,ETRETINATE,RARG,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C
4.0,Terminated,EFO_0003894,acne,CHEMBL1265,ADAPALENE,RARG,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2
4.0,Completed,EFO_0003894,acne,CHEMBL3707313,TRIFAROTENE,RARG,CC(C)(C)c1cc(-c2cc(-c3ccc(C(=O)O)cc3)ccc2OCCO)ccc1N1CCCC1
4.0,Not yet recruiting,EFO_0003894,acne,CHEMBL547,ISOTRETINOIN,RARG,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
4.0,,MONDO_0007606,fibrodysplasia ossificans progressiva,CHEMBL2105648,PALOVAROTENE,RARG,CC1(C)CCC(C)(C)c2cc(Cn3cccn3)c(/C=C/c3ccc(C(=O)O)cc3)cc21
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL1873475,IBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3707348,ACALABRUTINIB,BTK,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12
4.0,,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4594293,ACALABRUTINIB MALEATE,BTK,CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12.O=C(O)/C=C\C(=O)O
4.0,,EFO_0000616,neoplasm,CHEMBL3936761,ZANUBRUTINIB,BTK,C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1
4.0,,EFO_0004192,alopecia areata,CHEMBL5314649,RITLECITINIB TOSYLATE,BTK,C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_1001469,Mantle cell lymphoma,CHEMBL4650485,PIRTOBRUTINIB,BTK,COc1ccc(F)cc1C(=O)NCc1ccc(-c2nn([C@@H](C)C(F)(F)F)c(N)c2C(N)=O)cc1
3.0,Recruiting,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4650321,ORELABRUTINIB,BTK,C=CC(=O)N1CCC(c2ccc(C(N)=O)c(-c3ccc(Oc4ccccc4)cc3)n2)CC1
3.0,"Active, not recruiting",EFO_0003840,chronic progressive multiple sclerosis,CHEMBL4065122,FENEBRUTINIB,BTK,C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1
3.0,Not yet recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297865,ABIVERTINIB,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1
3.0,Recruiting,EFO_0004208,Vitiligo,CHEMBL4085457,RITLECITINIB,BTK,C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C
3.0,Not yet recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297866,ABIVERTINIB MALEATE,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc3[nH]ccc23)c1.O.O.O=C(O)/C=C\C(=O)O
3.0,Recruiting,EFO_0008520,primary progressive multiple sclerosis,CHEMBL4650323,TOLEBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)nccc32)C1
3.0,Recruiting,EFO_0007160,autoimmune thrombocytopenic purpura,CHEMBL3702854,RILZABRUTINIB,BTK,CC(C)(/C=C(\C#N)C(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3F)c3c(N)ncnc32)C1)N1CCN(C2COC2)CC1
3.0,Terminated,EFO_0003929,relapsing-remitting multiple sclerosis,CHEMBL4072833,EVOBRUTINIB,BTK,C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1
2.0,Recruiting,EFO_0000096,neoplasm of mature B-cells,CHEMBL4650338,EDRALBRUTINIB,BTK,CC#CC(=O)N1CC[C@@H](n2cc(-c3ccc(Oc4c(F)cccc4F)cc3)c3c(N)n[nH]c(=O)c32)C1
2.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL4071161,TIRABRUTINIB,BTK,CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3301600,SPEBRUTINIB BESYLATE,BTK,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3301625,SPEBRUTINIB,BTK,C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1
2.0,Terminated,EFO_0000685,rheumatoid arthritis,CHEMBL4163691,POSELTINIB,BTK,C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccoc23)c1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3900554,BMS-986142,BTK,Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4594348,ELSUBRUTINIB,BTK,C=CC(=O)N1CCC[C@@H](c2ccc(C(N)=O)c3[nH]ccc23)C1
1.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297674,BRANEBRUTINIB,BTK,CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1
1.0,Completed,MONDO_0007915,systemic lupus erythematosus,CHEMBL3545193,MSC-2364447,BTK,
4.0,Completed,EFO_0000180,HIV-1 infection,CHEMBL163,RITONAVIR,CYP3A4,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
4.0,Not yet recruiting,EFO_0000180,HIV-1 infection,CHEMBL2095208,COBICISTAT,CYP3A4,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
4.0,Completed,EFO_0000180,HIV-1 infection,CHEMBL1201187,MARAVIROC,CCR5,Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1
3.0,Terminated,EFO_0000764,HIV infection,CHEMBL1255794,APLAVIROC,CCR5,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2
3.0,Terminated,EFO_0000764,HIV infection,CHEMBL1668019,APLAVIROC HYDROCHLORIDE,CCR5,CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2.Cl
3.0,Completed,EFO_0000764,HIV infection,CHEMBL82301,VICRIVIROC,CCR5,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C
3.0,Terminated,EFO_1001249,non-alcoholic steatohepatitis,CHEMBL2110727,CENICRIVIROC,CCR5,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1
3.0,Suspended,MONDO_0100096,COVID-19,CHEMBL2109343,LERONLIMAB,CCR5,
2.0,Terminated,EFO_0000401,diabetic nephropathy,CHEMBL4594419,BMS-813160,CCR5,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL5095029,PF-04634817,CCR5,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2C[C@@H]3C[C@H]2CN3c2cc(C(F)(F)F)ncn2)(C(C)C)C1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL1951914,AZD5672,CCR5,CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1
2.0,Completed,EFO_0000764,HIV infection,CHEMBL1649931,PF-232798,CCR5,CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@@H](n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1
2.0,Completed,EFO_0000764,HIV infection,CHEMBL2107384,VICRIVIROC MALEATE,CCR5,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C.O=C(O)/C=C\C(=O)O
2.0,Completed,EFO_0000764,HIV infection,CHEMBL1688243,INCB-9471,CCR5,CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C
1.0,Withdrawn,EFO_0000729,ulcerative colitis,CHEMBL2109342,HGS-1025,CCR5,
1.0,Completed,EFO_0000764,HIV infection,CHEMBL2109341,CCR5MAB004,CCR5,
3.0,Terminated,EFO_1001249,non-alcoholic steatohepatitis,CHEMBL2110727,CENICRIVIROC,CCR2,CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3545221,AZD2423,CCR2,
2.0,Withdrawn,EFO_0000319,cardiovascular disease,CHEMBL3707228,PLOZALIZUMAB,CCR2,
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL2178573,ILACIRNON,CCR2,Cc1cnc(C(=O)c2ncnc3[nH]ccc23)c(NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)c1
2.0,Terminated,EFO_0000401,diabetic nephropathy,CHEMBL4594419,BMS-813160,CCR2,CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL5095029,PF-04634817,CCR2,CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2C[C@@H]3C[C@H]2CN3c2cc(C(F)(F)F)ncn2)(C(C)C)C1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297538,MK-0812,CCR2,
2.0,Terminated,EFO_0004220,chronic hepatitis C virus infection,CHEMBL4650501,PF-4136309,CCR2,
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL4457723,BMS-741672,CCR2,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1
2.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL2204263,JNJ-41443532,CCR2,O=C(CNC(=O)c1cccc(C(F)(F)F)c1)NC1CN([C@H]2CC[C@@](O)(c3cncs3)CC2)C1
4.0,,EFO_0000540,immune system disease,CHEMBL1201830,RILONACEPT,IL1B,
4.0,,EFO_0000540,immune system disease,CHEMBL1201834,CANAKINUMAB,IL1B,
3.0,Terminated,EFO_0003780,Behcet's syndrome,CHEMBL1743026,GEVOKIZUMAB,IL1B,
3.0,Recruiting,EFO_1000710,hidradenitis suppurativa,CHEMBL4594518,LUTIKIZUMAB,IL1B,
4.0,Completed,EFO_0000676,psoriasis,CHEMBL846,CALCITRIOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
4.0,Completed,EFO_0000676,psoriasis,CHEMBL1200666,CALCIPOTRIENE,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@@H](O)C4CC4)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
4.0,Recruiting,EFO_0003882,osteoporosis,CHEMBL1042,CHOLECALCIFEROL,VDR,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12
4.0,Terminated,EFO_0003884,chronic kidney disease,CHEMBL1200622,PARICALCITOL,VDR,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C
4.0,,EFO_0003884,chronic kidney disease,CHEMBL3544909,CALCIFEDIOL,VDR,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12.O
4.0,,EFO_0003884,chronic kidney disease,CHEMBL1200810,DOXERCALCIFEROL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
4.0,,EFO_0009451,hypoparathyroidism,CHEMBL1536,ERGOCALCIFEROL,VDR,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)/C=C/[C@H](C)C(C)C)CC[C@@H]12
3.0,Terminated,EFO_0000182,hepatocellular carcinoma,CHEMBL1908376,SEOCALCITOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)/C=C/C=C/C(O)(CC)CC)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
3.0,Completed,EFO_0000612,myocardial infarction,CHEMBL1040,CALCIFEDIOL ANHYDROUS,VDR,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]12
3.0,Completed,EFO_0000676,psoriasis,CHEMBL3989862,PEFCALCITOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)OCC(=O)NCC(F)(F)C(F)(F)F)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
3.0,Completed,EFO_0003882,osteoporosis,CHEMBL1601669,ALFACALCIDOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)C[C@@H]1O
3.0,Completed,EFO_0003882,osteoporosis,CHEMBL4297608,ELDECALCITOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@@H](O)[C@@H](OCCCO)[C@@H]1O
2.0,Unknown status,EFO_0000222,acute myeloid leukemia,CHEMBL2105107,INECALCITOL,VDR,C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C
2.0,Completed,EFO_0000676,psoriasis,CHEMBL2104955,BECOCALCIDIOL,VDR,C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@@H](C)CC)CC[C@@H]23)C[C@H]1O
2.0,Completed,EFO_0000676,psoriasis,CHEMBL2105705,LUNACALCIPOL,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
2.0,Completed,EFO_0003882,osteoporosis,CHEMBL605525,DP001,VDR,C=C1[C@H](O)CC(=C/C=C2\CCC[C@]3(C)[C@@H]([C@@H](C)CCCC(C)(C)O)CC[C@@H]23)C[C@H]1O
1.0,Completed,EFO_0000616,neoplasm,CHEMBL284121,ILX23-7553,VDR,C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)CC#CC(C)(C)O)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1690,HYDROXYCHLOROQUINE SULFATE,TLR9,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O
4.0,,EFO_0001068,malaria,CHEMBL1535,HYDROXYCHLOROQUINE,TLR9,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL4297564,COBITOLIMOD,TLR9,
3.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL2103792,AGATOLIMOD,TLR9,Cc1cn([C@H]2C[C@H](OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP(O)(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](CO)O2)c(=O)[nH]c1=O
3.0,Terminated,EFO_0002617,metastatic melanoma,CHEMBL4297838,TILSOTOLIMOD,TLR9,
3.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL2103793,AGATOLIMOD SODIUM,TLR9,Cc1cn([C@H]2C[C@H](OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4ccc(N)nc4=O)C[C@@H]3OP([O-])(=S)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](CO)O2)c(=O)[nH]c1=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
3.0,Terminated,MONDO_0100096,COVID-19,CHEMBL4297680,1018 ISS,TLR9,
2.0,Completed,EFO_0000180,HIV-1 infection,CHEMBL4297776,LEFITOLIMOD,TLR9,
2.0,Completed,EFO_0000398,dermatomyositis,CHEMBL4297995,BAZLITORAN,TLR9,
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4297993,EMD-1201081,TLR9,
2.0,Completed,EFO_0002617,metastatic melanoma,CHEMBL4297994,TILSOTOLIMOD SODIUM,TLR9,
4.0,Completed,EFO_0000305,breast carcinoma,CHEMBL1201583,BEVACIZUMAB,VEGFA,
4.0,,EFO_0000365,colorectal adenocarcinoma,CHEMBL1742982,AFLIBERCEPT,VEGFA,
4.0,,EFO_0003770,diabetic retinopathy,CHEMBL1201825,RANIBIZUMAB,VEGFA,
4.0,Withdrawn,EFO_0004683,wet macular degeneration,CHEMBL3707357,BROLUCIZUMAB,VEGFA,
4.0,,EFO_0010977,macrovascular complications of diabetes,CHEMBL4297750,FARICIMAB,VEGFA,
4.0,,EFO_0004683,wet macular degeneration,CHEMBL1201421,PEGAPTANIB SODIUM,VEGFA,
3.0,Terminated,EFO_0000182,hepatocellular carcinoma,CHEMBL4297163,MUPARFOSTAT,VEGFA,
3.0,Terminated,EFO_0001365,age-related macular degeneration,CHEMBL2108313,CONBERCEPT,VEGFA,
3.0,Withdrawn,EFO_0001365,age-related macular degeneration,CHEMBL2110581,BEVASIRANIB,VEGFA,Cc1cn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cc(C)c(=O)[nH]c4=O)C[C@@H]3O)[C@@H](COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(=O)[nH]c(N)nc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(=O)[nH]c4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4ccc(N)nc4=O)O[C@@H]3COP(=O)(O)O[C@H]3[C@@H](O)[C@H](n4cnc5c(N)ncnc54)O[C@@H]3CO)O2)c(=O)[nH]c1=O
3.0,,EFO_0005753,ocular vascular disease,CHEMBL4297684,ABICIPAR PEGOL,VEGFA,
3.0,Completed,MONDO_0810000,choroidal neovascularization,CHEMBL2108752,PEGAPTANIB OCTASODIUM,VEGFA,
2.0,Terminated,MONDO_0005575,colorectal cancer,CHEMBL3545259,VANUCIZUMAB,VEGFA,
4.0,,EFO_0000555,irritable bowel syndrome,CHEMBL2159122,ELUXADOLINE,OPRM1,COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2ncc(-c3ccccc3)[nH]2)cc1C(=O)O
4.0,,EFO_0003843,pain,CHEMBL596,FENTANYL,OPRM1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1
4.0,,EFO_0003843,pain,CHEMBL607,MEPERIDINE,OPRM1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1
4.0,,EFO_0003843,pain,CHEMBL651,METHADONE,OPRM1,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1
4.0,,EFO_0003843,pain,CHEMBL656,OXYCODONE,OPRM1,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314
4.0,,EFO_0003843,pain,CHEMBL688,FENTANYL CITRATE,OPRM1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,Completed,EFO_0003843,pain,CHEMBL70,MORPHINE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5
4.0,Unknown status,EFO_0003843,pain,CHEMBL895,NALBUPHINE,OPRM1,Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314
4.0,,EFO_0003843,pain,CHEMBL1200794,OXYMORPHONE HYDROCHLORIDE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl
4.0,,EFO_0003843,pain,CHEMBL1200825,METHADONE HYDROCHLORIDE,OPRM1,CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1.Cl
4.0,,EFO_0003843,pain,CHEMBL1200890,OXYCODONE HYDROCHLORIDE,OPRM1,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.Cl
4.0,,EFO_0003843,pain,CHEMBL1201132,NALBUPHINE HYDROCHLORIDE,OPRM1,Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314
4.0,Terminated,EFO_0003843,pain,CHEMBL1201149,NALTREXONE HYDROCHLORIDE,OPRM1,Cl.O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
4.0,,EFO_0003843,pain,CHEMBL1201163,SUFENTANIL CITRATE,OPRM1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,Recruiting,EFO_0003843,pain,CHEMBL1237044,TRAMADOL,OPRM1,COc1cccc(C2(O)CCCCC2CN(C)C)c1
4.0,,EFO_0003843,pain,CHEMBL1237055,HYDROMORPHONE HYDROCHLORIDE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5.Cl
4.0,,EFO_0003843,pain,CHEMBL1237065,TRAMADOL HYDROCHLORIDE,OPRM1,COc1cccc(C2(O)CCCCC2CN(C)C)c1.Cl
4.0,,EFO_0003843,pain,CHEMBL1237104,PROPOXYPHENE HYDROCHLORIDE,OPRM1,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.Cl
4.0,Completed,EFO_0003843,pain,CHEMBL1595,DIHYDROCODEINE,OPRM1,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341
4.0,,EFO_0003843,pain,CHEMBL1685,DEZOCINE,OPRM1,C[C@@]12CCCCC[C@@H](Cc3ccc(O)cc31)[C@@H]2N
4.0,Unknown status,EFO_0003843,pain,CHEMBL1701,MEPERIDINE HYDROCHLORIDE,OPRM1,CCOC(=O)C1(c2ccccc2)CCN(C)CC1.Cl
4.0,,EFO_0003843,pain,CHEMBL1718,NALOXONE HYDROCHLORIDE,OPRM1,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl
4.0,,EFO_0003843,pain,CHEMBL2062266,DIHYDROCODEINE BITARTRATE,OPRM1,COc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL2103744,MORPHINE SULFATE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.CN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5.O.O.O.O.O.O=S(=O)(O)O
4.0,,EFO_0003843,pain,CHEMBL2219416,NALOXEGOL OXALATE,OPRM1,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5.O=C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL2443262,OLICERIDINE,OPRM1,COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1
4.0,,EFO_0003843,pain,CHEMBL3137310,BENZHYDROCODONE HYDROCHLORIDE,OPRM1,COc1ccc2c3c1O[C@H]1C(OC(=O)c4ccccc4)=CC[C@@H]4[C@@H](C2)N(C)CC[C@@]341.Cl
4.0,,EFO_0003843,pain,CHEMBL3833389,DEXTROMORAMIDE,OPRM1,C[C@@H](CC(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1)N1CCOCC1
4.0,,EFO_0003843,pain,CHEMBL398707,HYDROMORPHONE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@H]3[C@H]1C5
4.0,,EFO_0003843,pain,CHEMBL3989677,HYDROCODONE BITARTRATE,OPRM1,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL4297091,CODEINE SULFATE,OPRM1,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341.O.O.O.O=S(=O)(O)O
4.0,Unknown status,EFO_0003843,pain,CHEMBL485,CODEINE,OPRM1,COc1ccc2c3c1O[C@H]1[C@@H](O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341
4.0,Completed,EFO_0003843,pain,CHEMBL511142,BUPRENORPHINE,OPRM1,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
4.0,,EFO_0003890,drug dependence,CHEMBL1201099,CODEINE PHOSPHATE,OPRM1,
4.0,,EFO_0003890,drug dependence,CHEMBL2368861,BUPRENORPHINE HYDROCHLORIDE,OPRM1,CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5.Cl
4.0,,EFO_0005611,opioid dependence,CHEMBL1201770,METHYLNALTREXONE BROMIDE,OPRM1,C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.[Br-]
4.0,,EFO_0005611,opioid dependence,CHEMBL1514,LEVOMETHADYL ACETATE,OPRM1,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1
4.0,,EFO_0003843,pain,CHEMBL1201776,TAPENTADOL,OPRM1,CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C
4.0,,EFO_0003843,pain,CHEMBL1201777,TAPENTADOL HYDROCHLORIDE,OPRM1,CC[C@@H](c1cccc(O)c1)[C@@H](C)CN(C)C.Cl
4.0,,EFO_0003843,pain,CHEMBL1213351,PROPOXYPHENE,OPRM1,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C
4.0,,EFO_0003843,pain,CHEMBL963,OXYMORPHONE,OPRM1,CN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
4.0,,EFO_0003843,pain,CHEMBL3039508,NALDEMEDINE TOSYLATE,OPRM1,CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_0003843,pain,CHEMBL314437,MEPTAZINOL,OPRM1,CCC1(c2cccc(O)c2)CCCCN(C)C1
4.0,,EFO_0003843,pain,CHEMBL33986,BUTORPHANOL,OPRM1,Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3
4.0,,EFO_0003843,pain,CHEMBL3989716,PROPOXYPHENE NAPSYLATE,OPRM1,CCC(=O)O[C@](Cc1ccccc1)(c1ccccc1)[C@H](C)CN(C)C.O.O=S(=O)(O)c1ccc2ccccc2c1
4.0,,EFO_0003843,pain,CHEMBL3989826,OXYCODONE TEREPHTHALATE,OPRM1,COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.O=C(O)c1ccc(C(=O)O)cc1
4.0,,EFO_0003890,drug dependence,CHEMBL299400,BUTORPHANOL TARTRATE,OPRM1,O=C(O)C(O)C(O)C(=O)O.Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3
4.0,,EFO_0005611,opioid dependence,CHEMBL5315056,NALOXONE HYDROCHLORIDE DIHYDRATE,OPRM1,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5.Cl.O.O
4.0,Terminated,HP_0002019,Constipation,CHEMBL2219418,NALOXEGOL,OPRM1,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2[C@@H](OCCOCCOCCOCCOCCOCCOCCOC)CC[C@@]3(O)[C@H]1C5
4.0,,HP_0002019,Constipation,CHEMBL270190,ALVIMOPAN,OPRM1,C[C@H]1CN(C[C@H](Cc2ccccc2)C(=O)NCC(=O)O)CC[C@@]1(C)c1cccc(O)c1
4.0,,HP_0002019,Constipation,CHEMBL80,NALOXONE,OPRM1,C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
4.0,Completed,HP_0002014,Diarrhea,CHEMBL1707,LOPERAMIDE HYDROCHLORIDE,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1.Cl
4.0,,EFO_0009963,bipolar I disorder,CHEMBL2105749,SAMIDORPHAN L-MALATE,OPRM1,NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3.O=C(O)C[C@H](O)C(=O)O
4.0,,HP_0002019,Constipation,CHEMBL2105755,NALDEMEDINE,OPRM1,CC(C)(NC(=O)C1=C(O)[C@@H]2Oc3c(O)ccc4c3[C@@]23CCN(CC2CC2)[C@H](C4)[C@]3(O)C1)c1nc(-c2ccccc2)no1
4.0,,HP_0012735,Cough,CHEMBL1457,HYDROCODONE,OPRM1,COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314
4.0,Completed,MONDO_0002046,alcohol abuse,CHEMBL19019,NALTREXONE,OPRM1,O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
4.0,,MONDO_0007079,alcohol dependence,CHEMBL5315055,NALMEFENE HYDROCHLORIDE DIHYDRATE,OPRM1,C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl.O.O
4.0,Terminated,MONDO_0007079,alcohol dependence,CHEMBL982,NALMEFENE,OPRM1,C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
3.0,Completed,EFO_0000546,injury,CHEMBL658,SUFENTANIL,OPRM1,CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1
3.0,Completed,EFO_0000616,neoplasm,CHEMBL1005,REMIFENTANIL,OPRM1,CCC(=O)N(c1ccccc1)C1(C(=O)OC)CCN(CCC(=O)OC)CC1
3.0,Withdrawn,EFO_0002618,pancreatic carcinoma,CHEMBL1186579,METHYLNALTREXONE,OPRM1,C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL841,LOPERAMIDE,OPRM1,CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1
3.0,Not yet recruiting,EFO_0003843,pain,CHEMBL2364605,CEBRANOPADOL,OPRM1,CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12
3.0,Completed,EFO_0005611,opioid dependence,CHEMBL459324,DIACETYLMORPHINE,OPRM1,CC(=O)Oc1ccc2c3c1O[C@H]1[C@@H](OC(C)=O)C=C[C@H]4[C@@H](C2)N(C)CC[C@@]341
3.0,Completed,EFO_0003843,pain,CHEMBL1201159,FENTANYL HYDROCHLORIDE,OPRM1,CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.Cl
3.0,Terminated,HP_0002019,Constipation,CHEMBL3039511,BEVENOPRAN,OPRM1,COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(C(N)=O)cn1
3.0,Completed,HP_0003419,Low back pain,CHEMBL4297632,OXYCODEGOL,OPRM1,COCCOCCOCCOCCOCCOCCO[C@H]1CCC2(O)[C@H]3Cc4ccc(OC)c5c4[C@@]2(CCN3C)[C@H]1O5
2.0,Completed,EFO_0000304,breast adenocarcinoma,CHEMBL1200665,DIPHENOXYLATE HYDROCHLORIDE,OPRM1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1.Cl
2.0,Completed,EFO_0000304,breast adenocarcinoma,CHEMBL1201294,DIPHENOXYLATE,OPRM1,CCOC(=O)C1(c2ccccc2)CCN(CCC(C#N)(c2ccccc2)c2ccccc2)CC1
2.0,Completed,EFO_0000555,irritable bowel syndrome,CHEMBL4594402,ORP-101,OPRM1,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(OCCOc5ccc6c7c5O[C@H]5[C@@]8(OC)CC[C@@]9(C[C@@H]8[C@](C)(O)C(C)(C)C)[C@@H](C6)N(CC6CC6)CC[C@]759)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5
2.0,Completed,EFO_0001073,obesity,CHEMBL4297383,GSK-1521498,OPRM1,Fc1cc(-c2cccc(-c3nc[nH]n3)c2)cc(F)c1CNC1Cc2ccccc2C1
2.0,Completed,EFO_0001073,obesity,CHEMBL3219616,CP-866087,OPRM1,CC[C@]1(c2cccc(NS(C)(=O)=O)c2)[C@@H]2CN(CC3(O)Cc4ccccc4C3)C[C@@H]21
2.0,Completed,EFO_0005687,fibromyalgia,CHEMBL2103829,FAXELADOL,OPRM1,CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1
2.0,Completed,EFO_0005203,eating disorder,CHEMBL426084,SAMIDORPHAN,OPRM1,NC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3
2.0,Completed,HP_0002019,Constipation,CHEMBL2364619,METHYLSAMIDORPHAN,OPRM1,C[N@+]1(CC2CC2)CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c13
2.0,Completed,HP_0002019,Constipation,CHEMBL3137313,AXELOPRAN,OPRM1,NC(=O)c1cccc([C@H]2C[C@H]3CC[C@@H](C2)N3CCN(CC2CCCCC2)C(=O)[C@@H](O)CO)c1
2.0,Completed,HP_0003419,Low back pain,CHEMBL3989680,AXOMADOL,OPRM1,COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1
2.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL2103878,ODELEPRAN,OPRM1,NC(=O)c1ccc(Oc2ccc(CNCCC3CCOCC3)cc2F)nc1
0.5,"Active, not recruiting",EFO_0003843,pain,CHEMBL592,LEVORPHANOL,OPRM1,CN1CC[C@]23CCCC[C@H]2[C@H]1Cc1ccc(O)cc13
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200914,TAMSULOSIN HYDROCHLORIDE,ADRA1A,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL24778,SILODOSIN,ADRA1A,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL611,TERAZOSIN,ADRA1A,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL836,TAMSULOSIN,ADRA1A,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201212,MIDODRINE,ADRA1A,COc1ccc(OC)c(C(O)CNC(=O)CN)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA1A,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201319,METARAMINOL,ADRA1A,C[C@H](N)[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA1A,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA1A,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA1A,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL524,METHOXAMINE,ADRA1A,COc1ccc(OC)c(C(O)C(C)N)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA1A,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200561,DOXAZOSIN MESYLATE,ADRA1A,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA1A,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA1A,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1723,ALFUZOSIN HYDROCHLORIDE,ADRA1A,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL3989562,TERAZOSIN HYDROCHLORIDE,ADRA1A,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL709,ALFUZOSIN,ADRA1A,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA1A,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA1A,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1215,PHENYLEPHRINE,ADRA1A,CNC[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA1A,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA1A,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA1A,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA1A,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL723,CARVEDILOL,ADRA1A,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,ADRA1A,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1201167,CARVEDILOL PHOSPHATE,ADRA1A,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA1A,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL2,PRAZOSIN,ADRA1A,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA1A,
4.0,Unknown status,EFO_0000537,hypertension,CHEMBL707,DOXAZOSIN,ADRA1A,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA1A,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0004190,open-angle glaucoma,CHEMBL1201044,DAPIPRAZOLE HYDROCHLORIDE,ADRA1A,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA1A,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA1A,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA1A,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA1A,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA1A,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA1A,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA1A,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,,EFO_0006834,septic shock,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,ADRA1A,CNC[C@H](O)c1cccc(O)c1.Cl
4.0,,EFO_0007214,common cold,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA1A,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0005407,psychosis,CHEMBL12713,SERTINDOLE,ADRA1A,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA1A,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0007214,common cold,CHEMBL2062264,PHENYLEPHRINE BITARTRATE,ADRA1A,CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,HP_0001742,Nasal congestion,CHEMBL61006,PHENYLPROPANOLAMINE,ADRA1A,CC(N)C(O)c1ccccc1
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA1A,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,MONDO_0005041,glaucoma,CHEMBL1201216,DAPIPRAZOLE,ADRA1A,Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA1A,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0002009,major depressive disorder,CHEMBL644,TRIMIPRAMINE,ADRA1A,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA1A,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA1A,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA1A,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Terminated,EFO_0006834,septic shock,CHEMBL1200461,MIDODRINE HYDROCHLORIDE,ADRA1A,COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL2107546,BUCINDOLOL HYDROCHLORIDE,ADRA1A,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL321582,BUCINDOLOL,ADRA1A,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N
2.0,,EFO_0000319,cardiovascular disease,CHEMBL1197051,ISOXSUPRINE,ADRA1A,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA1A,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
2.0,Completed,EFO_0009523,fecal incontinence,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,ADRA1A,COc1ccc(OC)c(C(O)C(C)N)c1.Cl
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2104986,TEDATIOXETINE,ADRA1A,Cc1ccc(Sc2ccccc2C2CCNCC2)cc1
1.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL559180,ISOXSUPRINE HYDROCHLORIDE,ADRA1A,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl
4.0,,EFO_0000274,atopic eczema,CHEMBL484785,CRISABOROLE,PDE4A,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
4.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL193240,ROFLUMILAST,PDE4A,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL628,PENTOXIFYLLINE,PDE4A,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
4.0,,EFO_0000540,immune system disease,CHEMBL514800,APREMILAST,PDE4A,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
4.0,,EFO_0000712,stroke,CHEMBL932,DIPYRIDAMOLE,PDE4A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
4.0,,EFO_0003830,prostatitis,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,PDE4A,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl
4.0,,EFO_0006505,chronic bronchitis,CHEMBL190,THEOPHYLLINE,PDE4A,Cn1c(=O)c2[nH]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1096,AMLEXANOX,PDE4A,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1
4.0,,HP_0006536,Airway obstruction,CHEMBL1752,DYPHYLLINE,PDE4A,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1200434,OXTRIPHYLLINE,PDE4A,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1370561,AMINOPHYLLINE,PDE4A,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN
3.0,"Active, not recruiting",EFO_0000274,atopic eczema,CHEMBL3989968,DIFAMILAST,PDE4A,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1
3.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4594287,ENSIFENTRINE,PDE4A,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL511115,CILOMILAST,PDE4A,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1
3.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3113974,TRANIMILAST,PDE4A,CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL332750,TETOMILAST,PDE4A,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC
3.0,Recruiting,HP_0002196,Myelopathy,CHEMBL19449,IBUDILAST,PDE4A,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
3.0,,EFO_0010282,gastrointestinal disease,CHEMBL551978,DROTAVERINE,PDE4A,CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL217899,TOFIMILAST,PDE4A,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL570015,GSK-256066,PDE4A,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL3989967,LOTAMILAST,PDE4A,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4297520,OGLEMILAST,PDE4A,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1
2.0,Terminated,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL485629,MK-0873,PDE4A,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297527,REVAMILAST,PDE4A,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
2.0,Completed,EFO_0001072,memory impairment,CHEMBL4297287,HT-0712,PDE4A,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1
2.0,Completed,EFO_0003834,cutaneous lupus erythematosus,CHEMBL4297460,DOVRAMILAST,PDE4A,CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC
2.0,,HP_0000020,Urinary incontinence,CHEMBL1493,FLAVOXATE,PDE4A,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O
2.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL63,ROLIPRAM,PDE4A,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1
4.0,Terminated,EFO_0003768,nicotine dependence,CHEMBL1076903,VARENICLINE,CHRNB2,c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
4.0,,EFO_0003768,nicotine dependence,CHEMBL3,NICOTINE,CHRNB2,CN1CCC[C@H]1c1cccnc1
3.0,Completed,EFO_0003768,nicotine dependence,CHEMBL187927,DIANICLINE,CHRNB2,c1cnc2c(c1)O[C@H]1CCN3CC[C@@]1(C2)C3
3.0,,EFO_0003768,nicotine dependence,CHEMBL497939,CYTISINICLINE,CHRNB2,O=c1cccc2n1C[C@@H]1CNC[C@H]2C1
3.0,Recruiting,EFO_0003768,nicotine dependence,CHEMBL5303393,VARENICLINE TARTRATE,CHRNB2,O=C(O)C(O)C(O)C(=O)O.c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
3.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1201536,NICOTINE POLACRILEX,CHRNB2,
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2103881,DEXMECAMYLAMINE,CHRNB2,CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL238465,SOFINICLINE,CHRNB2,Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl
2.0,Completed,EFO_0000555,irritable bowel syndrome,CHEMBL4594254,SIMPINICLINE,CHRNB2,C(=C/[C@H]1CCNC1)\c1cncnc1
2.0,Completed,EFO_0001072,memory impairment,CHEMBL188462,ISPRONICLINE,CHRNB2,CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1
2.0,Terminated,EFO_0003768,nicotine dependence,CHEMBL127071,POZANICLINE,CHRNB2,Cc1ncccc1OC[C@@H]1CCCN1
2.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL2179529,AZD1446,CHRNB2,O=C(c1ccc(Cl)o1)N1CC2CNCC2C1
2.0,Terminated,MONDO_0002009,major depressive disorder,CHEMBL3707250,CP-601927,CHRNB2,
1.0,Completed,EFO_0005230,anxiety,CHEMBL504652,TC-2216,CHRNB2,c1cncc(N2CCC3(CCCN3)C2)c1
4.0,,EFO_0000275,atrial fibrillation,CHEMBL198362,RIVAROXABAN,F10,O=C(NC[C@H]1CN(c2ccc(N3CCOCC3=O)cc2)C(=O)O1)c1ccc(Cl)s1
4.0,,EFO_0000275,atrial fibrillation,CHEMBL231779,APIXABAN,F10,COc1ccc(-n2nc(C(N)=O)c3c2C(=O)N(c2ccc(N4CCCCC4=O)cc2)CC3)cc1
4.0,,EFO_0000275,atrial fibrillation,CHEMBL2105682,EDOXABAN TOSYLATE,F10,CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_0004286,venous thromboembolism,CHEMBL512351,BETRIXABAN,F10,COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL1269025,EDOXABAN,F10,CN1CCc2nc(C(=O)N[C@@H]3C[C@@H](C(=O)N(C)C)CC[C@@H]3NC(=O)C(=O)Nc3ccc(Cl)cn3)sc2C1
4.0,,MONDO_0002247,factor X deficiency,CHEMBL4297951,COAGULATION FACTOR X HUMAN,F10,
4.0,,HP_0001976,Reduced antithrombin III activity,CHEMBL1201554,ANTITHROMBIN ALFA,F10,
4.0,"Active, not recruiting",MONDO_0010602,hemophilia A,CHEMBL3833393,EMICIZUMAB,F10,
3.0,Terminated,EFO_0000275,atrial fibrillation,CHEMBL4297768,IDRABIOTAPARINUX SODIUM,F10,
3.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL5314374,IDRAPARINUX SODIUM,F10,CO[C@H]1O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]2O[C@@H](C(=O)[O-])[C@@H](O[C@H]3O[C@H](COS(=O)(=O)[O-])[C@@H](O[C@@H]4O[C@H](C(=O)[O-])[C@@H](O[C@H]5O[C@H](COS(=O)(=O)[O-])[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)[O-])[C@H]3OS(=O)(=O)[O-])[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)[O-])[C@H]1OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
3.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL5314801,IDRAPARINUX,F10,CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O
3.0,Unknown status,EFO_0001422,cirrhosis of liver,CHEMBL3707365,BEMIPARIN,F10,
3.0,Completed,EFO_0004286,venous thromboembolism,CHEMBL1922235,DAREXABAN,F10,COc1ccc(C(=O)Nc2cccc(O)c2NC(=O)c2ccc(N3CCCN(C)CC3)cc2)cc1
3.0,Completed,EFO_0005672,acute coronary syndrome,CHEMBL46618,OTAMIXABAN,F10,COC(=O)[C@H](Cc1cccc(C(=N)N)c1)[C@@H](C)NC(=O)c1ccc(-c2cc[n+]([O-])cc2)cc1
2.0,Completed,EFO_0005672,acute coronary syndrome,CHEMBL1095032,LETAXABAN,F10,O=C([C@H](O)CS(=O)(=O)c1ccc2cc(Cl)ccc2c1)N1CCC(N2CCCNC2=O)CC1
4.0,,EFO_0000556,ischemia,CHEMBL1083385,CLOPIDOGREL BISULFATE,P2RY12,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1.O=S(=O)(O)O
4.0,,EFO_0000612,myocardial infarction,CHEMBL1097279,CANGRELOR TETRASODIUM,P2RY12,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])OP(=O)([O-])C(Cl)(Cl)P(=O)([O-])[O-])[C@@H](O)[C@H]1O.[Na+].[Na+].[Na+].[Na+]
4.0,,EFO_0000612,myocardial infarction,CHEMBL1201773,PRASUGREL HYDROCHLORIDE,P2RY12,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.Cl
4.0,Unknown status,EFO_0000612,myocardial infarction,CHEMBL398435,TICAGRELOR,P2RY12,CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(F)c(F)c2)c2nnn([C@@H]3C[C@H](OCCO)[C@@H](O)[C@H]3O)c2n1
4.0,,EFO_0000712,stroke,CHEMBL1717,TICLOPIDINE HYDROCHLORIDE,P2RY12,Cl.Clc1ccccc1CN1CCc2sccc2C1
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL1771,CLOPIDOGREL,P2RY12,COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL833,TICLOPIDINE,P2RY12,Clc1ccccc1CN1CCc2sccc2C1
3.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL1201772,PRASUGREL,P2RY12,CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2
3.0,Recruiting,EFO_0000556,ischemia,CHEMBL334966,CANGRELOR,P2RY12,CSCCNc1nc(SCCC(F)(F)F)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)C(Cl)(Cl)P(=O)(O)O)[C@@H](O)[C@H]1O
3.0,Enrolling by invitation,EFO_0008583,acute myocardial infarction,CHEMBL4297589,SELATOGREL,P2RY12,CCCCOC(=O)N1CCN(C(=O)[C@H](CP(=O)(O)O)NC(=O)c2cc(N3CC[C@H](OC)C3)nc(-c3ccccc3)n2)CC1
2.0,Terminated,EFO_0000612,myocardial infarction,CHEMBL2103828,ELINOGREL,P2RY12,CNc1cc2[nH]c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cc3)c(=O)c2cc1F
2.0,Terminated,EFO_0001645,coronary artery disease,CHEMBL1162175,REGRELOR,P2RY12,CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21
2.0,Terminated,EFO_0001645,coronary artery disease,CHEMBL261244,REGRELOR DISODIUM,P2RY12,CCNC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)([O-])[O-])[C@H]2O[C@H](/C=C/c3ccccc3)O[C@H]21.[Na+].[Na+]
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRA1,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,Completed,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA1,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA1,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRA1,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRA1,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA1,COC(F)(F)C(Cl)Cl
4.0,,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRA1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRA1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRA1,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRA1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,Completed,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRA1,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRA1,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRA1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRA1,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRA1,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRA1,CCCC(C)(COC(N)=O)COC(N)=O
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRA1,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRA1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRA1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRA1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRA1,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRA1,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA1,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRA1,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRA1,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA1,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA1,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRA1,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA1,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA1,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRA1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA1,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Terminated,EFO_0004698,insomnia,CHEMBL262075,INDIPLON,GABRA1,CC(=O)N(C)c1cccc(-c2ccnc3c(C(=O)c4cccs4)cnn23)c1
3.0,Completed,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA1,Oc1noc2c1CCNC2
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRA1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRA1,FC(F)OC(Cl)C(F)(F)F
2.0,Terminated,EFO_0004242,obsessive-compulsive disorder,CHEMBL407,FLUMAZENIL,GABRA1,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Terminated,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRA1,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRA1,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRA1,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA1,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA1,FC(F)OC(F)C(F)(F)F
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRA1,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA1,CC(C)c1cccc([C@H](C)C2CC2)c1O
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,KCNK10,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,KCNK10,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,KCNK10,FC(F)OC(F)C(F)(F)F
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,KCNK18,FCOC(C(F)(F)F)C(F)(F)F
3.0,Withdrawn,HP_0000023,Inguinal hernia,CHEMBL1256,ISOFLURANE,KCNK18,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,KCNK18,FC(F)OC(F)C(F)(F)F
4.0,,EFO_0000684,respiratory system disease,CHEMBL1754,DOXAPRAM,KCNK3,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O
4.0,,EFO_0003818,lung disease,CHEMBL3989519,DOXAPRAM HYDROCHLORIDE,KCNK3,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,KCNK3,FCOC(C(F)(F)F)C(F)(F)F
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,KCNK3,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,KCNK3,FC(F)OC(F)C(F)(F)F
4.0,,EFO_0000684,respiratory system disease,CHEMBL1754,DOXAPRAM,KCNK9,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O
4.0,,EFO_0003818,lung disease,CHEMBL3989519,DOXAPRAM HYDROCHLORIDE,KCNK9,CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O.Cl.O
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,KCNK9,FCOC(C(F)(F)F)C(F)(F)F
3.0,Withdrawn,HP_0000023,Inguinal hernia,CHEMBL1256,ISOFLURANE,KCNK9,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,KCNK9,FC(F)OC(F)C(F)(F)F
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,KCNK2,FCOC(C(F)(F)F)C(F)(F)F
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,KCNK2,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,KCNK2,FC(F)OC(F)C(F)(F)F
4.0,Unknown status,EFO_0000196,metastatic prostate cancer,CHEMBL1082407,ENZALUTAMIDE,AR,CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F
4.0,,EFO_0000313,carcinoma,CHEMBL806,FLUTAMIDE,AR,CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1
4.0,,EFO_0000313,carcinoma,CHEMBL409,BICALUTAMIDE,AR,CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
4.0,,EFO_0000616,neoplasm,CHEMBL2107067,TESTOSTERONE UNDECANOATE,AR,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000616,neoplasm,CHEMBL1200335,TESTOSTERONE ENANTHATE,AR,CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000616,neoplasm,CHEMBL1201101,TESTOSTERONE CYPIONATE,AR,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1
4.0,,EFO_0000616,neoplasm,CHEMBL1274,NILUTAMIDE,AR,CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O
4.0,,EFO_0000616,neoplasm,CHEMBL1445,FLUOXYMESTERONE,AR,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
4.0,,EFO_0000616,neoplasm,CHEMBL386630,TESTOSTERONE,AR,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O
4.0,,EFO_0000616,neoplasm,CHEMBL4297185,DAROLUTAMIDE,AR,CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1
4.0,,EFO_0000616,neoplasm,CHEMBL254328,ABIRATERONE,AR,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(c3cccnc3)=CC[C@@H]12
4.0,"Active, not recruiting",EFO_0000673,prostate adenocarcinoma,CHEMBL3183409,APALUTAMIDE,AR,CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F
4.0,,EFO_0001065,endometriosis,CHEMBL1479,DANAZOL,AR,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
4.0,"Active, not recruiting",EFO_0003894,acne,CHEMBL3590187,CLASCOTERONE,AR,CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C
4.0,,MONDO_0002146,hypogonadism,CHEMBL1395,METHYLTESTOSTERONE,AR,C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
3.0,Withdrawn,EFO_0000546,injury,CHEMBL1200436,OXANDROLONE,AR,C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
3.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL139835,CYPROTERONE ACETATE,AR,CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL4594417,PRUXELUTAMIDE,AR,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2F)C(=S)N1c1ccc(CCCc2ncco2)nc1
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1738889,ENOBOSARM,AR,C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1
3.0,"Active, not recruiting",MONDO_0008315,prostate cancer,CHEMBL4650276,SHR3680,AR,CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(OC[C@@H](O)CO)cc1
3.0,Terminated,MONDO_0008315,prostate cancer,CHEMBL2105738,GALETERONE,AR,C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(n3cnc4ccccc43)=CC[C@@H]12
2.0,Not yet recruiting,EFO_0000198,myelodysplastic syndrome,CHEMBL2079587,STANOZOLOL,AR,C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
2.0,Terminated,EFO_0000304,breast adenocarcinoma,CHEMBL3545092,CR 1447,AR,
2.0,Terminated,EFO_0000284,benign prostatic hyperplasia,CHEMBL3542265,LY2452473,AR,CC(C)OC(=O)N[C@H]1Cc2c(n(Cc3ccccn3)c3ccc(C#N)cc23)C1
2.0,Terminated,EFO_0000616,neoplasm,CHEMBL3264610,SEVITERONEL,AR,CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c1c[nH]nn1
2.0,Completed,EFO_0003964,hip fracture,CHEMBL1200946,NANDROLONE DECANOATE,AR,CCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C
2.0,Completed,EFO_0003964,hip fracture,CHEMBL5170587,VK5211,AR,N#Cc1ccc(N2CCC[C@@H]2[C@@H](O)C(F)(F)F)cc1C(F)(F)F
2.0,Completed,EFO_0003894,acne,CHEMBL128748,DIMETHYLCURCUMIN,AR,COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)c(OC)c2)cc1OC
2.0,Completed,EFO_1000653,sarcopenia,CHEMBL3545333,MK-0773,AR,
2.0,Completed,HP_0004326,Cachexia,CHEMBL3545174,GSK2881078,AR,
1.0,Completed,HP_0004326,Cachexia,CHEMBL3545046,GSK2849466,AR,
1.0,Suspended,EFO_1001271,Atrophic Vaginitis,CHEMBL1170,TESTOSTERONE PROPIONATE,AR,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3545237,HE3235,AR,C#C[C@]1(O)CCC2C3CCC4CC(O)CC[C@]4(C)C3CC[C@@]21C
1.0,Unknown status,MONDO_0008315,prostate cancer,CHEMBL37676,APC-100,AR,Cc1c(C)c2c(c(C)c1O)CCC(C)(C)O2
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL2346976,AZD3514,AR,CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1069,VALSARTAN,AGTR1,CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1200692,OLMESARTAN MEDOXOMIL,AGTR1,CCCc1nc(C(C)(C)O)c(C(=O)OCc2oc(=O)oc2C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1513,IRBESARTAN,AGTR1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL408403,ANGIOTENSIN II,AGTR1,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL813,EPROSARTAN,AGTR1,CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL191,LOSARTAN,AGTR1,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1014,CANDESARTAN CILEXETIL,AGTR1,CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1017,TELMISARTAN,AGTR1,CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
4.0,Completed,EFO_0000537,hypertension,CHEMBL995,LOSARTAN POTASSIUM,AGTR1,CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+]
4.0,,EFO_0000537,hypertension,CHEMBL1200987,EPROSARTAN MESYLATE,AGTR1,CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1.CS(=O)(=O)O
4.0,,EFO_0000537,hypertension,CHEMBL2103795,AZILSARTAN KAMEDOXOMIL,AGTR1,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[n-]2)cc1.[K+]
4.0,,EFO_0004194,IGA glomerulonephritis,CHEMBL539423,SPARSENTAN,AGTR1,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1
4.0,,EFO_0005251,hypotension,CHEMBL3989932,ANGIOTENSIN II ACETATE,AGTR1,CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O
3.0,Unknown status,EFO_0000266,aortic stenosis,CHEMBL1016,CANDESARTAN,AGTR1,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
3.0,,EFO_0000319,cardiovascular disease,CHEMBL2028661,AZILSARTAN MEDOXOMIL,AGTR1,CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1
3.0,,EFO_0000319,cardiovascular disease,CHEMBL1951143,FIMASARTAN,AGTR1,CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
3.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL1516,OLMESARTAN,AGTR1,CCCc1nc(C(C)(C)O)c(C(=O)O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
3.0,Completed,EFO_0000537,hypertension,CHEMBL57242,AZILSARTAN,AGTR1,CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1
2.0,,EFO_0000319,cardiovascular disease,CHEMBL432162,TASOSARTAN,AGTR1,Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nnn[nH]3)cc1)C(=O)CC2
2.0,Completed,EFO_0003144,heart failure,CHEMBL4297447,TRV-120027,AGTR1,CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC)C(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1690,HYDROXYCHLOROQUINE SULFATE,TLR7,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=S(=O)(O)O
4.0,,EFO_0001068,malaria,CHEMBL1535,HYDROXYCHLOROQUINE,TLR7,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
4.0,,EFO_0000763,viral disease,CHEMBL1282,IMIQUIMOD,TLR7,CC(C)Cn1cnc2c(N)nc3ccccc3c21
2.0,"Active, not recruiting",EFO_0000180,HIV-1 infection,CHEMBL2424780,VESATOLIMOD,TLR7,CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC(=O)N2
2.0,Recruiting,EFO_0000398,dermatomyositis,CHEMBL4802159,ENPATORAN,TLR7,N#Cc1ccc(N2C[C@H](N)C[C@H](C(F)(F)F)C2)c2cccnc12
2.0,Completed,EFO_0000389,cutaneous melanoma,CHEMBL549344,CPG-52852,TLR7,CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(C)(=O)=O
2.0,Completed,EFO_0000398,dermatomyositis,CHEMBL4297995,BAZLITORAN,TLR7,
2.0,"Active, not recruiting",EFO_0000632,oligodendroglioma,CHEMBL383322,RESIQUIMOD,TLR7,CCOCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O
2.0,Completed,EFO_0010638,atopic asthma,CHEMBL4297492,GSK-2245035,TLR7,CCC[C@H](C)Oc1nc(N)c2[nH]c(=O)n(CCCCCN3CCCCC3)c2n1
2.0,Completed,EFO_0005854,allergic rhinitis,CHEMBL4297356,AZD-8848,TLR7,CCCCOc1nc(N)c2[nH]c(=O)n(CCCN(CCCN3CCOCC3)Cc3cccc(CC(=O)OC)c3)c2n1
1.0,"Active, not recruiting",EFO_0000180,HIV-1 infection,CHEMBL4297631,TELRATOLIMOD,TLR7,CCCCCCCCCCCCCCCCCC(=O)NCCCCOn1c(CCCC)nc2c(N)nc3ccccc3c21
4.0,,DOID_7551,gonorrhea,CHEMBL1200699,DOXYCYCLINE,MMP7,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
4.0,,EFO_0003894,acne,CHEMBL3989740,DOXYCYCLINE HYCLATE,MMP7,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O
3.0,Unknown status,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1433,DOXYCYCLINE ANHYDROUS,MMP7,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21
3.0,Completed,MONDO_0007254,breast cancer,CHEMBL279785,MARIMASTAT,MMP7,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
0.5,Terminated,EFO_0003102,osteomyelitis,CHEMBL2364574,DOXYCYCLINE CALCIUM,MMP7,C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]
4.0,,DOID_7551,gonorrhea,CHEMBL1200699,DOXYCYCLINE,MMP8,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
4.0,Completed,EFO_0003894,acne,CHEMBL3989740,DOXYCYCLINE HYCLATE,MMP8,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1433,DOXYCYCLINE ANHYDROUS,MMP8,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21
2.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL76222,REBIMASTAT,MMP8,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C
2.0,Terminated,EFO_0003047,hepatitis C virus infection,CHEMBL440498,CTS-1027,MMP8,O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1
0.5,Terminated,EFO_0003102,osteomyelitis,CHEMBL2364574,DOXYCYCLINE CALCIUM,MMP8,C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]
4.0,,DOID_7551,gonorrhea,CHEMBL1200699,DOXYCYCLINE,MMP13,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
4.0,Completed,EFO_0003894,acne,CHEMBL3989740,DOXYCYCLINE HYCLATE,MMP13,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1433,DOXYCYCLINE ANHYDROUS,MMP13,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21
2.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL76222,REBIMASTAT,MMP13,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL206815,APRATASTAT,MMP13,CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCO)cc2)[C@H]1C(=O)NO
2.0,Completed,EFO_0003047,hepatitis C virus infection,CHEMBL440498,CTS-1027,MMP13,O=C(NO)C1(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cc3)cc2)CCOCC1
0.5,Terminated,EFO_0003102,osteomyelitis,CHEMBL2364574,DOXYCYCLINE CALCIUM,MMP13,C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]
4.0,,DOID_7551,gonorrhea,CHEMBL1200699,DOXYCYCLINE,MMP1,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.O
4.0,,EFO_0003894,acne,CHEMBL3989740,DOXYCYCLINE HYCLATE,MMP1,CCO.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.Cl.Cl.O
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL1433,DOXYCYCLINE ANHYDROUS,MMP1,C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21
3.0,Completed,MONDO_0008903,lung cancer,CHEMBL279785,MARIMASTAT,MMP1,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C
2.0,Completed,EFO_0000673,prostate adenocarcinoma,CHEMBL76222,REBIMASTAT,MMP1,CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C
0.5,Terminated,EFO_0003102,osteomyelitis,CHEMBL2364574,DOXYCYCLINE CALCIUM,MMP1,C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.C[C@H]1c2cccc([O-])c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21.[Ca+2]
4.0,,EFO_0000540,immune system disease,CHEMBL1201570,ANAKINRA,IL1R1,
2.0,Withdrawn,EFO_0000400,diabetes mellitus,CHEMBL2109458,AMG-108,IL1R1,
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL2109607,MEDI-8968,IL1R1,
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1519,TRANDOLAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@H]2CCCC[C@@H]21
4.0,,EFO_0000319,cardiovascular disease,CHEMBL419213,LISINOPRIL,ACE,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL431,SPIRAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2
4.0,,EFO_0000319,cardiovascular disease,CHEMBL515606,CILAZAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCCN2CCC[C@@H](C(=O)O)N2C1=O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1165,MOEXIPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1168,RAMIPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1560,CAPTOPRIL,ACE,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1581,PERINDOPRIL,ACE,CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1592,QUINAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL3039598,FOSINOPRIL,ACE,CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL317094,IMIDAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1C(=O)N(C)C[C@H]1C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL578,ENALAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL838,BENAZEPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O
4.0,,EFO_0000373,congestive heart failure,CHEMBL1200659,ENALAPRIL MALEATE,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O.O=C(O)/C=C\C(=O)O
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1694,BENAZEPRIL HYDROCHLORIDE,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1201011,QUINAPRIL HYDROCHLORIDE,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200343,PERINDOPRIL ERBUMINE,ACE,CC(C)(C)N.CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC
4.0,,EFO_0000537,hypertension,CHEMBL1200534,MOEXIPRIL HYDROCHLORIDE,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2cc(OC)c(OC)cc2C[C@H]1C(=O)O.Cl
4.0,,EFO_0000537,hypertension,CHEMBL3039596,FOSINOPRIL SODIUM,ACE,CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)[O-])C(C)C.[Na+]
4.0,,EFO_0000537,hypertension,CHEMBL3544986,PERINDOPRIL ARGININE,ACE,CCC[C@H](N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCCC[C@@H]21)C(=O)OCC.N=C(N)NCCC[C@H](N)C(=O)O
3.0,Withdrawn,EFO_0000319,cardiovascular disease,CHEMBL1237,LISINOPRIL ANHYDROUS,ACE,NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O
3.0,,EFO_0000319,cardiovascular disease,CHEMBL589583,DELAPRIL,ACE,CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N(CC(=O)O)C1Cc2ccccc2C1
3.0,Completed,EFO_0000407,dilated cardiomyopathy,CHEMBL3989406,ENALAPRILAT,ACE,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O
3.0,Completed,EFO_0000407,dilated cardiomyopathy,CHEMBL577,ENALAPRILAT ANHYDROUS,ACE,C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O
2.0,Completed,EFO_0000537,hypertension,CHEMBL3187812,ILEPATRIL,ACE,CC(=O)S[C@H](C(=O)N[C@H]1Cc2ccccc2[C@H]2CCC[C@@H](C(=O)O)N2C1=O)C(C)C
4.0,,EFO_0000540,immune system disease,CHEMBL2364653,ANIFROLUMAB,IFNAR1,
4.0,,EFO_0000558,Kaposi's sarcoma,CHEMBL1201558,INTERFERON ALFA-2B,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL1201557,INTERFERON ALFACON-1,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL1201561,PEGINTERFERON ALFA-2B,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL1201562,INTERFERON BETA-1A,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL1201560,PEGINTERFERON ALFA-2A,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL1201563,INTERFERON BETA-1B,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL2108508,INTERFERON ALFA-2A,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL2108677,PEGINTERFERON BETA-1A,IFNAR1,
4.0,,EFO_0000616,neoplasm,CHEMBL4297819,ROPEGINTERFERON ALFA-2B,IFNAR1,
3.0,,EFO_0000616,neoplasm,CHEMBL2107842,ALBINTERFERON ALFA-2B,IFNAR1,
2.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL2109047,INTERFERON ALFA-N3,IFNAR1,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL142703,VILDAGLIPTIN,DPP4,N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(CC(O)(C3)C1)C2
4.0,,EFO_0000400,diabetes mellitus,CHEMBL237500,LINAGLIPTIN,DPP4,CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C
4.0,,EFO_0000612,myocardial infarction,CHEMBL1201174,SITAGLIPTIN PHOSPHATE,DPP4,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O.O=P(O)(O)O
4.0,,MONDO_0005148,type 2 diabetes mellitus,CHEMBL1201743,SAXAGLIPTIN HYDROCHLORIDE,DPP4,Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2
4.0,,MONDO_0005148,type 2 diabetes mellitus,CHEMBL227529,ALOGLIPTIN BENZOATE,DPP4,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O.O=C(O)c1ccccc1
4.0,,MONDO_0005148,type 2 diabetes mellitus,CHEMBL5315049,SITAGLIPTIN FUMARATE,DPP4,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F.O=C(O)/C=C\C(=O)O
3.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1422,SITAGLIPTIN,DPP4,N[C@@H](CC(=O)N1CCn2c(nnc2C(F)(F)F)C1)Cc1cc(F)c(F)cc1F
3.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1779710,EVOGLIPTIN,DPP4,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F
3.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL2105762,OMARIGLIPTIN,DPP4,CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2
3.0,,EFO_0000400,diabetes mellitus,CHEMBL385517,SAXAGLIPTIN ANHYDROUS,DPP4,N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2
3.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1650443,TRELAGLIPTIN,DPP4,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O
3.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL2105754,TRELAGLIPTIN SUCCINATE,DPP4,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O
3.0,,EFO_0000400,diabetes mellitus,CHEMBL3707235,GEMIGLIPTIN,DPP4,N[C@@H](CC(=O)N1CCc2c(nc(C(F)(F)F)nc2C(F)(F)F)C1)CN1CC(F)(F)CCC1=O
3.0,,EFO_0000400,diabetes mellitus,CHEMBL376359,ALOGLIPTIN,DPP4,Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2ccccc2C#N)c1=O
3.0,,EFO_0000540,immune system disease,CHEMBL3833357,BEGELOMAB,DPP4,
3.0,Not yet recruiting,EFO_0008585,ST Elevation Myocardial Infarction,CHEMBL4296719,DUTOGLIPTIN,DPP4,O=C(CN[C@@H]1CCNC1)N1CCC[C@H]1B(O)O
3.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL1082462,DBPR-108,DPP4,CC(C)(CC(=O)N1CCCC1)NCC(=O)N1C[C@@H](F)C[C@H]1C#N
3.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL1929396,ANAGLIPTIN,DPP4,Cc1cc2ncc(C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N)cn2n1
3.0,Recruiting,MONDO_0005148,type 2 diabetes mellitus,CHEMBL2147777,TENELIGLIPTIN,DPP4,Cc1cc(N2CCN([C@@H]3CN[C@H](C(=O)N4CCSC4)C3)CC2)n(-c2ccccc2)n1
3.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL515387,GOSOGLIPTIN,DPP4,O=C([C@@H]1C[C@H](N2CCN(c3ncccn3)CC2)CN1)N1CCC(F)(F)C1
2.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL591118,CARMEGLIPTIN,DPP4,COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2
2.0,Completed,MONDO_0005148,type 2 diabetes mellitus,CHEMBL4297624,BISEGLIPTIN,DPP4,CCOC(=O)C12CCC(NCC(=O)N3C[C@@H](F)C[C@H]3C#N)(CC1)CC2
4.0,,HP_0000132,Menorrhagia,CHEMBL877,TRANEXAMIC ACID,PLG,NC[C@H]1CC[C@H](C(=O)O)CC1
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL2108147,STREPTOKINASE,PLG,
4.0,,HP_0004419,Recurrent thrombophlebitis,CHEMBL2108250,ANISTREPLASE,PLG,
4.0,Unknown status,MP_0001914,hemorrhage,CHEMBL1046,AMINOCAPROIC ACID,PLG,NCCCCCC(=O)O
4.0,Completed,MP_0001914,hemorrhage,CHEMBL1201619,APROTININ,PLG,
4.0,,MONDO_0019514,hepatic veno-occlusive disease,CHEMBL3707226,DEFIBROTIDE SODIUM,PLG,
3.0,Completed,EFO_0000712,stroke,CHEMBL2109084,DESMOTEPLASE,PLG,
4.0,,EFO_0003843,pain,CHEMBL112,ACETAMINOPHEN,FAAH,CC(=O)Nc1ccc(O)cc1
2.0,Terminated,EFO_0001358,post-traumatic stress disorder,CHEMBL1651534,REDAFAMDASTAT,FAAH,O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1
2.0,Completed,EFO_0003756,autism spectrum disorder,CHEMBL4297294,JNJ-42165279,FAAH,O=C(Nc1cnccc1Cl)N1CCN(Cc2ccc3c(c2)OC(F)(F)O3)CC1
4.0,,EFO_0003843,pain,CHEMBL112,ACETAMINOPHEN,TRPV1,CC(=O)Nc1ccc(O)cc1
4.0,,EFO_0003843,pain,CHEMBL294199,CAPSAICIN,TRPV1,COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O
3.0,Completed,EFO_0000274,atopic eczema,CHEMBL3707398,PAC-14028,TRPV1,
3.0,Completed,EFO_0003843,pain,CHEMBL313971,ZUCAPSAICIN,TRPV1,COc1cc(CNC(=O)CCCC/C=C\C(C)C)ccc1O
3.0,Completed,EFO_1000906,dry eye syndrome,CHEMBL3707356,TIVANISIRAN,TRPV1,
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3707293,XEN-D0501,TRPV1,
2.0,Terminated,EFO_0000555,irritable bowel syndrome,CHEMBL207433,SB-705498,TRPV1,O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1
2.0,Completed,EFO_0003843,pain,CHEMBL3544953,SAF312,TRPV1,
2.0,Completed,EFO_0003843,pain,CHEMBL3545039,AZD1386,TRPV1,Cc1cc(Cl)cc2c1N(Cc1cccc(C(F)(F)F)c1)C(=O)C21NC(=O)NC1=O
2.0,Completed,EFO_0003843,pain,CHEMBL214796,NGD-8243,TRPV1,FC(F)(F)c1ccc(Nc2ncnc3cc(-c4ncccc4C(F)(F)F)ccc23)cc1
2.0,Completed,MONDO_0041052,postherpetic neuralgia,CHEMBL5314400,DWP05195,TRPV1,FC(F)(F)c1cccnc1-c1ccc(-c2nc3ccc(Br)cc3[nH]2)nc1
1.0,Completed,EFO_0004616,"osteoarthritis, knee",CHEMBL17976,RESINIFERATOXIN,TRPV1,C=C(C)[C@]12C[C@@H](C)[C@@]34O[C@](Cc5ccccc5)(O[C@@H]1[C@@H]3C=C(COC(=O)Cc1ccc(O)c(OC)c1)C[C@]1(O)C(=O)C(C)=C[C@@H]41)O2
1.0,Completed,EFO_0004616,"osteoarthritis, knee",CHEMBL2364618,MAVATREP,TRPV1,CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1
4.0,,EFO_0000540,immune system disease,CHEMBL1743034,IXEKIZUMAB,IL17A,
4.0,,EFO_0000540,immune system disease,CHEMBL1743068,SECUKINUMAB,IL17A,
4.0,,EFO_0000540,immune system disease,CHEMBL4297700,BIMEKIZUMAB,IL17A,
3.0,Not yet recruiting,EFO_0000676,psoriasis,CHEMBL4298102,VUNAKIZUMAB,IL17A,
3.0,Recruiting,EFO_1000710,hidradenitis suppurativa,CHEMBL4298023,M-1095,IL17A,
3.0,"Active, not recruiting",EFO_1000710,hidradenitis suppurativa,CHEMBL4297686,IZOKIBEP,IL17A,
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297863,REMTOLUMAB,IL17A,
2.0,Withdrawn,EFO_0000699,Sjogren syndrome,CHEMBL3990000,TIBULIZUMAB,IL17A,
2.0,Completed,EFO_0003894,acne,CHEMBL4297926,CJM-112,IL17A,
1.0,Completed,EFO_0003778,psoriatic arthritis,CHEMBL2109470,PERAKIZUMAB,IL17A,
3.0,Completed,EFO_0000182,hepatocellular carcinoma,CHEMBL3039547,PEXASTIMOGENE DEVACIREPVEC,CSF2,
3.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL2109433,OTILIMAB,CSF2,
3.0,"Active, not recruiting",EFO_0003106,pneumonia,CHEMBL3707325,LENZILUMAB,CSF2,
2.0,Terminated,EFO_0000685,rheumatoid arthritis,CHEMBL1743044,NAMILUMAB,CSF2,
2.0,Completed,MONDO_0100096,COVID-19,CHEMBL4650518,PLONMARLIMAB,CSF2,
2.0,Completed,MONDO_0100096,COVID-19,CHEMBL2109430,GIMSILUMAB,CSF2,
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN1,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN1,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN1,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN1,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN1,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN1,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN1,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN1,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
4.0,,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN1,NC12CC3CC(CC(C3)C1)C2
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN1,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN1,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN1,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL742,KETAMINE,GRIN1,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN1,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN1,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN1,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Terminated,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN1,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN1,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN1,Cc1ccccc1C(OCCN(C)C)c1ccccc1
2.0,Terminated,EFO_0000712,stroke,CHEMBL17350,TRAXOPRODIL,GRIN1,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN1,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL182066,RADIPRODIL,GRIN1,O=C(Nc1ccc2nc(O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL3707400,INDANTADOL,GRIN1,
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2068839,RISLENEMDAZ,GRIN1,Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN1,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL467084,LANICEMINE,GRIN1,N[C@@H](Cc1ccccn1)c1ccccc1
2.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL3545350,EVT-101,GRIN1,Cc1nccn1Cc1cc(-c2ccc(F)c(C(F)F)c2)cnn1
4.0,,EFO_0000540,immune system disease,CHEMBL1743070,SILTUXIMAB,IL6,
3.0,,EFO_0000540,immune system disease,CHEMBL1743071,SIRUKUMAB,IL6,
3.0,,EFO_0000540,immune system disease,CHEMBL1743050,OLOKIZUMAB,IL6,
2.0,Completed,EFO_0000384,Crohn's disease,CHEMBL2109613,PF-04236921,IL6,
2.0,Terminated,EFO_0000384,Crohn's disease,CHEMBL2108589,CLAZAKIZUMAB,IL6,
1.0,Terminated,EFO_0000685,rheumatoid arthritis,CHEMBL2109614,MEDI-5117,IL6,
1.0,Completed,EFO_0003884,chronic kidney disease,CHEMBL4297732,ZILTIVEKIMAB,IL6,
1.0,Completed,MONDO_0007915,systemic lupus erythematosus,CHEMBL2109615,MRA 003 US,IL6,
4.0,Completed,EFO_0000319,cardiovascular disease,CHEMBL1144,PRAVASTATIN,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1477,CERIVASTATIN,HMGCR,COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1487,ATORVASTATIN,HMGCR,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1496,ROSUVASTATIN,HMGCR,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL690,PRAVASTATIN SODIUM,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1064,SIMVASTATIN,HMGCR,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201753,PITAVASTATIN,HMGCR,O=C(O)C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2220442,FLUVASTATIN,HMGCR,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21
4.0,,EFO_0000319,cardiovascular disease,CHEMBL503,LOVASTATIN,HMGCR,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21
4.0,,EFO_0000373,congestive heart failure,CHEMBL393220,ATORVASTATIN CALCIUM,HMGCR,CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]
4.0,,EFO_0003914,atherosclerosis,CHEMBL1744447,ROSUVASTATIN CALCIUM,HMGCR,CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-].[Ca+2]
4.0,,EFO_0004911,familial hypercholesterolemia,CHEMBL2218894,FLUVASTATIN SODIUM,HMGCR,CC(C)n1c(/C=C/C(O)CC(O)CC(=O)[O-])c(-c2ccc(F)cc2)c2ccccc21.[Na+]
4.0,,EFO_0004911,familial hypercholesterolemia,CHEMBL1237061,PITAVASTATIN CALCIUM,HMGCR,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]
4.0,,HP_0003119,Abnormal circulating lipid concentration,CHEMBL3989923,PITAVASTATIN MAGNESIUM,HMGCR,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Mg+2]
4.0,,HP_0003119,Abnormal circulating lipid concentration,CHEMBL3989920,PITAVASTATIN SODIUM,HMGCR,O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Na+]
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,HRH2,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL902,FAMOTIDINE,HRH2,NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1
4.0,,EFO_0004607,duodenal ulcer,CHEMBL2110372,RANITIDINE HYDROCHLORIDE,HRH2,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.Cl
4.0,,EFO_0004607,duodenal ulcer,CHEMBL30,CIMETIDINE,HRH2,CN/C(=N\CCSCc1nc[nH]c1C)NC#N
4.0,,EFO_0004607,duodenal ulcer,CHEMBL3183075,NIZATIDINE,HRH2,CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1
4.0,,EFO_0003948,gastroesophageal reflux disease,CHEMBL1790041,RANITIDINE,HRH2,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1
4.0,,EFO_0003948,gastroesophageal reflux disease,CHEMBL2111286,RANITIDINE BISMUTH CITRATE,HRH2,CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Bi+3]
4.0,,EFO_0010282,gastrointestinal disease,CHEMBL1201264,METHANTHELINE,HRH2,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21
3.0,Completed,EFO_0003948,gastroesophageal reflux disease,CHEMBL1742461,LAFUTIDINE,HRH2,O=C(C[S+]([O-])Cc1ccco1)NC/C=C\COc1cc(CN2CCCCC2)ccn1
1.0,Completed,HP_0000011,Neurogenic bladder,CHEMBL1200988,METHANTHELINE BROMIDE,HRH2,CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc2ccccc21.[Br-]
4.0,,EFO_0000274,atopic eczema,CHEMBL3655081,ABROCITINIB,JAK1,CCCS(=O)(=O)N[C@H]1C[C@@H](N(C)c2ncnc3[nH]ccc23)C1
4.0,,EFO_0000540,immune system disease,CHEMBL3301607,FILGOTINIB,JAK1,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1
4.0,,EFO_0000540,immune system disease,CHEMBL2105759,BARICITINIB,JAK1,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1789941,RUXOLITINIB,JAK1,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103743,TOFACITINIB CITRATE,JAK1,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL4298167,FILGOTINIB MALEATE,JAK1,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,JAK1,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O
4.0,,EFO_0002429,polycythemia vera,CHEMBL1795071,RUXOLITINIB PHOSPHATE,JAK1,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O
3.0,Completed,EFO_0000274,atopic eczema,CHEMBL3622821,UPADACITINIB,JAK1,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12
3.0,Recruiting,EFO_0000398,dermatomyositis,CHEMBL4297477,BREPOCITINIB,JAK1,Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1
3.0,Recruiting,EFO_0000519,glioblastoma multiforme,CHEMBL221959,TOFACITINIB,JAK1,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12
3.0,,EFO_0000540,immune system disease,CHEMBL3137308,PEFICITINIB,JAK1,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2
3.0,,EFO_0000540,immune system disease,CHEMBL3622820,ITACITINIB,JAK1,N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1
3.0,Completed,EFO_0002430,primary myelofibrosis,CHEMBL1078178,MOMELOTINIB,JAK1,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1
3.0,Recruiting,HP_0000964,Eczematoid dermatitis,CHEMBL4297507,DELGOCITINIB,JAK1,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2
2.0,Recruiting,EFO_0000211,unspecified peripheral T-cell lymphoma,CHEMBL4577523,GOLIDOCITINIB,JAK1,COc1nn(C)cc1Nc1nccc(-c2c[nH]c3c(NC(=O)[C@@H](C)N4CCN(C)CC4)cccc23)n1
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL4594275,GUSACITINIB,JAK1,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1
2.0,Terminated,EFO_0000384,Crohn's disease,CHEMBL4650343,IZENCITINIB,JAK1,Cc1cc(Nc2cc3ncccc3c(N[C@@H]3C[C@H]4CC[C@@H](C3)N4CCC#N)n2)n[nH]1
2.0,Completed,EFO_0000676,psoriasis,CHEMBL3301606,SOLCITINIB,JAK1,CC1(C)CN(C(=O)c2ccc(-c3cccc4nc(NC(=O)C5CC5)nn34)cc2)C1
2.0,Terminated,EFO_0000685,rheumatoid arthritis,CHEMBL3545225,INCB-047986,JAK1,
2.0,Completed,EFO_0004208,Vitiligo,CHEMBL4116008,CERDULATINIB,JAK1,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1
1.0,Completed,EFO_0004610,acute lung injury,CHEMBL4802163,NEZULCITINIB,JAK1,CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1
4.0,,EFO_0000540,immune system disease,CHEMBL2105759,BARICITINIB,JAK2,CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1
4.0,,EFO_0000540,immune system disease,CHEMBL3301607,FILGOTINIB,JAK2,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1
4.0,,EFO_0000616,neoplasm,CHEMBL2035187,PACRITINIB,JAK2,C1=N/C2=N/c3ccc(OCCN4CCCC4)c(c3)COC/C=C/COCc3cccc(c3)C(=C1)N2
4.0,,EFO_0000616,neoplasm,CHEMBL1789941,RUXOLITINIB,JAK2,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1
4.0,,EFO_0000616,neoplasm,CHEMBL1287853,FEDRATINIB,JAK2,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103743,TOFACITINIB CITRATE,JAK2,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL4298167,FILGOTINIB MALEATE,JAK2,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,JAK2,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O
4.0,,EFO_0002430,primary myelofibrosis,CHEMBL5095049,PACRITINIB CITRATE,JAK2,C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0002429,polycythemia vera,CHEMBL1795071,RUXOLITINIB PHOSPHATE,JAK2,N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1.O=P(O)(O)O
4.0,,EFO_0002430,primary myelofibrosis,CHEMBL4297216,FEDRATINIB HYDROCHLORIDE,JAK2,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cl.Cl.O
3.0,"Active, not recruiting",EFO_0000220,acute lymphoblastic leukemia,CHEMBL603469,LESTAURTINIB,JAK2,C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O
3.0,Enrolling by invitation,EFO_0000274,atopic eczema,CHEMBL3622821,UPADACITINIB,JAK2,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12
3.0,,EFO_0000540,immune system disease,CHEMBL3137308,PEFICITINIB,JAK2,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2
3.0,Recruiting,EFO_0000519,glioblastoma multiforme,CHEMBL221959,TOFACITINIB,JAK2,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12
3.0,Completed,EFO_0002430,primary myelofibrosis,CHEMBL1078178,MOMELOTINIB,JAK2,N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1
3.0,Completed,HP_0000964,Eczematoid dermatitis,CHEMBL4297507,DELGOCITINIB,JAK2,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL4594275,GUSACITINIB,JAK2,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1
2.0,Terminated,EFO_0000384,Crohn's disease,CHEMBL4650343,IZENCITINIB,JAK2,Cc1cc(Nc2cc3ncccc3c(N[C@@H]3C[C@H]4CC[C@@H](C3)N4CCC#N)n2)n[nH]1
2.0,"Active, not recruiting",EFO_0000616,neoplasm,CHEMBL2107823,GANDOTINIB,JAK2,Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1
2.0,Completed,EFO_0001378,multiple myeloma,CHEMBL495727,AT-9283,JAK2,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL1944698,ZOTIRACICLIB,JAK2,CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1
1.0,Terminated,EFO_0000182,hepatocellular carcinoma,CHEMBL1231124,AZD-1480,JAK2,Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1
1.0,Terminated,EFO_0000479,essential thrombocythemia,CHEMBL3545328,XL-019,JAK2,O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1
1.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3545241,AC-430,JAK2,Cc1cc(Nc2nc(C(O)c3ccc(F)cc3)nc3ccccc23)n[nH]1
1.0,Completed,EFO_0002430,primary myelofibrosis,CHEMBL4303389,NS-018,JAK2,C[C@H](Nc1cc(-c2cnn(C)c2)cc(Nc2cnccn2)n1)c1ccc(F)cc1
1.0,Completed,EFO_0004610,acute lung injury,CHEMBL4802163,NEZULCITINIB,JAK2,CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1
1.0,Terminated,MONDO_0004992,cancer,CHEMBL3545215,BMS-911543,JAK2,CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB4B,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB4B,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000228,adenocarcinoma,CHEMBL3545252,DOCETAXEL,TUBB4B,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB4B,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB4B,
4.0,,EFO_0000305,breast carcinoma,CHEMBL428647,PACLITAXEL,TUBB4B,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB4B,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB4B,
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB4B,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB4B,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB4B,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB4B,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB4B,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB4B,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB4B,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB4B,
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB4B,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB4B,
3.0,Not yet recruiting,EFO_0000181,head and neck squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB4B,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB4B,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB4B,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB4B,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB4B,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB4B,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB4B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB4B,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Withdrawn,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB4B,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB4B,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB4B,
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB4B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB4B,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB4B,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB4B,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB4B,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB4B,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB4B,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB4B,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB4B,
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB4B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB4B,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB4B,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB4B,
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB4B,
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB4B,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB4B,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB4B,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB4B,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB4B,
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB4B,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB4B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB4B,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB4B,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB4B,
2.0,Terminated,MONDO_0008903,lung cancer,CHEMBL96172,EPOTHILONE D,TUBB4B,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB4B,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB4B,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB4B,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB4B,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB4B,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB4B,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB4B,
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB4B,
1.0,Completed,MONDO_0002108,thyroid cancer,CHEMBL2103852,CROLIBULIN,TUBB4B,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB4B,
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL779,TADALAFIL,PDE5A,CN1CC(=O)N2[C@H](c3ccc4c(c3)OCO4)c3[nH]c4ccccc4c3C[C@@H]2C1=O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL628,PENTOXIFYLLINE,PDE5A,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
4.0,,EFO_0000712,stroke,CHEMBL932,DIPYRIDAMOLE,PDE5A,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
4.0,,EFO_0001361,pulmonary arterial hypertension,CHEMBL1737,SILDENAFIL CITRATE,PDE5A,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0004234,erectile dysfunction,CHEMBL1339,VARDENAFIL HYDROCHLORIDE,PDE5A,CCCc1nc(C)c2c(O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)nn12.Cl
4.0,Completed,EFO_0004234,erectile dysfunction,CHEMBL1520,VARDENAFIL,PDE5A,CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12
4.0,Unknown status,EFO_0004234,erectile dysfunction,CHEMBL192,SILDENAFIL,PDE5A,CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12
4.0,,EFO_0004234,erectile dysfunction,CHEMBL1963681,AVANAFIL,PDE5A,COc1ccc(CNc2nc(N3CCC[C@H]3CO)ncc2C(=O)NCc2ncccn2)cc1Cl
3.0,Unknown status,EFO_0001361,pulmonary arterial hypertension,CHEMBL2103849,UDENAFIL,PDE5A,CCCOc1ccc(S(=O)(=O)NCCC2CCCN2C)cc1-c1nc2c(CCC)nn(C)c2c(=O)[nH]1
3.0,Recruiting,HP_0002196,Myelopathy,CHEMBL19449,IBUDILAST,PDE5A,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
2.0,Completed,EFO_0000284,benign prostatic hyperplasia,CHEMBL1928262,GISADENAFIL,PDE5A,CCOc1ncc(S(=O)(=O)N2CCN(CC)CC2)cc1-c1nc2c(CC)n(CCOC)nc2c(=O)[nH]1
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL4210847,PF-00489791,PDE5A,CCOCCn1nc(C(=O)NS(C)(=O)=O)c2nc(N(C)CC)nc(Nc3cc(C)ccn3)c21
2.0,Terminated,HP_0002140,Ischemic stroke,CHEMBL591501,PF-03049423,PDE5A,CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21
3.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3989992,PEGILODECAKIN,IL10RB,
3.0,Completed,EFO_0003047,hepatitis C virus infection,CHEMBL2108723,PEGINTERFERON LAMBDA-1A,IL10RB,
2.0,Terminated,MONDO_0100096,COVID-19,CHEMBL4594542,EFLEPEDOCOKIN ALFA,IL10RB,
4.0,,EFO_0000319,cardiovascular disease,CHEMBL6,INDOMETHACIN,PTGS1,COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL521,IBUPROFEN,PTGS1,CC(C)Cc1ccc(C(C)C(=O)O)cc1
4.0,,EFO_0000612,myocardial infarction,CHEMBL25,ASPIRIN,PTGS1,CC(=O)Oc1ccccc1C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200804,DICLOFENAC POTASSIUM,PTGS1,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[K+]
4.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL139,DICLOFENAC,PTGS1,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL154,NAPROXEN,PTGS1,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1562610,MECLOFENAMATE SODIUM,PTGS1,Cc1ccc(Cl)c(Nc2ccccc2C(=O)[O-])c1Cl.O.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL15770,SULINDAC,PTGS1,CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL421,SULFASALAZINE,PTGS1,O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL571,KETOPROFEN,PTGS1,CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1200760,BALSALAZIDE DISODIUM,PTGS1,O=C([O-])CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)[O-])c2)cc1.[Na+].[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1034,DICLOFENAC SODIUM,PTGS1,O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1071,OXAPROZIN,PTGS1,O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL704,MESALAMINE,PTGS1,Nc1ccc(O)c(C(=O)O)c1
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200613,TOLMETIN SODIUM,PTGS1,Cc1ccc(C(=O)c2ccc(CC(=O)[O-])n2C)cc1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL1200806,NAPROXEN SODIUM,PTGS1,COc1ccc2cc([C@H](C)C(=O)[O-])ccc2c1.[Na+]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103736,FENOPROFEN CALCIUM,PTGS1,CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.CC(C(=O)[O-])c1cccc(Oc2ccccc2)c1.O.O.[Ca+2]
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL527,PIROXICAM,PTGS1,CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL898,DIFLUNISAL,PTGS1,O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O
4.0,,EFO_0000729,ulcerative colitis,CHEMBL1201013,OLSALAZINE SODIUM,PTGS1,O=C([O-])c1cc(/N=N/c2ccc(O)c(C(=O)[O-])c2)ccc1O.[Na+].[Na+]
4.0,,EFO_0003843,pain,CHEMBL1021,NEPAFENAC,PTGS1,NC(=O)Cc1cccc(C(=O)c2ccccc2)c1N
4.0,,EFO_0003843,pain,CHEMBL112,ACETAMINOPHEN,PTGS1,CC(=O)Nc1ccc(O)cc1
4.0,Completed,EFO_0003843,pain,CHEMBL1201124,KETOROLAC TROMETHAMINE,PTGS1,NC(CO)(CO)CO.O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0003843,pain,CHEMBL277474,ANTIPYRINE,PTGS1,Cc1cc(=O)n(-c2ccccc2)n1C
4.0,,EFO_0003843,pain,CHEMBL3181947,BROMFENAC SODIUM,PTGS1,Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.O.O.O.[Na+].[Na+]
4.0,Completed,EFO_0003843,pain,CHEMBL3989803,DIPYRONE,PTGS1,Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.O.[Na+]
4.0,,EFO_0005752,eye inflammation,CHEMBL1077,BROMFENAC,PTGS1,Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1
4.0,,EFO_0005752,eye inflammation,CHEMBL469,KETOROLAC,PTGS1,O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O
4.0,,EFO_0005752,eye inflammation,CHEMBL563,FLURBIPROFEN,PTGS1,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1565476,APAZONE,PTGS1,CCCC1C(=O)N2C(N(C)C)=Nc3ccc(C)cc3N2C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL15870,INDOPROFEN,PTGS1,CC(C(=O)O)c1ccc(N2Cc3ccccc3C2=O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL75435,DEXKETOPROFEN,PTGS1,C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL94081,ALCLOFENAC,PTGS1,C=CCOc1ccc(CC(=O)O)cc1Cl
4.0,,EFO_0005755,rheumatic disease,CHEMBL956,SUPROFEN,PTGS1,CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1
4.0,,EFO_0005757,vaginal inflammation,CHEMBL12610,BENZYDAMINE,PTGS1,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12
4.0,,EFO_0003843,pain,CHEMBL1201180,DICLOFENAC EPOLAMINE,PTGS1,O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl.OCCN1CCCC1
4.0,,EFO_0003843,pain,CHEMBL146095,GLAFENINE,PTGS1,O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12
4.0,,EFO_0003843,pain,CHEMBL2108222,ALOXIPRIN,PTGS1,
4.0,,EFO_0005752,eye inflammation,CHEMBL3989676,OXYPHENBUTAZONE,PTGS1,CCCCC1C(=O)N(c2ccccc2)N(c2ccc(O)cc2)C1=O.O
4.0,,EFO_0005755,rheumatic disease,CHEMBL101,PHENYLBUTAZONE,PTGS1,CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL1020,TOLMETIN,PTGS1,Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1297,FENOPROFEN,PTGS1,CC(C(=O)O)c1cccc(Oc2ccccc2)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL1569487,LORNOXICAM,PTGS1,CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O
4.0,,EFO_0005755,rheumatic disease,CHEMBL175,DEXIBUPROFEN,PTGS1,CC(C)Cc1ccc([C@H](C)C(=O)O)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL188952,PIRPROFEN,PTGS1,CC(C(=O)O)c1ccc(N2CC=CC2)c(Cl)c1
4.0,,EFO_0005755,rheumatic disease,CHEMBL189171,ACEMETACIN,PTGS1,COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1
4.0,,EFO_0005755,rheumatic disease,CHEMBL509,MECLOFENAMIC ACID,PTGS1,Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl
4.0,,EFO_0005755,rheumatic disease,CHEMBL686,MEFENAMIC ACID,PTGS1,Cc1cccc(Nc2ccccc2C(=O)O)c1C
4.0,,HP_0001643,Patent ductus arteriosus,CHEMBL1201141,IBUPROFEN LYSINE,PTGS1,CC(C)Cc1ccc(C(C)C(=O)O)cc1.NCCCC[C@H](N)C(=O)O
4.0,,HP_0002018,Nausea,CHEMBL1120,BISMUTH SUBSALICYLATE,PTGS1,
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL1201346,BALSALAZIDE,PTGS1,O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1
3.0,Completed,EFO_0003843,pain,CHEMBL19299,LOXOPROFEN,PTGS1,CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1
3.0,Completed,EFO_0003843,pain,CHEMBL3989408,IBUPROFEN SODIUM,PTGS1,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.O.O.[Na+]
3.0,Unknown status,EFO_0003843,pain,CHEMBL461522,METAMIZOLE,PTGS1,Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C
3.0,,EFO_0005755,rheumatic disease,CHEMBL2103831,NAPROXCINOD,PTGS1,COc1ccc2cc([C@H](C)C(=O)OCCCCO[N+](=O)[O-])ccc2c1
3.0,Not yet recruiting,EFO_1001904,oral mucositis,CHEMBL1528134,BENZYDAMINE HYDROCHLORIDE,PTGS1,CN(C)CCCOc1nn(Cc2ccccc2)c2ccccc12.Cl
3.0,Completed,HP_0030839,Knee pain,CHEMBL435298,ESFLURBIPROFEN,PTGS1,C[C@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1
2.0,Completed,EFO_0003898,ankylosing spondylitis,CHEMBL425,OLSALAZINE,PTGS1,O=C(O)c1cc(/N=N/c2ccc(O)c(C(=O)O)c2)ccc1O
2.0,Completed,MONDO_0005178,osteoarthritis,CHEMBL2105683,NAPROXEN ETEMESIL,PTGS1,COc1ccc2cc([C@H](C)C(=O)OCCS(C)(=O)=O)ccc2c1
1.0,Completed,MP_0001845,inflammation,CHEMBL3989410,INDOMETHACIN SODIUM,PTGS1,COc1ccc2c(c1)c(CC(=O)[O-])c(C)n2C(=O)c1ccc(Cl)cc1.O.O.O.[Na+]
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1421,DASATINIB,BLK,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
2.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL52885,ENMD-981693,BLK,Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21
2.0,Terminated,EFO_0009606,macular degeneration,CHEMBL403989,TG100-801,BLK,Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12
2.0,Terminated,MONDO_0004992,cancer,CHEMBL1980297,ILORASERTIB,BLK,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12
1.0,Terminated,EFO_0000220,acute lymphoblastic leukemia,CHEMBL3545085,XL-228,BLK,CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL2095208,COBICISTAT,CYP3A5,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL163,RITONAVIR,CYP3A5,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,HRH1,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000274,atopic eczema,CHEMBL1200750,PROMETHAZINE HYDROCHLORIDE,HRH1,CC(CN1c2ccccc2Sc2ccccc21)N(C)C.Cl
4.0,,EFO_0000701,skin disease,CHEMBL1201190,LEVOCETIRIZINE DIHYDROCHLORIDE,HRH1,Cl.Cl.O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,EFO_0000701,skin disease,CHEMBL1200467,HYDROXYZINE PAMOATE,HRH1,O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,HRH1,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL1659,CHLORPHENIRAMINE MALEATE,HRH1,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200618,FEXOFENADINE HYDROCHLORIDE,HRH1,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200795,CLEMASTINE FUMARATE,HRH1,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200961,BROMPHENIRAMINE MALEATE,HRH1,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1201006,PYRILAMINE MALEATE,HRH1,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1716,CYPROHEPTADINE HYDROCHLORIDE,HRH1,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1719,OLOPATADINE HYDROCHLORIDE,HRH1,CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL3188034,TRIPROLIDINE HYDROCHLORIDE,HRH1,Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1.Cl.O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL998,LORATADINE,HRH1,CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1
4.0,,EFO_0003958,sunburn,CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE,HRH1,CN(C)CCOC(c1ccccc1)c1ccccc1.Cl
4.0,Terminated,EFO_0005531,urticaria,CHEMBL1172,DESLORATADINE,HRH1,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1
4.0,,EFO_0005531,urticaria,CHEMBL1607273,CETIRIZINE HYDROCHLORIDE,HRH1,Cl.Cl.O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,EFO_0005532,angioedema,CHEMBL1200927,DEXCHLORPHENIRAMINE MALEATE,HRH1,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0005751,eye allergy,CHEMBL1106,EPINASTINE,HRH1,NC1=NCC2c3ccccc3Cc3ccccc3N12
4.0,,EFO_0005751,eye allergy,CHEMBL1201747,ALCAFTADINE,HRH1,CN1CCC(=C2c3ccccc3CCn3c(C=O)cnc32)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL1742423,BILASTINE,HRH1,CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21
4.0,,EFO_0005751,eye allergy,CHEMBL534,KETOTIFEN,HRH1,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL639,AZELASTINE,HRH1,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
4.0,Completed,EFO_0005854,allergic rhinitis,CHEMBL1200809,AZELASTINE HYDROCHLORIDE,HRH1,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1201759,BEPOTASTINE BESYLATE,HRH1,O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200638,DEXBROMPHENIRAMINE MALEATE,HRH1,CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200974,CARBINOXAMINE MALEATE,HRH1,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0005230,anxiety,CHEMBL896,HYDROXYZINE,HRH1,OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL1000,CETIRIZINE,HRH1,O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL1189432,OLOPATADINE,HRH1,CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21
4.0,,EFO_0005751,eye allergy,CHEMBL1615438,LEVOCABASTINE,HRH1,C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1
4.0,,EFO_0005751,eye allergy,CHEMBL594,EMEDASTINE,HRH1,CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21
4.0,,EFO_0006928,motion sickness,CHEMBL3989555,MECLIZINE HYDROCHLORIDE,HRH1,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1.Cl.Cl.O
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL1200491,EPINASTINE HYDROCHLORIDE,HRH1,Cl.NC1=NCC2c3ccccc3Cc3ccccc3N12
4.0,,EFO_0007141,allergic conjunctivitis,CHEMBL2103739,EMEDASTINE DIFUMARATE,HRH1,CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O
4.0,,HP_0000989,Pruritus,CHEMBL1193,PHENIRAMINE,HRH1,CN(C)CCC(c1ccccc1)c1ccccn1
4.0,,HP_0000989,Pruritus,CHEMBL1241,TRIPELENNAMINE,HRH1,CN(C)CCN(Cc1ccccc1)c1ccccn1
4.0,,HP_0000989,Pruritus,CHEMBL2105458,THENALIDINE,HRH1,CN1CCC(N(Cc2cccs2)c2ccccc2)CC1
4.0,,HP_0000989,Pruritus,CHEMBL2110774,CHLORPHENOXAMINE,HRH1,CN(C)CCOC(C)(c1ccccc1)c1ccc(Cl)cc1
4.0,,HP_0000989,Pruritus,CHEMBL643,PROMETHAZINE,HRH1,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
4.0,,HP_0000989,Pruritus,CHEMBL657,DIPHENHYDRAMINE,HRH1,CN(C)CCOC(c1ccccc1)c1ccccc1
4.0,,HP_0002321,Vertigo,CHEMBL24441,BETAHISTINE,HRH1,CNCCc1ccccn1
4.0,Unknown status,MONDO_0002050,depressive disorder,CHEMBL644,TRIMIPRAMINE,HRH1,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
4.0,,HP_0000989,Pruritus,CHEMBL1626,CLEMASTINE,HRH1,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
4.0,,HP_0000989,Pruritus,CHEMBL511,PYRILAMINE,HRH1,COc1ccc(CN(CCN(C)C)c2ccccn2)cc1
4.0,,HP_0002321,Vertigo,CHEMBL43064,CINNARIZINE,HRH1,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL1200959,METHDILAZINE,HRH1,CN1CCC(CN2c3ccccc3Sc3ccccc32)C1
4.0,,MONDO_0005271,allergic disease,CHEMBL1201191,LEVOCETIRIZINE,HRH1,O=C(O)COCCN1CCN([C@H](c2ccccc2)c2ccc(Cl)cc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL1201245,BROMODIPHENHYDRAMINE,HRH1,CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL1201271,BUCLIZINE,HRH1,CC(C)(C)c1ccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL1201287,DEXBROMPHENIRAMINE,HRH1,CN(C)CC[C@@H](c1ccc(Br)cc1)c1ccccn1
4.0,,MONDO_0005271,allergic disease,CHEMBL1224,ACRIVASTINE,HRH1,Cc1ccc(/C(=C\CN2CCCC2)c2cccc(/C=C/C(=O)O)n2)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL13828,OXATOMIDE,HRH1,O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL1411979,METHAPYRILENE,HRH1,CN(C)CCN(Cc1cccs1)c1ccccn1
4.0,,MONDO_0005271,allergic disease,CHEMBL1492,DIPHENYLPYRALINE,HRH1,CN1CCC(OC(c2ccccc2)c2ccccc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL1623,MECLIZINE,HRH1,Cc1cccc(CN2CCN(C(c3ccccc3)c3ccc(Cl)cc3)CC2)c1
4.0,,MONDO_0005271,allergic disease,CHEMBL296419,ASTEMIZOLE,HRH1,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL505,CHLORPHENIRAMINE,HRH1,CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
4.0,,MONDO_0005271,allergic disease,CHEMBL648,CYCLIZINE,HRH1,CN1CCN(C(c2ccccc2)c2ccccc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL829,METHYLPROMAZINE,HRH1,CC(CN(C)C)CN1c2ccccc2Sc2ccccc21
4.0,,MONDO_0005271,allergic disease,CHEMBL855,TRIPROLIDINE,HRH1,Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL864,CARBINOXAMINE,HRH1,CN(C)CCOC(c1ccc(Cl)cc1)c1ccccn1
4.0,,MONDO_0005271,allergic disease,CHEMBL914,FEXOFENADINE,HRH1,CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1442422,DIBENZEPIN,HRH1,CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,HRH1,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
4.0,,MONDO_0005271,allergic disease,CHEMBL1200406,DIMENHYDRINATE,HRH1,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
4.0,,MONDO_0005271,allergic disease,CHEMBL17157,TERFENADINE,HRH1,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
4.0,,MONDO_0005271,allergic disease,CHEMBL278398,PHENINDAMINE,HRH1,CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12
4.0,,MONDO_0005271,allergic disease,CHEMBL516,CYPROHEPTADINE,HRH1,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL73451,MEQUITAZINE,HRH1,c1ccc2c(c1)Sc1ccccc1N2CC1CN2CCC1CC2
4.0,,MONDO_0005271,allergic disease,CHEMBL811,BROMPHENIRAMINE,HRH1,CN(C)CCC(c1ccc(Br)cc1)c1ccccn1
4.0,,MONDO_0005271,allergic disease,CHEMBL94454,MIZOLASTINE,HRH1,CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1
4.0,,MONDO_0005271,allergic disease,CHEMBL946,AZATADINE,HRH1,CN1CCC(=C2c3ccccc3CCc3cccnc32)CC1
3.0,Unknown status,EFO_0000389,cutaneous melanoma,CHEMBL90,HISTAMINE,HRH1,NCCc1c[nH]cn1
3.0,Recruiting,EFO_0000555,irritable bowel syndrome,CHEMBL305660,EBASTINE,HRH1,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
3.0,Recruiting,EFO_0000685,rheumatoid arthritis,CHEMBL91397,RUPATADINE,HRH1,Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1
3.0,Completed,EFO_0000684,respiratory system disease,CHEMBL1653,PHENIRAMINE MALEATE,HRH1,CN(C)CCC(c1ccccc1)c1ccccn1.O=C(O)/C=C\C(=O)O
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1305,ANTAZOLINE,HRH1,c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1
3.0,"Active, not recruiting",EFO_0003931,bone fracture,CHEMBL1633,KETOTIFEN FUMARATE,HRH1,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
3.0,Completed,EFO_0004698,insomnia,CHEMBL2107339,ESMIRTAZAPINE MALEATE,HRH1,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O
3.0,Unknown status,EFO_0003958,sunburn,CHEMBL1201353,DEXCHLORPHENIRAMINE,HRH1,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
3.0,Completed,EFO_0004698,insomnia,CHEMBL1366933,ESMIRTAZAPINE,HRH1,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1
3.0,Completed,EFO_1001417,"Rhinitis, Allergic, Perennial",CHEMBL1201758,BEPOTASTINE,HRH1,O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1
3.0,Completed,EFO_1001417,"Rhinitis, Allergic, Perennial",CHEMBL1237102,LEVOCABASTINE HYDROCHLORIDE,HRH1,C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1.Cl
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,HRH1,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Completed,HP_0002017,Nausea and vomiting,CHEMBL1004,DOXYLAMINE,HRH1,CN(C)CCOC(C)(c1ccccc1)c1ccccn1
3.0,Completed,HP_0002017,Nausea and vomiting,CHEMBL1200392,DOXYLAMINE SUCCINATE,HRH1,CN(C)CCOC(C)(c1ccccc1)c1ccccn1.O=C(O)CCC(=O)O
3.0,Completed,MONDO_0005277,migraine disorder,CHEMBL1201089,DIPHENHYDRAMINE CITRATE,HRH1,CN(C)CCOC(c1ccccc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
2.0,Completed,EFO_0004698,insomnia,CHEMBL5314393,LY2624803,HRH1,CC(C)(CN1CCN(C2=Nc3ccccc3Oc3ccccc32)CC1)C(=O)O
2.0,Completed,EFO_0003956,seasonal allergic rhinitis,CHEMBL1767164,GSK-1004723,HRH1,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
2.0,,HP_0000989,Pruritus,CHEMBL22108,DIMETHINDENE,HRH1,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
4.0,,EFO_0000274,atopic eczema,CHEMBL484785,CRISABOROLE,PDE4B,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL193240,ROFLUMILAST,PDE4B,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL628,PENTOXIFYLLINE,PDE4B,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
4.0,,EFO_0000540,immune system disease,CHEMBL514800,APREMILAST,PDE4B,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
4.0,,EFO_0000712,stroke,CHEMBL932,DIPYRIDAMOLE,PDE4B,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
4.0,,EFO_0003830,prostatitis,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,PDE4B,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl
4.0,,EFO_0006505,chronic bronchitis,CHEMBL190,THEOPHYLLINE,PDE4B,Cn1c(=O)c2[nH]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1200434,OXTRIPHYLLINE,PDE4B,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1096,AMLEXANOX,PDE4B,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1
4.0,,HP_0006536,Airway obstruction,CHEMBL1370561,AMINOPHYLLINE,PDE4B,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN
4.0,,HP_0006536,Airway obstruction,CHEMBL1752,DYPHYLLINE,PDE4B,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O
3.0,"Active, not recruiting",EFO_0000274,atopic eczema,CHEMBL3989968,DIFAMILAST,PDE4B,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1
3.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3113974,TRANIMILAST,PDE4B,CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL511115,CILOMILAST,PDE4B,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4594287,ENSIFENTRINE,PDE4B,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL332750,TETOMILAST,PDE4B,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC
3.0,Recruiting,HP_0002196,Myelopathy,CHEMBL19449,IBUDILAST,PDE4B,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
3.0,,EFO_0010282,gastrointestinal disease,CHEMBL551978,DROTAVERINE,PDE4B,CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL217899,TOFIMILAST,PDE4B,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL3989967,LOTAMILAST,PDE4B,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4297520,OGLEMILAST,PDE4B,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1
2.0,Terminated,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL485629,MK-0873,PDE4B,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL570015,GSK-256066,PDE4B,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297527,REVAMILAST,PDE4B,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
2.0,Completed,EFO_0001072,memory impairment,CHEMBL4297287,HT-0712,PDE4B,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1
2.0,Completed,EFO_0003834,cutaneous lupus erythematosus,CHEMBL4297460,DOVRAMILAST,PDE4B,CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC
2.0,,HP_0000020,Urinary incontinence,CHEMBL1493,FLAVOXATE,PDE4B,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O
2.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL63,ROLIPRAM,PDE4B,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1
4.0,"Active, not recruiting",EFO_0000274,atopic eczema,CHEMBL484785,CRISABOROLE,PDE4D,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
4.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL193240,ROFLUMILAST,PDE4D,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL628,PENTOXIFYLLINE,PDE4D,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
4.0,,EFO_0000540,immune system disease,CHEMBL514800,APREMILAST,PDE4D,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
4.0,,EFO_0000712,stroke,CHEMBL932,DIPYRIDAMOLE,PDE4D,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
4.0,,EFO_0003901,dysuria,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,PDE4D,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl
4.0,,EFO_0006505,chronic bronchitis,CHEMBL190,THEOPHYLLINE,PDE4D,Cn1c(=O)c2[nH]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1096,AMLEXANOX,PDE4D,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1
4.0,,MONDO_0004979,asthma,CHEMBL1370561,AMINOPHYLLINE,PDE4D,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN
4.0,,HP_0006536,Airway obstruction,CHEMBL1200434,OXTRIPHYLLINE,PDE4D,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1752,DYPHYLLINE,PDE4D,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O
3.0,Completed,EFO_0000274,atopic eczema,CHEMBL3989968,DIFAMILAST,PDE4D,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL511115,CILOMILAST,PDE4D,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1
3.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3113974,TRANIMILAST,PDE4D,CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4594287,ENSIFENTRINE,PDE4D,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL332750,TETOMILAST,PDE4D,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC
3.0,,EFO_0010282,gastrointestinal disease,CHEMBL551978,DROTAVERINE,PDE4D,CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
3.0,Recruiting,HP_0002196,Myelopathy,CHEMBL19449,IBUDILAST,PDE4D,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
3.0,Enrolling by invitation,MONDO_0010383,fragile X syndrome,CHEMBL4541964,ZATOLMILAST,PDE4D,O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL217899,TOFIMILAST,PDE4D,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4297520,OGLEMILAST,PDE4D,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL570015,GSK-256066,PDE4D,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL3989967,LOTAMILAST,PDE4D,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1
2.0,Terminated,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL485629,MK-0873,PDE4D,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297527,REVAMILAST,PDE4D,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
2.0,Completed,EFO_0001072,memory impairment,CHEMBL4297287,HT-0712,PDE4D,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1
2.0,Completed,EFO_0003834,cutaneous lupus erythematosus,CHEMBL4297460,DOVRAMILAST,PDE4D,CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC
2.0,,HP_0000103,Polyuria,CHEMBL1493,FLAVOXATE,PDE4D,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O
2.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL63,ROLIPRAM,PDE4D,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1421,DASATINIB,PDGFRB,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
4.0,,EFO_0000222,acute myeloid leukemia,CHEMBL608533,MIDOSTAURIN,PDGFRB,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL1642,IMATINIB MESYLATE,PDGFRB,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
4.0,,EFO_0000616,neoplasm,CHEMBL535,SUNITINIB,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
4.0,,EFO_0000616,neoplasm,CHEMBL1946170,REGORAFENIB,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
4.0,,EFO_0000616,neoplasm,CHEMBL1908391,MASITINIB,PDGFRB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL1200485,SORAFENIB TOSYLATE,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL1567,SUNITINIB MALATE,PDGFRB,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL2105756,TIVOZANIB HYDROCHLORIDE,PDGFRB,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O
4.0,,EFO_0000691,sarcoma,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,PDGFRB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl
4.0,,EFO_0000717,systemic scleroderma,CHEMBL3039504,NINTEDANIB ESYLATE,PDGFRB,CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1
4.0,,HP_0200042,Skin ulcer,CHEMBL1201556,BECAPLERMIN,PDGFRB,
3.0,Completed,EFO_0000182,hepatocellular carcinoma,CHEMBL1336,SORAFENIB,PDGFRB,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1
3.0,Terminated,EFO_0000182,hepatocellular carcinoma,CHEMBL274654,ORANTINIB,PDGFRB,Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O
3.0,Recruiting,EFO_0000182,hepatocellular carcinoma,CHEMBL4303201,CATEQUENTINIB,PDGFRB,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1
3.0,Terminated,EFO_0000182,hepatocellular carcinoma,CHEMBL223360,LINIFANIB,PDGFRB,Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1
3.0,Recruiting,EFO_0000209,T-cell acute lymphoblastic leukemia,CHEMBL941,IMATINIB,PDGFRB,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
3.0,Completed,EFO_0000222,acute myeloid leukemia,CHEMBL576982,QUIZARTINIB,PDGFRB,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
3.0,Recruiting,EFO_0000222,acute myeloid leukemia,CHEMBL2105728,CRENOLANIB,PDGFRB,CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1
3.0,"Active, not recruiting",EFO_0000349,clear cell renal carcinoma,CHEMBL477772,PAZOPANIB,PDGFRB,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
3.0,Completed,EFO_0000365,colorectal adenocarcinoma,CHEMBL1278146,FAMITINIB,PDGFRB,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O
3.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL491473,CEDIRANIB,PDGFRB,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1
3.0,,EFO_0000616,neoplasm,CHEMBL1289494,TIVOZANIB,PDGFRB,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
3.0,,EFO_0000616,neoplasm,CHEMBL502835,NINTEDANIB,PDGFRB,COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1
3.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL522892,DOVITINIB,PDGFRB,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1
3.0,Unknown status,EFO_0000681,renal cell carcinoma,CHEMBL3545427,CM-082,PDGFRB,
3.0,Not yet recruiting,EFO_0001361,pulmonary arterial hypertension,CHEMBL4650333,SERALUTINIB,PDGFRB,COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC
3.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL572881,MOTESANIB,PDGFRB,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21
3.0,Completed,EFO_0004288,colonic neoplasm,CHEMBL101253,VATALANIB,PDGFRB,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
2.0,Terminated,EFO_0000222,acute myeloid leukemia,CHEMBL5314391,XL-999,PDGFRB,CCN1CCC(Nc2ccc3c(c2)/C(=C(\c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1
2.0,Completed,EFO_0000349,clear cell renal carcinoma,CHEMBL124660,TANDUTINIB,PDGFRB,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1
2.0,Completed,EFO_0000616,neoplasm,CHEMBL1230609,FORETINIB,PDGFRB,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1
2.0,Terminated,EFO_0001365,age-related macular degeneration,CHEMBL3545401,X-82,PDGFRB,
2.0,Completed,EFO_0003869,breast neoplasm,CHEMBL1721885,SU-014813,PDGFRB,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1
2.0,Terminated,EFO_0001365,age-related macular degeneration,CHEMBL3545316,RINUCUMAB,PDGFRB,
2.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL52885,ENMD-981693,PDGFRB,Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21
2.0,Terminated,EFO_0009606,macular degeneration,CHEMBL403989,TG100-801,PDGFRB,Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12
2.0,Completed,MONDO_0001056,gastric cancer,CHEMBL2079588,TELATINIB,PDGFRB,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1
2.0,Terminated,MONDO_0004992,cancer,CHEMBL1980297,ILORASERTIB,PDGFRB,Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12
2.0,Completed,MONDO_0011719,gastrointestinal stromal tumor,CHEMBL3545402,XL-820,PDGFRB,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL1980391,RG-1530,PDGFRB,COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2
1.0,Completed,EFO_0000616,neoplasm,CHEMBL3545155,JI-101,PDGFRB,COc1ccc(Br)cc1NC(=O)Nc1cccc2c1ccn2Cc1ccnc(N)c1
1.0,Completed,EFO_0000616,neoplasm,CHEMBL2180604,TAK-593,PDGFRB,Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1421,DASATINIB,KIT,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
4.0,,EFO_0000222,acute myeloid leukemia,CHEMBL608533,MIDOSTAURIN,KIT,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL1642,IMATINIB MESYLATE,KIT,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
4.0,,EFO_0000616,neoplasm,CHEMBL3813873,PEXIDARTINIB,KIT,FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
4.0,Completed,EFO_0000616,neoplasm,CHEMBL535,SUNITINIB,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C
4.0,,EFO_0000616,neoplasm,CHEMBL4204794,AVAPRITINIB,KIT,Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1
4.0,,EFO_0000616,neoplasm,CHEMBL4216467,RIPRETINIB,KIT,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21
4.0,,EFO_0000616,neoplasm,CHEMBL1908391,MASITINIB,KIT,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1
4.0,,EFO_0000616,neoplasm,CHEMBL1946170,REGORAFENIB,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL1201733,PAZOPANIB HYDROCHLORIDE,KIT,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O.Cl
4.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL1567,SUNITINIB MALATE,KIT,CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C.O=C(O)C[C@H](O)C(=O)O
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL2105756,TIVOZANIB HYDROCHLORIDE,KIT,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O
4.0,,EFO_0000681,renal cell carcinoma,CHEMBL1200485,SORAFENIB TOSYLATE,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1.Cc1ccc(S(=O)(=O)O)cc1
4.0,,EFO_1000562,Tenosynovial Giant Cell Tumor,CHEMBL3989973,PEXIDARTINIB HYDROCHLORIDE,KIT,Cl.FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1
3.0,Not yet recruiting,EFO_0000182,hepatocellular carcinoma,CHEMBL1336,SORAFENIB,KIT,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1
3.0,Not yet recruiting,EFO_0000182,hepatocellular carcinoma,CHEMBL4303201,CATEQUENTINIB,KIT,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ccnc2cc1OCC1(N)CC1
3.0,"Active, not recruiting",EFO_0000220,acute lymphoblastic leukemia,CHEMBL941,IMATINIB,KIT,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
3.0,Withdrawn,EFO_0000222,acute myeloid leukemia,CHEMBL576982,QUIZARTINIB,KIT,CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1
3.0,"Active, not recruiting",EFO_0000349,clear cell renal carcinoma,CHEMBL477772,PAZOPANIB,KIT,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O
3.0,Completed,EFO_0000365,colorectal adenocarcinoma,CHEMBL1278146,FAMITINIB,KIT,CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O
3.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL491473,CEDIRANIB,KIT,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1
3.0,,EFO_0000616,neoplasm,CHEMBL1289494,TIVOZANIB,KIT,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
3.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL522892,DOVITINIB,KIT,CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1
3.0,Unknown status,EFO_0000681,renal cell carcinoma,CHEMBL3545427,CM-082,KIT,
3.0,Not yet recruiting,EFO_0001361,pulmonary arterial hypertension,CHEMBL4650333,SERALUTINIB,KIT,COc1ccc(-c2cncc(N[C@@H](C)c3cccc(NC(=O)c4cncc(C)c4)c3)n2)cc1OC
3.0,Completed,EFO_0004288,colonic neoplasm,CHEMBL101253,VATALANIB,KIT,Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
3.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL572881,MOTESANIB,KIT,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21
3.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL276711,SEMAXANIB,KIT,Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1
2.0,Completed,EFO_0000182,hepatocellular carcinoma,CHEMBL482968,ENMD-2076,KIT,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1
2.0,Terminated,EFO_0000222,acute myeloid leukemia,CHEMBL5314391,XL-999,KIT,CCN1CCC(Nc2ccc3c(c2)/C(=C(\c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1
2.0,Completed,EFO_0000349,clear cell renal carcinoma,CHEMBL124660,TANDUTINIB,KIT,COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1
2.0,Completed,EFO_0000616,neoplasm,CHEMBL1230609,FORETINIB,KIT,COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1
2.0,Completed,EFO_0000702,small cell lung carcinoma,CHEMBL2103851,AMUVATINIB,KIT,S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1
2.0,Completed,EFO_0003869,breast neoplasm,CHEMBL1721885,SU-014813,KIT,Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1
2.0,Unknown status,MONDO_0001056,gastric cancer,CHEMBL2079588,TELATINIB,KIT,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1
2.0,Completed,MONDO_0011719,gastrointestinal stromal tumor,CHEMBL3545402,XL-820,KIT,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL1614710,OSI-930,KIT,O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12
1.0,Recruiting,MONDO_0015974,severe combined immunodeficiency,CHEMBL2109325,AMG-191,KIT,
4.0,,EFO_0009963,bipolar I disorder,CHEMBL1200826,LITHIUM CARBONATE,GSK3B,O=C([O-])[O-].[Li+].[Li+]
4.0,,EFO_0009963,bipolar I disorder,CHEMBL2103738,LITHIUM CITRATE,GSK3B,O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
2.0,Completed,EFO_0000565,leukemia,CHEMBL362558,LY-2090314,GSK3B,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2
2.0,"Active, not recruiting",EFO_0000691,sarcoma,CHEMBL483465,ELRAGLUSIB,GSK3B,Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3
2.0,Completed,EFO_0003756,autism spectrum disorder,CHEMBL3545157,TIDEGLUSIB,GSK3B,O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1
4.0,,EFO_0000540,immune system disease,CHEMBL3301607,FILGOTINIB,TYK2,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1
4.0,Completed,EFO_0000676,psoriasis,CHEMBL4435170,DEUCRAVACITINIB,TYK2,[2H]C([2H])([2H])NC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL2103743,TOFACITINIB CITRATE,TYK2,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL5315119,UPADACITINIB HEMIHYDRATE,TYK2,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O
4.0,,EFO_0000685,rheumatoid arthritis,CHEMBL4298167,FILGOTINIB MALEATE,TYK2,O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1.O=C(O)/C=C\C(=O)O
3.0,"Active, not recruiting",EFO_0000274,atopic eczema,CHEMBL3622821,UPADACITINIB,TYK2,CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12
3.0,Recruiting,EFO_0000398,dermatomyositis,CHEMBL4297477,BREPOCITINIB,TYK2,Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1
3.0,,EFO_0000540,immune system disease,CHEMBL3137308,PEFICITINIB,TYK2,NC(=O)c1cnc2[nH]ccc2c1N[C@@H]1[C@@H]2CC3C[C@H]1C[C@@](O)(C3)C2
3.0,Recruiting,EFO_0000519,glioblastoma multiforme,CHEMBL221959,TOFACITINIB,TYK2,C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12
3.0,"Active, not recruiting",EFO_0000676,psoriasis,CHEMBL4596392,CRAVACITINIB,TYK2,CNC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC
3.0,Completed,HP_0000964,Eczematoid dermatitis,CHEMBL4297507,DELGOCITINIB,TYK2,C[C@H]1CN(C(=O)CC#N)[C@]12CCN(c1ncnc3[nH]ccc13)C2
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL4594275,GUSACITINIB,TYK2,N#CCC1CCN(c2nc(Nc3ccc(N4CCC(O)CC4)cc3)c3c(=O)[nH]ncc3n2)CC1
2.0,Terminated,EFO_0000384,Crohn's disease,CHEMBL4650343,IZENCITINIB,TYK2,Cc1cc(Nc2cc3ncccc3c(N[C@@H]3C[C@H]4CC[C@@H](C3)N4CCC#N)n2)n[nH]1
2.0,Completed,EFO_0000676,psoriasis,CHEMBL4459585,ROPSACITINIB,TYK2,Cn1cc(-c2cn3nccc3c(-c3cnn([C@]4(CC#N)C[C@@H](C#N)C4)c3)n2)cn1
2.0,Completed,EFO_0004208,Vitiligo,CHEMBL4116008,CERDULATINIB,TYK2,CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1
1.0,Completed,EFO_0004610,acute lung injury,CHEMBL4802163,NEZULCITINIB,TYK2,CCc1cc(O)ccc1-c1ccc2c(-c3nc4c([nH]3)C[C@@H](C(=O)N3CC(N(C)C)C3)N(C(C)C)C4)n[nH]c2c1
4.0,Unknown status,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1421,DASATINIB,ABL1,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL2105708,PONATINIB HYDROCHLORIDE,ABL1,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl
4.0,Completed,EFO_0000339,chronic myelogenous leukemia,CHEMBL1642,IMATINIB MESYLATE,ABL1,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,ABL1,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL2095206,BOSUTINIB MONOHYDRATE,ABL1,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl.O
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL4297220,ASCIMINIB HYDROCHLORIDE,ABL1,Cl.O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
4.0,,EFO_0000616,neoplasm,CHEMBL3948730,UMBRALISIB,ABL1,CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F
4.0,,EFO_0000616,neoplasm,CHEMBL4208229,ASCIMINIB,ABL1,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
4.0,,EFO_0000616,neoplasm,CHEMBL1946170,REGORAFENIB,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1
4.0,,EFO_1000630,marginal zone B-cell lymphoma,CHEMBL3989869,UMBRALISIB TOSYLATE,ABL1,CC(C)Oc1ccc(-c2nn([C@@H](C)c3oc4ccc(F)cc4c(=O)c3-c3cccc(F)c3)c3ncnc(N)c23)cc1F.Cc1ccc(S(=O)(=O)O)cc1
3.0,Recruiting,EFO_0000209,T-cell acute lymphoblastic leukemia,CHEMBL941,IMATINIB,ABL1,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
3.0,Recruiting,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1171837,PONATINIB,ABL1,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
3.0,Recruiting,EFO_0000220,acute lymphoblastic leukemia,CHEMBL2316582,OLVEREMBATINIB,ABL1,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1
3.0,Recruiting,EFO_0000220,acute lymphoblastic leukemia,CHEMBL3545413,FLUMATINIB,ABL1,Cc1ncc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1
3.0,Recruiting,EFO_0000222,acute myeloid leukemia,CHEMBL3678958,RUSERONTINIB,ABL1,CC(C)n1c(Nc2cccnc2)nc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21
3.0,"Active, not recruiting",EFO_0000339,chronic myelogenous leukemia,CHEMBL255863,NILOTINIB,ABL1,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
3.0,"Active, not recruiting",EFO_0000339,chronic myelogenous leukemia,CHEMBL288441,BOSUTINIB,ABL1,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
3.0,"Active, not recruiting",EFO_0000339,chronic myelogenous leukemia,CHEMBL4297524,RADOTINIB,ABL1,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1
2.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL206834,BAFETINIB,ABL1,Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1
2.0,Terminated,EFO_0000365,colorectal adenocarcinoma,CHEMBL217092,SARACATINIB,ABL1,CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1
2.0,Completed,EFO_0001378,multiple myeloma,CHEMBL495727,AT-9283,ABL1,O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1
2.0,Recruiting,HP_0000726,Dementia,CHEMBL4130229,VODOBATINIB,ABL1,Cc1ccc(C(=O)NNC(=O)c2c(C)cccc2Cl)cc1C#Cc1cnc2ccccc2c1
1.0,Terminated,EFO_0000220,acute lymphoblastic leukemia,CHEMBL3545085,XL-228,ABL1,CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1
1.0,Terminated,EFO_0000222,acute myeloid leukemia,CHEMBL1908397,KW-2449,ABL1,O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1
1.0,Terminated,EFO_0000304,breast adenocarcinoma,CHEMBL1738757,REBASTINIB,ABL1,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314408,AZD-0424,ABL1,CC(=O)N1CCN(CCOc2cc(OC(C)C)c3c(Nc4c(Cl)cnc5c4OCO5)ncnc3c2)CC1
4.0,,EFO_0009963,bipolar I disorder,CHEMBL1200826,LITHIUM CARBONATE,GSK3A,O=C([O-])[O-].[Li+].[Li+]
4.0,,EFO_0009963,bipolar I disorder,CHEMBL2103738,LITHIUM CITRATE,GSK3A,O.O.O.O.O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]
2.0,Completed,EFO_0000565,leukemia,CHEMBL362558,LY-2090314,GSK3A,O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2
4.0,Unknown status,EFO_0003956,seasonal allergic rhinitis,CHEMBL787,MONTELUKAST,CYSLTR1,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1
4.0,,EFO_0005854,allergic rhinitis,CHEMBL1200681,MONTELUKAST SODIUM,CYSLTR1,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)[O-])CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1.[Na+]
4.0,,HP_0006536,Airway obstruction,CHEMBL603,ZAFIRLUKAST,CYSLTR1,COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12
3.0,Completed,EFO_0003956,seasonal allergic rhinitis,CHEMBL21333,PRANLUKAST,CYSLTR1,O=C(Nc1cccc2c(=O)cc(-c3nnn[nH]3)oc12)c1ccc(OCCCCc2ccccc2)cc1
3.0,Terminated,EFO_0000401,diabetic nephropathy,CHEMBL1762621,BARDOXOLONE METHYL,IKBKB,COC(=O)[C@]12CCC(C)(C)C[C@H]1[C@H]1C(=O)C=C3[C@@]4(C)C=C(C#N)C(=O)C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)CC2
2.0,Unknown status,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3545168,IMD-1041,IKBKB,
2.0,Completed,EFO_0004616,"osteoarthritis, knee",CHEMBL3544945,SAR-113945,IKBKB,
4.0,,EFO_0000474,epilepsy,CHEMBL328560,SULTHIAME,CA6,NS(=O)(=O)c1ccc(N2CCCCS2(=O)=O)cc1
4.0,,EFO_0001073,obesity,CHEMBL1419,SIBUTRAMINE,SLC6A4,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1
4.0,,EFO_0001358,post-traumatic stress disorder,CHEMBL1200609,PAROXETINE MESYLATE,SLC6A4,CS(=O)(=O)O.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
4.0,,EFO_0001358,post-traumatic stress disorder,CHEMBL1708,PAROXETINE HYDROCHLORIDE,SLC6A4,Cl.Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
4.0,,EFO_0001073,obesity,CHEMBL781,MAZINDOL,SLC6A4,OC1(c2ccc(Cl)cc2)c2ccccc2C2=NCCN21
4.0,,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE,SLC6A4,CN[C@@H](C)Cc1ccccc1.Cl
4.0,,EFO_0001358,post-traumatic stress disorder,CHEMBL1709,SERTRALINE HYDROCHLORIDE,SLC6A4,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl
4.0,,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL1201201,METHAMPHETAMINE,SLC6A4,CN[C@@H](C)Cc1ccccc1
4.0,,EFO_0004242,obsessive-compulsive disorder,CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21.Cl
4.0,,EFO_0004242,obsessive-compulsive disorder,CHEMBL1201082,FLUOXETINE HYDROCHLORIDE,SLC6A4,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1.Cl
4.0,,EFO_0004242,obsessive-compulsive disorder,CHEMBL1409,FLUVOXAMINE MALEATE,SLC6A4,COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1.O=C(O)/C=C\C(=O)O
4.0,,EFO_0002970,muscular disease,CHEMBL1200328,DULOXETINE HYDROCHLORIDE,SLC6A4,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1.Cl
4.0,,EFO_0005687,fibromyalgia,CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE,SLC6A4,CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl
4.0,,EFO_0005687,fibromyalgia,CHEMBL4297064,MILNACIPRAN HYDROCHLORIDE,SLC6A4,CCN(CC)C(=O)C1(c2ccccc2)CC1CN.Cl
4.0,Terminated,EFO_0005407,psychosis,CHEMBL3306803,LUMATEPERONE,SLC6A4,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
4.0,,EFO_0004262,panic disorder,CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE,SLC6A4,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1.Cl
4.0,,EFO_0006788,anxiety disorder,CHEMBL1200322,ESCITALOPRAM OXALATE,SLC6A4,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21.O=C(O)C(=O)O
4.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL11,IMIPRAMINE,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccccc21
4.0,Completed,MONDO_0002050,depressive disorder,CHEMBL1118,DESVENLAFAXINE,SLC6A4,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1
4.0,Completed,MONDO_0002050,depressive disorder,CHEMBL1508,ESCITALOPRAM,SLC6A4,CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1113,AMOXAPINE,SLC6A4,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1200781,CITALOPRAM HYDROBROMIDE,SLC6A4,Br.CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1200798,TRAZODONE HYDROCHLORIDE,SLC6A4,Cl.O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE,SLC6A4,CNCCC=C1c2ccccc2CCc2ccccc21.Cl
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1201728,DESVENLAFAXINE SUCCINATE,SLC6A4,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1492500,DOTHIEPIN,SLC6A4,CN(C)CC/C=C1\c2ccccc2CSc2ccccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1615374,VILAZODONE HYDROCHLORIDE,SLC6A4,Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
4.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL445,NORTRIPTYLINE,SLC6A4,CNCCC=C1c2ccccc2CCc2ccccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL259209,MILNACIPRAN,SLC6A4,CCN(CC)C(=O)C1(c2ccccc2)CC1CN
4.0,,MONDO_0002009,major depressive disorder,CHEMBL273575,NOMIFENSINE,SLC6A4,CN1Cc2c(N)cccc2C(c2ccccc2)C1
4.0,Completed,MONDO_0002050,depressive disorder,CHEMBL490,PAROXETINE,SLC6A4,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
4.0,Completed,MONDO_0002050,depressive disorder,CHEMBL549,CITALOPRAM,SLC6A4,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL3989861,DESVENLAFAXINE FUMARATE,SLC6A4,CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O.O=C(O)/C=C/C(=O)O
4.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL621,TRAZODONE,SLC6A4,O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12
4.0,,MONDO_0002009,major depressive disorder,CHEMBL415,CLOMIPRAMINE,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL439849,VILAZODONE,SLC6A4,N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1
4.0,Unknown status,MONDO_0002050,depressive disorder,CHEMBL629,AMITRIPTYLINE,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc21
4.0,Completed,MONDO_0002050,depressive disorder,CHEMBL637,VENLAFAXINE,SLC6A4,COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1
4.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL809,SERTRALINE,SLC6A4,CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
4.0,Unknown status,MONDO_0002050,depressive disorder,CHEMBL814,FLUVOXAMINE,SLC6A4,COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
4.0,,MONDO_0002009,major depressive disorder,CHEMBL623,NEFAZODONE,SLC6A4,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2107387,VORTIOXETINE HYDROBROMIDE,SLC6A4,Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
4.0,,MONDO_0002009,major depressive disorder,CHEMBL668,PROTRIPTYLINE,SLC6A4,CNCCCC1c2ccccc2C=Cc2ccccc21
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1200492,NEFAZODONE HYDROCHLORIDE,SLC6A4,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
4.0,,MONDO_0002009,major depressive disorder,CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE,SLC6A4,CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl
4.0,,MONDO_0002009,major depressive disorder,CHEMBL99946,LEVOMILNACIPRAN,SLC6A4,CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN
4.0,,MONDO_0002050,depressive disorder,CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE,SLC6A4,CNCCCC1c2ccccc2C=Cc2ccccc21.Cl
4.0,,MONDO_0024290,enuresis,CHEMBL1692,IMIPRAMINE HYDROCHLORIDE,SLC6A4,CN(C)CCCN1c2ccccc2CCc2ccccc21.Cl
3.0,Recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL41,FLUOXETINE,SLC6A4,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
3.0,Completed,EFO_0001073,obesity,CHEMBL3989830,SIBUTRAMINE HYDROCHLORIDE,SLC6A4,CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O
3.0,Completed,EFO_0003843,pain,CHEMBL1175,DULOXETINE,SLC6A4,CNCC[C@H](Oc1cccc2ccccc12)c1cccs1
3.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL3301595,DASOTRALINE,SLC6A4,N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21
3.0,Completed,EFO_0004234,erectile dysfunction,CHEMBL2110900,DAPOXETINE,SLC6A4,CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1
3.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL3301621,CENTANAFADINE,SLC6A4,c1ccc2cc([C@]34CNC[C@H]3C4)ccc2c1
3.0,Completed,EFO_1001917,social anxiety disorder,CHEMBL4297919,PAROXETINE HYDROCHLORIDE HEMIHYDRATE,SLC6A4,
3.0,Completed,HP_0003419,Low back pain,CHEMBL511099,BICIFADINE,SLC6A4,Cc1ccc(C23CNCC2C3)cc1
3.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL2104993,VORTIOXETINE,SLC6A4,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
2.0,Completed,EFO_0001073,obesity,CHEMBL3989690,TESOFENSINE,SLC6A4,CCOC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C
2.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL4297385,NS-2359,SLC6A4,COC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C
2.0,Completed,EFO_0005687,fibromyalgia,CHEMBL2103829,FAXELADOL,SLC6A4,CN(C)C[C@@H]1CCCC[C@H]1c1cccc(O)c1
2.0,Completed,EFO_0009854,treatment resistant depression,CHEMBL2364614,LIAFENSINE,SLC6A4,CN1Cc2cc(-c3ccc(N)nn3)ccc2[C@H](c2ccc3ccccc3c2)C1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2104986,TEDATIOXETINE,SLC6A4,Cc1ccc(Sc2ccccc2C2CCNCC2)cc1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL592374,AMITIFADINE,SLC6A4,Clc1ccc([C@]23CNC[C@H]2C3)cc1Cl
2.0,Completed,MONDO_0002050,depressive disorder,CHEMBL1631540,GSK163090,SLC6A4,Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA2A,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA2A,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA2A,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL27810,CELIPROLOL,ADRA2A,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA2A,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA2A,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA2A,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA2A,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA2A,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA2A,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA2A,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA2A,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA2A,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA2A,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000537,hypertension,CHEMBL862,GUANFACINE,ADRA2A,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,ADRA2A,Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL134,CLONIDINE,ADRA2A,Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA2A,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1705,CLONIDINE HYDROCHLORIDE,ADRA2A,Cl.Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL2062257,BRIMONIDINE TARTRATE,ADRA2A,Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA2A,
4.0,,EFO_0000537,hypertension,CHEMBL459,METHYLDOPA,ADRA2A,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA2A,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA2A,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA2A,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA2A,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA2A,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA2A,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA2A,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA2A,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA2A,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL844,BRIMONIDINE,ADRA2A,Brc1c(NC2=NCCN2)ccc2nccnc12
4.0,,EFO_0003890,drug dependence,CHEMBL17860,LOFEXIDINE,ADRA2A,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
4.0,,EFO_0004698,insomnia,CHEMBL654,MIRTAZAPINE,ADRA2A,CN1CCN2c3ncccc3Cc3ccccc3C2C1
4.0,,EFO_0005800,substance withdrawal syndrome,CHEMBL1788132,LOFEXIDINE HYDROCHLORIDE,ADRA2A,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA2A,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,,HP_0001257,Spasticity,CHEMBL1200329,TIZANIDINE HYDROCHLORIDE,ADRA2A,Cl.Clc1ccc2nsnc2c1NC1=NCCN1
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA2A,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,MONDO_0005041,glaucoma,CHEMBL647,APRACLONIDINE,ADRA2A,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA2A,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA2A,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Recruiting,EFO_0000546,injury,CHEMBL778,DEXMEDETOMIDINE,ADRA2A,Cc1cccc([C@H](C)c2c[nH]cn2)c1C
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA2A,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA2A,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,ADRA2A,Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl
3.0,Completed,EFO_0004698,insomnia,CHEMBL2107339,ESMIRTAZAPINE MALEATE,ADRA2A,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O
3.0,Completed,EFO_0004698,insomnia,CHEMBL1366933,ESMIRTAZAPINE,ADRA2A,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1
3.0,Withdrawn,MONDO_0002009,major depressive disorder,CHEMBL10316,IDAZOXAN,ADRA2A,c1ccc2c(c1)OCC(C1=NCCN1)O2
3.0,Completed,HP_0003419,Low back pain,CHEMBL1079,TIZANIDINE,ADRA2A,Clc1ccc2nsnc2c1NC1=NCCN1
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA2A,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
2.0,Completed,MONDO_0005180,Parkinson disease,CHEMBL1255582,FIPAMEZOLE,ADRA2A,CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
1.0,Terminated,EFO_0003929,relapsing-remitting multiple sclerosis,CHEMBL420,GUANABENZ,ADRA2A,N=C(N)N/N=C/c1c(Cl)cccc1Cl
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA2B,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA2B,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL27810,CELIPROLOL,ADRA2B,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA2B,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA2B,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA2B,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA2B,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA2B,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA2B,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA2B,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA2B,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA2B,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA2B,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA2B,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000537,hypertension,CHEMBL862,GUANFACINE,ADRA2B,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA2B,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,ADRA2B,Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL134,CLONIDINE,ADRA2B,Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL1705,CLONIDINE HYDROCHLORIDE,ADRA2B,Cl.Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL2062257,BRIMONIDINE TARTRATE,ADRA2B,Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA2B,
4.0,,EFO_0000537,hypertension,CHEMBL459,METHYLDOPA,ADRA2B,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA2B,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA2B,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003890,drug dependence,CHEMBL17860,LOFEXIDINE,ADRA2B,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA2B,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA2B,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA2B,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0004698,insomnia,CHEMBL654,MIRTAZAPINE,ADRA2B,CN1CCN2c3ncccc3Cc3ccccc3C2C1
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA2B,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA2B,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA2B,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL844,BRIMONIDINE,ADRA2B,Brc1c(NC2=NCCN2)ccc2nccnc12
4.0,,EFO_0005800,substance withdrawal syndrome,CHEMBL1788132,LOFEXIDINE HYDROCHLORIDE,ADRA2B,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA2B,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA2B,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,,HP_0001257,Spasticity,CHEMBL1200329,TIZANIDINE HYDROCHLORIDE,ADRA2B,Cl.Clc1ccc2nsnc2c1NC1=NCCN1
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA2B,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA2B,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0005041,glaucoma,CHEMBL647,APRACLONIDINE,ADRA2B,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA2B,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Recruiting,EFO_0000546,injury,CHEMBL778,DEXMEDETOMIDINE,ADRA2B,Cc1cccc([C@H](C)c2c[nH]cn2)c1C
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA2B,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA2B,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Completed,EFO_0003843,pain,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,ADRA2B,Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl
3.0,Completed,EFO_0004698,insomnia,CHEMBL2107339,ESMIRTAZAPINE MALEATE,ADRA2B,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O
3.0,Completed,EFO_0004698,insomnia,CHEMBL1366933,ESMIRTAZAPINE,ADRA2B,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1
3.0,Completed,HP_0003419,Low back pain,CHEMBL1079,TIZANIDINE,ADRA2B,Clc1ccc2nsnc2c1NC1=NCCN1
3.0,Withdrawn,MONDO_0002009,major depressive disorder,CHEMBL10316,IDAZOXAN,ADRA2B,c1ccc2c(c1)OCC(C1=NCCN1)O2
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA2B,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
2.0,Completed,MONDO_0005180,Parkinson disease,CHEMBL1255582,FIPAMEZOLE,ADRA2B,CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
1.0,Terminated,EFO_0003929,relapsing-remitting multiple sclerosis,CHEMBL420,GUANABENZ,ADRA2B,N=C(N)N/N=C/c1c(Cl)cccc1Cl
3.0,Terminated,MONDO_0100096,COVID-19,CHEMBL4297886,ASUNERCEPT,FASLG,
4.0,Unknown status,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GLRA1,COC(F)(F)C(Cl)Cl
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GLRA1,FCOC(C(F)(F)F)C(F)(F)F
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GLRA1,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GLRA1,FC(F)OC(F)C(F)(F)F
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS23,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS23,
2.0,Terminated,MONDO_0016239,cystinosis,CHEMBL4297744,ELX-02,RPS23,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFC1,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFC1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFC1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFAF1,CN(C)C(=N)NC(=N)N
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFAF1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFAF1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRG1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRG1,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRG1,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRG1,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRG1,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRG1,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,Terminated,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRG1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRG1,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRG1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRG1,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRG1,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRG1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRG1,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRG1,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRG1,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRG1,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRG1,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRG1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRG1,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRG1,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRG1,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRG1,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRG1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRG1,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRG1,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRG1,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRG1,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRG1,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRG1,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRG1,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRG1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRG1,FCOC(C(F)(F)F)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRG1,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRG1,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
3.0,Withdrawn,HP_0000023,Inguinal hernia,CHEMBL1256,ISOFLURANE,GABRG1,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRG1,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRG1,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Terminated,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRG1,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRG1,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRG1,FC(F)OC(F)C(F)(F)F
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRG1,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRG1,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRG1,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB1,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200561,DOXAZOSIN MESYLATE,ADRA1D,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200914,TAMSULOSIN HYDROCHLORIDE,ADRA1D,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1723,ALFUZOSIN HYDROCHLORIDE,ADRA1D,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL611,TERAZOSIN,ADRA1D,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
4.0,Completed,EFO_0000284,benign prostatic hyperplasia,CHEMBL709,ALFUZOSIN,ADRA1D,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
4.0,Completed,EFO_0000284,benign prostatic hyperplasia,CHEMBL836,TAMSULOSIN,ADRA1D,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA1D,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA1D,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1215,PHENYLEPHRINE,ADRA1D,CNC[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA1D,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA1D,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA1D,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA1D,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL524,METHOXAMINE,ADRA1D,COc1ccc(OC)c(C(O)C(C)N)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA1D,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL3989562,TERAZOSIN HYDROCHLORIDE,ADRA1D,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201212,MIDODRINE,ADRA1D,COc1ccc(OC)c(C(O)CNC(=O)CN)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA1D,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201319,METARAMINOL,ADRA1D,C[C@H](N)[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA1D,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA1D,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA1D,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA1D,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL723,CARVEDILOL,ADRA1D,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA1D,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,ADRA1D,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA1D,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1201167,CARVEDILOL PHOSPHATE,ADRA1D,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O
4.0,,EFO_0000537,hypertension,CHEMBL2,PRAZOSIN,ADRA1D,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA1D,
4.0,,EFO_0000537,hypertension,CHEMBL707,DOXAZOSIN,ADRA1D,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA1D,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,ADRA1D,CNC[C@H](O)c1cccc(O)c1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA1D,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA1D,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA1D,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA1D,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA1D,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA1D,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0007214,common cold,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA1D,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0005407,psychosis,CHEMBL12713,SERTINDOLE,ADRA1D,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA1D,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA1D,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,,EFO_0007214,common cold,CHEMBL2062264,PHENYLEPHRINE BITARTRATE,ADRA1D,CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA1D,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,MONDO_0002009,major depressive disorder,CHEMBL644,TRIMIPRAMINE,ADRA1D,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA1D,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA1D,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Withdrawn,EFO_0000536,hyperplasia,CHEMBL142635,NAFTOPIDIL,ADRA1D,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA1D,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA1D,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Terminated,EFO_0006834,septic shock,CHEMBL1200461,MIDODRINE HYDROCHLORIDE,ADRA1D,COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl
2.0,,EFO_0000319,cardiovascular disease,CHEMBL1197051,ISOXSUPRINE,ADRA1D,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL2107546,BUCINDOLOL HYDROCHLORIDE,ADRA1D,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL321582,BUCINDOLOL,ADRA1D,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N
2.0,Completed,EFO_0009523,fecal incontinence,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,ADRA1D,COc1ccc(OC)c(C(O)C(C)N)c1.Cl
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA1D,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
1.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL559180,ISOXSUPRINE HYDROCHLORIDE,ADRA1D,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB9,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB9,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB9,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFV3,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFV3,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFV3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL4297762,GOLODIRSEN,DMD,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL4298062,VILTOLARSEN,DMD,
4.0,,MONDO_0020121,muscular dystrophy,CHEMBL2108278,ETEPLIRSEN,DMD,
4.0,,MONDO_0020121,muscular dystrophy,CHEMBL4297566,CASIMERSEN,DMD,
3.0,Terminated,MONDO_0020121,muscular dystrophy,CHEMBL2108735,DRISAPERSEN,DMD,
2.0,Terminated,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL4298192,SUVODIRSEN,DMD,
4.0,,EFO_0000540,immune system disease,CHEMBL4298211,PEGCETACOPLAN,C3,
2.0,Completed,EFO_0001365,age-related macular degeneration,CHEMBL4594457,AL-78898A,C3,
1.0,Completed,MONDO_0002508,gingivitis,CHEMBL4297260,AMY-101,C3,CC[C@H](C)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C(=O)N[C@H]1CSSC[C@@H](C(=O)N(C)[C@H](C(N)=O)[C@@H](C)CC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](C)NC(=O)CN(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cn(C)c3ccccc23)NC(=O)[C@H](C(C)C)NC1=O
4.0,,EFO_0000474,epilepsy,CHEMBL856,PRIMIDONE,GABRB3,CCC1(c2ccccc2)C(=O)NCNC1=O
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRB3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRB3,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL450,METHARBITAL,GABRB3,CCC1(CC)C(=O)NC(=O)N(C)C1=O
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRB3,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,Completed,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRB3,COC(F)(F)C(Cl)Cl
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRB3,CCCC(C)(COC(N)=O)COC(N)=O
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRB3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0004698,insomnia,CHEMBL448,PENTOBARBITAL,GABRB3,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRB3,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRB3,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0005277,migraine disorder,CHEMBL454,BUTALBITAL,GABRB3,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRB3,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRB3,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRB3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRB3,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRB3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,Terminated,EFO_0005230,anxiety,CHEMBL315795,CLOMETHIAZOLE,GABRB3,Cc1ncsc1CCCl
3.0,Terminated,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRB3,Oc1noc2c1CCNC2
3.0,Completed,EFO_0006834,septic shock,CHEMBL441,THIOPENTAL,GABRB3,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRB3,FC(F)OC(Cl)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRB3,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRB3,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRB3,FC(F)OC(F)C(F)(F)F
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL356388,ETAZOLATE,GABRB3,CCOC(=O)c1cnc2c(cnn2CC)c1NN=C(C)C
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRB3,CC(C)c1cccc([C@H](C)C2CC2)c1O
1.0,Completed,EFO_1001454,amnesia,CHEMBL738,THIOPENTAL SODIUM,GABRB3,CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
4.0,Recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND4,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND4,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND4,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS18,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS18,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS18,
4.0,,EFO_0003966,eye disease,CHEMBL2095222,OCRIPLASMIN,LAMB1,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB7,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB7,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB7,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB4A,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB4A,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB4A,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB4A,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB4A,
4.0,,EFO_0000305,breast carcinoma,CHEMBL3545252,DOCETAXEL,TUBB4A,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL428647,PACLITAXEL,TUBB4A,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB4A,
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB4A,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB4A,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB4A,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB4A,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB4A,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB4A,
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB4A,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB4A,
4.0,Recruiting,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB4A,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB4A,
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB4A,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,"Active, not recruiting",EFO_0000196,metastatic prostate cancer,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB4A,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB4A,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB4A,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB4A,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB4A,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB4A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB4A,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB4A,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB4A,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB4A,
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB4A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
3.0,Completed,MONDO_0002158,fallopian tube cancer,CHEMBL94657,PATUPILONE,TUBB4A,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB4A,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB4A,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB4A,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB4A,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB4A,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB4A,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB4A,
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB4A,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB4A,
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB4A,
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB4A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB4A,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB4A,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB4A,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB4A,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB4A,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB4A,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB4A,
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB4A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB4A,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL96172,EPOTHILONE D,TUBB4A,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB4A,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB4A,
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB4A,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB4A,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB4A,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB4A,
1.0,Withdrawn,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB4A,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB4A,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB4A,
1.0,Completed,MONDO_0002108,thyroid cancer,CHEMBL2103852,CROLIBULIN,TUBB4A,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB4A,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB4A,
2.0,Completed,EFO_0001378,multiple myeloma,CHEMBL2108621,MAPATUMUMAB,TNFRSF10A,
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL2107846,DULANERMIN,TNFRSF10A,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS4X,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS4X,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS4X,
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN3A,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN3A,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN3A,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,Completed,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN3A,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN3A,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN3A,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN3A,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,Completed,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN3A,NC12CC3CC(CC(C3)C1)C2
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN3A,CC(=O)NCCCS(=O)(=O)O
4.0,Not yet recruiting,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN3A,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN3A,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
3.0,Recruiting,EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN3A,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL742,KETAMINE,GRIN3A,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN3A,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN3A,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN3A,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN3A,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN3A,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN3A,Cc1ccccc1C(OCCN(C)C)c1ccccc1
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN3A,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,EFO_0003843,pain,CHEMBL3707400,INDANTADOL,GRIN3A,
2.0,Completed,MONDO_0002050,depressive disorder,CHEMBL467084,LANICEMINE,GRIN3A,N[C@@H](Cc1ccccn1)c1ccccc1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN3A,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS4,CN(C)C(=N)NC(=N)N
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS4,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS4,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL163,RITONAVIR,CYP3A7,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL2095208,COBICISTAT,CYP3A7,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS5,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS5,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS5,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA8,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA8,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA8,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
2.0,Terminated,EFO_0000574,lymphoma,CHEMBL574737,UCN-01,PDPK1,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O
1.0,Completed,EFO_0000574,lymphoma,CHEMBL1650595,AR-12,PDPK1,NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS6,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS6,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS6,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRG2,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,Unknown status,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRG2,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRG2,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRG2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRG2,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRG2,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,Unknown status,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRG2,COC(F)(F)C(Cl)Cl
4.0,,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRG2,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRG2,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRG2,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0004698,insomnia,CHEMBL1521,ZALEPLON,GABRG2,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRG2,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRG2,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,Completed,EFO_0004698,insomnia,CHEMBL3989820,ZOLPIDEM TARTRATE,GABRG2,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRG2,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRG2,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0006788,anxiety disorder,CHEMBL451,CHLORDIAZEPOXIDE,GABRG2,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRG2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRG2,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRG2,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRG2,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRG2,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRG2,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRG2,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRG2,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRG2,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRG2,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRG2,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRG2,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRG2,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRG2,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRG2,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRG2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRG2,FCOC(C(F)(F)F)C(F)(F)F
3.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL911,ZOLPIDEM,GABRG2,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRG2,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRG2,FC(F)OC(Cl)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRG2,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRG2,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRG2,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRG2,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRG2,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRG2,FC(F)OC(F)C(F)(F)F
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRG2,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRG2,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRG2,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS17,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS17,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS17,
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB6,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB6,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB6,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA10,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA10,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA10,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA5,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA5,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA5,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Unknown status,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFAB1,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFAB1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFAB1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRA2,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,Completed,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA2,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA2,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRA2,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRA2,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,Unknown status,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA2,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRA2,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRA2,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRA2,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,Completed,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRA2,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRA2,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRA2,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRA2,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,Completed,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRA2,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRA2,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRA2,CCCC(C)(COC(N)=O)COC(N)=O
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA2,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRA2,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRA2,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRA2,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRA2,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRA2,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRA2,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0005230,anxiety,CHEMBL277062,BROMAZEPAM,GABRA2,O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRA2,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRA2,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA2,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA2,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRA2,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA2,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA2,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRA2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA2,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Completed,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA2,Oc1noc2c1CCNC2
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRA2,FC(F)OC(Cl)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRA2,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRA2,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Completed,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRA2,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Completed,EFO_0005230,anxiety,CHEMBL1783282,AZD7325,GABRA2,CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRA2,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA2,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA2,FC(F)OC(F)C(F)(F)F
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRA2,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRA2,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA2,CC(C)c1cccc([C@H](C)C2CC2)c1O
1.0,Completed,EFO_0005230,anxiety,CHEMBL1783256,AZD6280,GABRA2,CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS16,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS16,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS16,
2.0,"Active, not recruiting",EFO_0000274,atopic eczema,CHEMBL4297218,ROVAZOLAC,NR1H2,CCOC(=O)Cn1nc(C(F)(F)F)cc1-c1ccc(-c2cccc(S(C)(=O)=O)c2)cc1
1.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL573677,ABEQUOLIXRON,NR1H2,C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1
1.0,Completed,EFO_0003914,atherosclerosis,CHEMBL3360975,BMS-779788,NR1H2,CC(C)(O)c1cn(-c2ccc(-c3cccc(S(C)(=O)=O)c3)cc2)c(C(C)(C)c2ccccc2Cl)n1
1.0,Terminated,HP_0003124,Hypercholesterolemia,CHEMBL3945199,BMS-852927,NR1H2,CC(C)(O)c1cn(-c2ccc(-c3cc(F)c(CO)c(S(C)(=O)=O)c3)cc2F)c(C(C)(C)c2c(Cl)cccc2Cl)n1
1.0,Unknown status,HP_0003124,Hypercholesterolemia,CHEMBL272621,HYODEOXYCHOLIC_ACID,NR1H2,C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA12,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA12,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA12,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS27,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS27,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS27,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS10,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS10,
2.0,Terminated,MONDO_0016239,cystinosis,CHEMBL4297744,ELX-02,RPS10,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS8,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS8,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS8,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA9,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA9,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA9,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRB1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRB1,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL450,METHARBITAL,GABRB1,CCC1(CC)C(=O)NC(=O)N(C)C1=O
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRB1,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL856,PRIMIDONE,GABRB1,CCC1(c2ccccc2)C(=O)NCNC1=O
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRB1,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0004698,insomnia,CHEMBL3989820,ZOLPIDEM TARTRATE,GABRB1,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0004698,insomnia,CHEMBL448,PENTOBARBITAL,GABRB1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
4.0,,EFO_0005230,anxiety,CHEMBL979,MEPROBAMATE,GABRB1,CCCC(C)(COC(N)=O)COC(N)=O
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRB1,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRB1,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0004698,insomnia,CHEMBL1521,ZALEPLON,GABRB1,CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL454,BUTALBITAL,GABRB1,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRB1,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRB1,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRB1,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRB1,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRB1,FCOC(C(F)(F)F)C(F)(F)F
3.0,Completed,EFO_0003918,obstructive sleep apnea,CHEMBL135400,ZOPICLONE,GABRB1,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL911,ZOLPIDEM,GABRB1,Cc1ccc(-c2nc3ccc(C)cn3c2CC(=O)N(C)C)cc1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRB1,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Completed,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRB1,Oc1noc2c1CCNC2
3.0,Completed,EFO_0006834,septic shock,CHEMBL441,THIOPENTAL,GABRB1,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
3.0,Terminated,EFO_0005230,anxiety,CHEMBL315795,CLOMETHIAZOLE,GABRB1,Cc1ncsc1CCCl
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRB1,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRB1,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRB1,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRB1,CC(C)c1cccc([C@H](C)C2CC2)c1O
1.0,Completed,EFO_1001454,amnesia,CHEMBL738,THIOPENTAL SODIUM,GABRB1,CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS4Y1,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS4Y1,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS4Y1,
4.0,,EFO_0000224,acute promyelocytic leukemia,CHEMBL38,TRETINOIN,RARA,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1
4.0,,EFO_0000558,Kaposi's sarcoma,CHEMBL705,ALITRETINOIN,RARA,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1
4.0,Completed,EFO_0000676,psoriasis,CHEMBL1657,TAZAROTENE,RARA,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1
4.0,,EFO_0000676,psoriasis,CHEMBL464,ETRETINATE,RARA,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C
4.0,,EFO_0000676,psoriasis,CHEMBL1131,ACITRETIN,RARA,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
4.0,Completed,EFO_0003894,acne,CHEMBL1265,ADAPALENE,RARA,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2
4.0,Not yet recruiting,EFO_0003894,acne,CHEMBL547,ISOTRETINOIN,RARA,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
3.0,Recruiting,EFO_0000198,myelodysplastic syndrome,CHEMBL25202,TAMIBAROTENE,RARA,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21
2.0,Withdrawn,EFO_0000224,acute promyelocytic leukemia,CHEMBL107430,NRX195183,RARA,CC1(C)CCC(C)(C)c2c1cc(C(=O)Nc1cc(F)c(C(=O)O)c(F)c1)c(O)c2Cl
4.0,,EFO_0000616,neoplasm,CHEMBL24828,VANDETANIB,EPHA7,COc1cc2/c(=N/c3ccc(Br)cc3F)nc[nH]c2cc1OCC1CCN(C)CC1
4.0,,EFO_0000540,immune system disease,CHEMBL1742996,BRODALUMAB,IL17RA,
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA6,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA6,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA6,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRA6,CCCC(C)(COC(N)=O)COC(N)=O
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA6,COC(F)(F)C(Cl)Cl
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA6,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA6,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA6,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA6,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA6,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA6,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA6,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRA6,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA6,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Completed,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA6,Oc1noc2c1CCNC2
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRA6,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA6,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA6,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA6,CC(C)c1cccc([C@H](C)C2CC2)c1O
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL2178570,AZD4818,CCR1,CC(=O)Nc1ccc(O)cc1OC[C@@](C)(O)CNC1CCN(Cc2ccc(Cl)cc2)CC1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL3334824,BMS-817399,CCR1,CC(C)[C@@H](NC(=O)NCC(C)(C)O)C(=O)N1CC[C@](O)(c2ccc(Cl)cc2)C(C)(C)C1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4444976,CCX354,CCR1,COc1cc(N2CCN(C(=O)Cn3nc(-c4ncc[nH]4)c4cccnc43)CC2)ccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRE,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRE,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRE,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRE,COC(F)(F)C(Cl)Cl
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRE,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRE,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRE,CC(=O)NCCCS(=O)(=O)O
4.0,Not yet recruiting,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRE,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRE,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRE,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRE,FCOC(C(F)(F)F)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRE,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRE,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRE,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRE,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRE,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS24,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS24,
2.0,Terminated,MONDO_0016239,cystinosis,CHEMBL4297744,ELX-02,RPS24,
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200914,TAMSULOSIN HYDROCHLORIDE,ADRA1B,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL836,TAMSULOSIN,ADRA1B,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA1B,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA1B,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1215,PHENYLEPHRINE,ADRA1B,CNC[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA1B,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA1B,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA1B,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA1B,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA1B,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1200561,DOXAZOSIN MESYLATE,ADRA1B,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL723,CARVEDILOL,ADRA1B,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA1B,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL1723,ALFUZOSIN HYDROCHLORIDE,ADRA1B,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL3989562,TERAZOSIN HYDROCHLORIDE,ADRA1B,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC.Cl.O.O
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL611,TERAZOSIN,ADRA1B,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
4.0,,EFO_0000284,benign prostatic hyperplasia,CHEMBL709,ALFUZOSIN,ADRA1B,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA1B,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201212,MIDODRINE,ADRA1B,COc1ccc(OC)c(C(O)CNC(=O)CN)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201319,METARAMINOL,ADRA1B,C[C@H](N)[C@H](O)c1cccc(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA1B,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA1B,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL524,METHOXAMINE,ADRA1B,COc1ccc(OC)c(C(O)C(C)N)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA1B,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA1B,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1558,PRAZOSIN HYDROCHLORIDE,ADRA1B,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA1B,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL2,PRAZOSIN,ADRA1B,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
4.0,,EFO_0000537,hypertension,CHEMBL1201167,CARVEDILOL PHOSPHATE,ADRA1B,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12.O=P(O)(O)O
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA1B,
4.0,Completed,EFO_0000537,hypertension,CHEMBL707,DOXAZOSIN,ADRA1B,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA1B,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA1B,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0005251,hypotension,CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE,ADRA1B,CNC[C@H](O)c1cccc(O)c1.Cl
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA1B,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0007214,common cold,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA1B,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0007214,common cold,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA1B,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0007214,common cold,CHEMBL2062264,PHENYLEPHRINE BITARTRATE,ADRA1B,CNC[C@H](O)c1cccc(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA1B,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA1B,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005407,psychosis,CHEMBL12713,SERTINDOLE,ADRA1B,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA1B,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA1B,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA1B,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,Unknown status,MONDO_0002050,depressive disorder,CHEMBL644,TRIMIPRAMINE,ADRA1B,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA1B,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA1B,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA1B,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA1B,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA1B,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Terminated,EFO_0006834,septic shock,CHEMBL1200461,MIDODRINE HYDROCHLORIDE,ADRA1B,COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL2107546,BUCINDOLOL HYDROCHLORIDE,ADRA1B,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N.Cl
2.0,Completed,EFO_0000275,atrial fibrillation,CHEMBL321582,BUCINDOLOL,ADRA1B,CC(C)(Cc1c[nH]c2ccccc12)NCC(O)COc1ccccc1C#N
2.0,,EFO_0000319,cardiovascular disease,CHEMBL1197051,ISOXSUPRINE,ADRA1B,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1
2.0,Completed,EFO_0009523,fecal incontinence,CHEMBL1201103,METHOXAMINE HYDROCHLORIDE,ADRA1B,COc1ccc(OC)c(C(O)C(C)N)c1.Cl
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA1B,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
1.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL559180,ISOXSUPRINE HYDROCHLORIDE,ADRA1B,CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1.Cl
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPSA,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPSA,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPSA,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS9,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS9,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS9,
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRQ,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRQ,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRQ,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRQ,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRQ,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRQ,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,Terminated,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRQ,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRQ,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRQ,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRQ,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRQ,FCOC(C(F)(F)F)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRQ,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRQ,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRQ,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRQ,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRQ,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA1,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000540,immune system disease,CHEMBL314854,FINGOLIMOD,S1PR4,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
4.0,,EFO_0000729,ulcerative colitis,CHEMBL3989933,ETRASIMOD ARGININE,S1PR4,N=C(N)NCCC[C@@H](N)C(=O)O.O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21
4.0,,MONDO_0005301,multiple sclerosis,CHEMBL544665,FINGOLIMOD HYDROCHLORIDE,S1PR4,CCCCCCCCc1ccc(CCC(N)(CO)CO)cc1.Cl
3.0,Recruiting,EFO_0000384,Crohn's disease,CHEMBL3358920,ETRASIMOD,S1PR4,O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21
2.0,Completed,EFO_0000384,Crohn's disease,CHEMBL3707374,AMISELIMOD HYDROCHLORIDE,S1PR4,CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F.Cl
2.0,Completed,EFO_0000384,Crohn's disease,CHEMBL3707375,AMISELIMOD,S1PR4,CCCCCCCOc1ccc(CCC(N)(CO)CO)cc1C(F)(F)F
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS20,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS20,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS20,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS13,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS13,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS13,
4.0,,EFO_0000558,Kaposi's sarcoma,CHEMBL1201558,INTERFERON ALFA-2B,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL2108508,INTERFERON ALFA-2A,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL1201563,INTERFERON BETA-1B,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL1201557,INTERFERON ALFACON-1,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL1201560,PEGINTERFERON ALFA-2A,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL1201561,PEGINTERFERON ALFA-2B,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL1201562,INTERFERON BETA-1A,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL2108677,PEGINTERFERON BETA-1A,IFNAR2,
4.0,,EFO_0000616,neoplasm,CHEMBL4297819,ROPEGINTERFERON ALFA-2B,IFNAR2,
3.0,,EFO_0000616,neoplasm,CHEMBL2107842,ALBINTERFERON ALFA-2B,IFNAR2,
2.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL2109047,INTERFERON ALFA-N3,IFNAR2,
4.0,,EFO_0000224,acute promyelocytic leukemia,CHEMBL38,TRETINOIN,RARB,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1
4.0,,EFO_0000558,Kaposi's sarcoma,CHEMBL705,ALITRETINOIN,RARB,CC1=C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C(C)(C)CCC1
4.0,,EFO_0000676,psoriasis,CHEMBL1657,TAZAROTENE,RARB,CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1
4.0,,EFO_0000676,psoriasis,CHEMBL1131,ACITRETIN,RARB,COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C
4.0,,EFO_0000676,psoriasis,CHEMBL464,ETRETINATE,RARB,CCOC(=O)/C=C(C)/C=C/C=C(C)/C=C/c1c(C)cc(OC)c(C)c1C
4.0,,EFO_0003894,acne,CHEMBL1265,ADAPALENE,RARB,COc1ccc(-c2ccc3cc(C(=O)O)ccc3c2)cc1C12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003894,acne,CHEMBL547,ISOTRETINOIN,RARB,CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1
3.0,Recruiting,EFO_0000198,myelodysplastic syndrome,CHEMBL25202,TAMIBAROTENE,RARB,CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21
3.0,Completed,EFO_0000319,cardiovascular disease,CHEMBL313006,DALCETRAPIB,CETP,CCC(CC)CC1(C(=O)Nc2ccccc2SC(=O)C(C)C)CCCCC1
3.0,Terminated,EFO_0000319,cardiovascular disease,CHEMBL2017179,EVACETRAPIB,CETP,Cc1cc(C)c2c(c1)[C@@H](N(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nnn(C)n1)CCCN2C[C@H]1CC[C@H](C(=O)O)CC1
3.0,Completed,EFO_0001645,coronary artery disease,CHEMBL479527,TORCETRAPIB,CETP,CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)OC)C[C@H]1CC
3.0,"Active, not recruiting",EFO_0003914,atherosclerosis,CHEMBL3785197,OBICETRAPIB,CETP,CCOC(=O)N1c2ccc(C(F)(F)F)cc2[C@@H](N(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2ncc(OCCCC(=O)O)cn2)C[C@H]1CC
3.0,Completed,EFO_0001645,coronary artery disease,CHEMBL1800807,ANACETRAPIB,CETP,COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H]1C
1.0,Completed,Orphanet_309005,Disorder of lipid metabolism,CHEMBL4297601,ROCACETRAPIB,CETP,COc1cc(F)c(C(C)C)cc1C1=C(CN2C(=O)O[C@H](c3cc(C(F)(F)F)cc(C(F)(F)F)c3)[C@@H]2C)CC(C)(C)CC1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL163,RITONAVIR,CYP3A43,CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1
4.0,,EFO_0000180,HIV-1 infection,CHEMBL2095208,COBICISTAT,CYP3A43,CC(C)c1nc(CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)Cc2ccccc2)cs1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA2,CN(C)C(=N)NC(=N)N
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS15A,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS15A,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS15A,
4.0,Recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB11,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB11,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB11,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL404849,SULOCTIDIL,CACNA1A,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1008,BEPRIDIL,CACNA1A,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1
4.0,,HP_0000103,Polyuria,CHEMBL363295,TERODILINE,CACNA1A,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C
4.0,,EFO_0010282,gastrointestinal disease,CHEMBL473159,PHLOROGLUCINOL,CACNA1A,Oc1cc(O)cc(O)c1
3.0,Terminated,EFO_0005230,anxiety,CHEMBL2103836,IMAGABALIN,CACNA1A,CCC[C@@H](C)C[C@H](N)CC(=O)O
2.0,Completed,EFO_0004698,insomnia,CHEMBL593430,ATAGABALIN,CACNA1A,C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C
4.0,,EFO_0000537,hypertension,CHEMBL957,BOSENTAN,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO
4.0,,EFO_0000537,hypertension,CHEMBL1111,AMBRISENTAN,EDNRA,COC(c1ccccc1)(c1ccccc1)[C@H](Oc1nc(C)cc(C)n1)C(=O)O
4.0,,EFO_0000537,hypertension,CHEMBL2103873,MACITENTAN,EDNRA,CCCNS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
4.0,,EFO_0000537,hypertension,CHEMBL282724,SITAXENTAN,EDNRA,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2
4.0,,EFO_0004194,IGA glomerulonephritis,CHEMBL539423,SPARSENTAN,EDNRA,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2S(=O)(=O)Nc2noc(C)c2C)c(COCC)c1
4.0,,MONDO_0005149,pulmonary hypertension,CHEMBL2105740,SITAXENTAN SODIUM,EDNRA,Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)[N-]c1onc(C)c1Cl)OCO2.[Na+]
3.0,Terminated,EFO_0000401,diabetic nephropathy,CHEMBL3989834,AVOSENTAN,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccncc2)nc1OC
3.0,Terminated,EFO_0000401,diabetic nephropathy,CHEMBL9194,ATRASENTAN,EDNRA,CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1
3.0,Completed,EFO_0000537,hypertension,CHEMBL2165326,APROCITENTAN,EDNRA,NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1
3.0,Completed,EFO_0000537,hypertension,CHEMBL23261,DARUSENTAN,EDNRA,COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c2ccccc2)n1
3.0,Terminated,EFO_0000713,subarachnoid hemorrhage,CHEMBL109648,CLAZOSENTAN,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nnn[nH]3)c2)nc1OCCO
3.0,Completed,EFO_0003144,heart failure,CHEMBL61780,TEZOSENTAN,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nnn[nH]3)c2)nc1OCCO
3.0,Completed,MONDO_0008315,prostate cancer,CHEMBL2106068,ATRASENTAN HYDROCHLORIDE,EDNRA,CCCCN(CCCC)C(=O)CN1C[C@H](c2ccc3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1c1ccc(OC)cc1.Cl
3.0,Completed,MONDO_0008315,prostate cancer,CHEMBL1628688,ZIBOTENTAN,EDNRA,COc1nc(C)cnc1NS(=O)(=O)c1cccnc1-c1ccc(-c2nnco2)cc1
2.0,Terminated,EFO_0000673,prostate adenocarcinoma,CHEMBL2107760,NEBENTAN,EDNRA,COc1ccccc1Oc1c(NS(=O)(=O)/C=C/c2ccccc2)nc(-c2ncccn2)nc1OC
2.0,Unknown status,EFO_0001645,coronary artery disease,CHEMBL1269102,BQ-123,EDNRA,
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA4,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,Completed,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA4,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA4,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,Unknown status,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA4,COC(F)(F)C(Cl)Cl
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRA4,CCCC(C)(COC(N)=O)COC(N)=O
4.0,Withdrawn,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA4,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA4,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA4,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA4,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA4,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA4,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA4,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRA4,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA4,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Terminated,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA4,Oc1noc2c1CCNC2
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRA4,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA4,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA4,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA4,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFV1,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFV1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFV1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB4,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB4,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB4,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS2,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS2,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS2,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS7,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS7,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS7,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA4,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA4,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA4,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS3,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS3,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS2,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN2C,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN2C,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN2C,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,Completed,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN2C,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,Completed,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN2C,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,,MONDO_0002050,depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN2C,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN2C,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN2C,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
4.0,Terminated,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN2C,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN2C,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN2C,NC12CC3CC(CC(C3)C1)C2
3.0,Withdrawn,EFO_0000474,epilepsy,CHEMBL742,KETAMINE,GRIN2C,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN2C,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN2C,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN2C,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN2C,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN2C,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN2C,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN2C,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN2C,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL3707400,INDANTADOL,GRIN2C,
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL467084,LANICEMINE,GRIN2C,N[C@@H](Cc1ccccn1)c1ccccc1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN2C,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,EFO_0000182,hepatocellular carcinoma,CHEMBL2364611,GALUNISERTIB,TGFBR1,Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1
2.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3260567,VACTOSERTIB,TGFBR1,Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1
4.0,Terminated,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND4L,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND4L,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND4L,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND1,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB3,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB3,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB3,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB3,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL3545252,DOCETAXEL,TUBB3,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL428647,PACLITAXEL,TUBB3,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB3,
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB3,
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB3,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB3,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB3,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB3,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB3,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB3,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB3,
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB3,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,Completed,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB3,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB3,
3.0,"Active, not recruiting",EFO_0000178,gastric carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB3,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB3,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB3,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB3,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB3,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB3,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB3,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB3,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB3,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB3,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB3,
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB3,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB3,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB3,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB3,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB3,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB3,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB3,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB3,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB3,
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB3,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB3,
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB3,
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB3,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB3,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB3,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB3,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB3,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB3,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB3,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB3,
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB3,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB3,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB3,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB3,
2.0,Completed,MONDO_0008903,lung cancer,CHEMBL96172,EPOTHILONE D,TUBB3,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB3,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB3,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB3,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB3,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB3,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB3,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB3,
1.0,Completed,MONDO_0002108,thyroid cancer,CHEMBL2103852,CROLIBULIN,TUBB3,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB3,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB3,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA6,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA6,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA6,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB8,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB8,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB8,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA5,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA5,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA5,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRA5,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRA5,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRA5,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,Completed,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA5,COC(F)(F)C(Cl)Cl
4.0,,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRA5,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRA5,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRA5,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,Completed,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRA5,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,Completed,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRA5,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRA5,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRA5,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRA5,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRA5,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRA5,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRA5,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA5,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRA5,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRA5,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRA5,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL979,MEPROBAMATE,GABRA5,CCCC(C)(COC(N)=O)COC(N)=O
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRA5,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRA5,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA5,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRA5,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA5,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA5,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA5,CC(C)c1cccc(C(C)C)c1O
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRA5,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA5,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA5,FCOC(C(F)(F)F)C(F)(F)F
3.0,Completed,EFO_0003918,obstructive sleep apnea,CHEMBL135400,ZOPICLONE,GABRA5,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,Terminated,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA5,Oc1noc2c1CCNC2
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRA5,FC(F)OC(Cl)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRA5,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA5,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA5,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRA5,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRA5,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Completed,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRA5,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRA5,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA5,FC(F)OC(F)C(F)(F)F
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRA5,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA5,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRA3,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRA3,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRA3,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRA3,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRA3,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRA3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRA3,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRA3,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRA3,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRA3,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,"Active, not recruiting",EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRA3,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRA3,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRA3,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRA3,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,Completed,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRA3,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0006788,anxiety disorder,CHEMBL580,LORAZEPAM,GABRA3,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRA3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRA3,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRA3,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRA3,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRA3,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRA3,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL979,MEPROBAMATE,GABRA3,CCCC(C)(COC(N)=O)COC(N)=O
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRA3,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRA3,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRA3,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRA3,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,Not yet recruiting,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRA3,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRA3,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRA3,CC(C)c1cccc(C(C)C)c1O
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRA3,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRA3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRA3,FCOC(C(F)(F)F)C(F)(F)F
3.0,Completed,EFO_0003918,obstructive sleep apnea,CHEMBL135400,ZOPICLONE,GABRA3,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRA3,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Terminated,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRA3,Oc1noc2c1CCNC2
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRA3,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
3.0,Withdrawn,HP_0000023,Inguinal hernia,CHEMBL1256,ISOFLURANE,GABRA3,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRA3,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRA3,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRA3,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Completed,EFO_0005230,anxiety,CHEMBL1783282,AZD7325,GABRA3,CCCNC(=O)c1nnc2c(-c3c(F)cccc3OC)cccc2c1N
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRA3,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRA3,FC(F)OC(F)C(F)(F)F
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRA3,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRA3,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRA3,CC(C)c1cccc([C@H](C)C2CC2)c1O
1.0,Completed,EFO_0005230,anxiety,CHEMBL1783256,AZD6280,GABRA3,CCCNC(=O)c1nnc2c(-c3cc(OC)ccc3OC)cccc2c1N
4.0,,EFO_0003768,nicotine dependence,CHEMBL1076903,VARENICLINE,CHRNA4,c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
4.0,,EFO_0003768,nicotine dependence,CHEMBL3,NICOTINE,CHRNA4,CN1CCC[C@H]1c1cccnc1
3.0,Recruiting,EFO_0003768,nicotine dependence,CHEMBL1201536,NICOTINE POLACRILEX,CHRNA4,
3.0,Completed,EFO_0003768,nicotine dependence,CHEMBL187927,DIANICLINE,CHRNA4,c1cnc2c(c1)O[C@H]1CCN3CC[C@@]1(C2)C3
3.0,,EFO_0003768,nicotine dependence,CHEMBL497939,CYTISINICLINE,CHRNA4,O=c1cccc2n1C[C@@H]1CNC[C@H]2C1
3.0,Completed,EFO_0004319,smoking cessation,CHEMBL5303393,VARENICLINE TARTRATE,CHRNA4,O=C(O)C(O)C(O)C(=O)O.c1cnc2cc3c(cc2n1)[C@@H]1CNC[C@H]3C1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2103881,DEXMECAMYLAMINE,CHRNA4,CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C
2.0,Completed,EFO_0000401,diabetic nephropathy,CHEMBL238465,SOFINICLINE,CHRNA4,Clc1cc(N2C[C@@H]3CN[C@@H]3C2)cnc1Cl
2.0,Completed,EFO_0000555,irritable bowel syndrome,CHEMBL4594254,SIMPINICLINE,CHRNA4,C(=C/[C@H]1CCNC1)\c1cncnc1
2.0,Completed,EFO_0001072,memory impairment,CHEMBL188462,ISPRONICLINE,CHRNA4,CN[C@@H](C)C/C=C/c1cncc(OC(C)C)c1
2.0,Terminated,EFO_0003768,nicotine dependence,CHEMBL127071,POZANICLINE,CHRNA4,Cc1ncccc1OC[C@@H]1CCCN1
2.0,Completed,EFO_0003888,attention deficit hyperactivity disorder,CHEMBL2179529,AZD1446,CHRNA4,O=C(c1ccc(Cl)o1)N1CC2CNCC2C1
2.0,Terminated,MONDO_0002009,major depressive disorder,CHEMBL3707250,CP-601927,CHRNA4,
1.0,Completed,EFO_0005230,anxiety,CHEMBL504652,TC-2216,CHRNA4,c1cncc(N2CCC3(CCCN3)C2)c1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFV2,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFV2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFV2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000274,atopic eczema,CHEMBL484785,CRISABOROLE,PDE4C,N#Cc1ccc(Oc2ccc3c(c2)COB3O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL628,PENTOXIFYLLINE,PDE4C,CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O
4.0,,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL193240,ROFLUMILAST,PDE4C,O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1
4.0,,EFO_0000540,immune system disease,CHEMBL514800,APREMILAST,PDE4C,CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC
4.0,Completed,EFO_0000712,stroke,CHEMBL932,DIPYRIDAMOLE,PDE4C,OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1
4.0,,EFO_0003830,prostatitis,CHEMBL1200875,FLAVOXATE HYDROCHLORIDE,PDE4C,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl
4.0,,EFO_0006505,chronic bronchitis,CHEMBL190,THEOPHYLLINE,PDE4C,Cn1c(=O)c2[nH]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1096,AMLEXANOX,PDE4C,CC(C)c1ccc2oc3nc(N)c(C(=O)O)cc3c(=O)c2c1
4.0,,HP_0006536,Airway obstruction,CHEMBL1200434,OXTRIPHYLLINE,PDE4C,C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O
4.0,,HP_0006536,Airway obstruction,CHEMBL1370561,AMINOPHYLLINE,PDE4C,Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN
4.0,,HP_0006536,Airway obstruction,CHEMBL1752,DYPHYLLINE,PDE4C,Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O
3.0,Recruiting,EFO_0000274,atopic eczema,CHEMBL3989968,DIFAMILAST,PDE4C,CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1
3.0,Recruiting,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL3113974,TRANIMILAST,PDE4C,CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4594287,ENSIFENTRINE,PDE4C,COc1cc2c(cc1OC)-c1c/c(=N\c3c(C)cc(C)cc3C)n(CCNC(N)=O)c(=O)n1CC2
3.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL511115,CILOMILAST,PDE4C,COc1ccc([C@]2(C#N)CC[C@@H](C(=O)O)CC2)cc1OC1CCCC1
3.0,Completed,EFO_0000729,ulcerative colitis,CHEMBL332750,TETOMILAST,PDE4C,CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC
3.0,,EFO_0010282,gastrointestinal disease,CHEMBL551978,DROTAVERINE,PDE4C,CCOc1ccc(/C=C2\NCCc3cc(OCC)c(OCC)cc32)cc1OCC
3.0,Recruiting,HP_0002196,Myelopathy,CHEMBL19449,IBUDILAST,PDE4C,CC(C)C(=O)c1c(C(C)C)nn2ccccc12
2.0,Completed,EFO_0000274,atopic eczema,CHEMBL3989967,LOTAMILAST,PDE4C,CNc1nc(-c2cccc(NC(=O)c3ccc(C(=O)OC)cc3)c2)c2cc(OC)c(OC)cc2n1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL4297520,OGLEMILAST,PDE4C,CS(=O)(=O)Nc1ccc2oc3c(OC(F)F)ccc(C(=O)Nc4c(Cl)cncc4Cl)c3c2c1
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL217899,TOFIMILAST,PDE4C,CCc1nn(C2CCCC2)c2c1CCn1c(-c3cccs3)nnc1-2
2.0,Terminated,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL485629,MK-0873,PDE4C,O=C(NC1CC1)c1cn(-c2cccc(C#Cc3ccc[n+]([O-])c3)c2)c2ncccc2c1=O
2.0,Completed,EFO_0000341,chronic obstructive pulmonary disease,CHEMBL570015,GSK-256066,PDE4C,COc1cccc(Nc2c(C(N)=O)cnc3c(C)cc(S(=O)(=O)c4cccc(C(=O)N(C)C)c4)cc23)c1
2.0,Completed,EFO_0000685,rheumatoid arthritis,CHEMBL4297527,REVAMILAST,PDE4C,O=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
2.0,Completed,EFO_0001072,memory impairment,CHEMBL4297287,HT-0712,PDE4C,COc1ccc([C@H]2CNC(=O)[C@H](Cc3cccc(C)c3)C2)cc1OC1CCCC1
2.0,Completed,EFO_0003834,cutaneous lupus erythematosus,CHEMBL4297460,DOVRAMILAST,PDE4C,CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC
2.0,,HP_0000020,Urinary incontinence,CHEMBL1493,FLAVOXATE,PDE4C,Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O
2.0,Completed,MONDO_0005301,multiple sclerosis,CHEMBL63,ROLIPRAM,PDE4C,COc1ccc(C2CNC(=O)C2)cc1OC1CCCC1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,GPD2,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,GPD2,CN(C)C(=N)NC(=N)N.Cl
4.0,,EFO_0000765,AIDS,CHEMBL2108184,CROFELEMER,ANO1,
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN3B,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN3B,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN3B,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN3B,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN3B,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,Recruiting,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN3B,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN3B,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN3B,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
4.0,,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN3B,NC12CC3CC(CC(C3)C1)C2
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN3B,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN3B,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Withdrawn,EFO_0000474,epilepsy,CHEMBL742,KETAMINE,GRIN3B,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN3B,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN3B,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN3B,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN3B,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN3B,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN3B,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN3B,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,EFO_0003843,pain,CHEMBL3707400,INDANTADOL,GRIN3B,
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN3B,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN3B,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL467084,LANICEMINE,GRIN3B,N[C@@H](Cc1ccccn1)c1ccccc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS28,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS28,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS28,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB5,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB5,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB5,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB2,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND2,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL2105708,PONATINIB HYDROCHLORIDE,BCR,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12.Cl
4.0,,EFO_0000220,acute lymphoblastic leukemia,CHEMBL1421,DASATINIB,BCR,Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL1642,IMATINIB MESYLATE,BCR,CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL2095206,BOSUTINIB MONOHYDRATE,BCR,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl.O
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL4297220,ASCIMINIB HYDROCHLORIDE,BCR,Cl.O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
4.0,,EFO_0000339,chronic myelogenous leukemia,CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE,BCR,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1.Cl.O
4.0,,EFO_0000616,neoplasm,CHEMBL4208229,ASCIMINIB,BCR,O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(N2CC[C@@H](O)C2)c(-c2cc[nH]n2)c1
3.0,Recruiting,EFO_0000209,T-cell acute lymphoblastic leukemia,CHEMBL941,IMATINIB,BCR,Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1
3.0,"Active, not recruiting",EFO_0000220,acute lymphoblastic leukemia,CHEMBL1171837,PONATINIB,BCR,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12
3.0,Recruiting,EFO_0000220,acute lymphoblastic leukemia,CHEMBL2316582,OLVEREMBATINIB,BCR,Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1
3.0,Terminated,EFO_0000339,chronic myelogenous leukemia,CHEMBL255863,NILOTINIB,BCR,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1
3.0,"Active, not recruiting",EFO_0000339,chronic myelogenous leukemia,CHEMBL288441,BOSUTINIB,BCR,COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl
3.0,"Active, not recruiting",EFO_0000339,chronic myelogenous leukemia,CHEMBL4297524,RADOTINIB,BCR,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cnccn5)n4)c3)cc(C(F)(F)F)c2)cn1
2.0,Recruiting,HP_0000726,Dementia,CHEMBL4130229,VODOBATINIB,BCR,Cc1ccc(C(=O)NNC(=O)c2c(C)cccc2Cl)cc1C#Cc1cnc2ccccc2c1
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB6,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB6,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB6,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB6,
4.0,,EFO_0000305,breast carcinoma,CHEMBL3545252,DOCETAXEL,TUBB6,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB6,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000313,carcinoma,CHEMBL428647,PACLITAXEL,TUBB6,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB6,
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB6,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB6,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB6,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB6,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB6,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB6,
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB6,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB6,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB6,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB6,
3.0,Completed,EFO_0000181,head and neck squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB6,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB6,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB6,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB6,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB6,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB6,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB6,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Withdrawn,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB6,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB6,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB6,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB6,
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB6,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB6,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB6,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB6,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB6,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB6,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB6,
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB6,
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB6,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB6,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB6,
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB6,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB6,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB6,
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB6,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB6,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB6,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB6,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB6,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Recruiting,EFO_0003968,angiosarcoma,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB6,
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB6,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB6,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB6,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL96172,EPOTHILONE D,TUBB6,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB6,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB6,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB6,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB6,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB6,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB6,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB6,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB6,
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB6,
1.0,Completed,MONDO_0002108,thyroid cancer,CHEMBL2103852,CROLIBULIN,TUBB6,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB6,
2.0,Completed,EFO_0000182,hepatocellular carcinoma,CHEMBL4298089,CODRITUZUMAB,GPC3,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS8,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS8,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS8,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA7,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA7,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA7,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS3A,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS3A,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS3A,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS27A,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS27A,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS27A,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND3,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND3,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1200675,TOREMIFENE CITRATE,ESR1,CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1358,FULVESTRANT,ESR1,C[C@]12CC[C@@H]3c4ccc(O)cc4C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@H]3[C@@H]1CC[C@@H]2O
4.0,,EFO_0000545,infertility,CHEMBL3185958,CLOMIPHENE CITRATE,ESR1,CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0000616,neoplasm,CHEMBL411,DIETHYLSTILBESTROL,ESR1,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
4.0,,EFO_0000616,neoplasm,CHEMBL691,ETHINYL ESTRADIOL,ESR1,C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C
4.0,,EFO_0000616,neoplasm,CHEMBL83,TAMOXIFEN,ESR1,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
4.0,,EFO_0000616,neoplasm,CHEMBL1200598,DIETHYLSTILBESTROL DIPHOSPHATE,ESR1,CC/C(=C(/CC)c1ccc(OP(=O)(O)O)cc1)c1ccc(OP(=O)(O)O)cc1
4.0,,EFO_0000616,neoplasm,CHEMBL1201477,POLYESTRADIOL PHOSPHATE,ESR1,
4.0,,EFO_0003854,postmenopausal osteoporosis,CHEMBL1201649,"ESTROGENS, CONJUGATED",ESR1,
4.0,,EFO_0003854,postmenopausal osteoporosis,CHEMBL2106615,BAZEDOXIFENE ACETATE,ESR1,CC(=O)O.Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12
4.0,,EFO_0003882,osteoporosis,CHEMBL135,ESTRADIOL,ESR1,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O
4.0,,EFO_0003869,breast neoplasm,CHEMBL4594273,ELACESTRANT HYDROCHLORIDE,ESR1,CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1.Cl.Cl
4.0,,EFO_0004266,primary ovarian insufficiency,CHEMBL1200980,ESTROPIPATE,ESR1,C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O
4.0,,EFO_0004266,primary ovarian insufficiency,CHEMBL1511,ESTRADIOL VALERATE,ESR1,CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C
4.0,,EFO_0002950,pregnancy,CHEMBL1230314,ESTETROL,ESR1,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1[C@@H](O)[C@@H](O)[C@@H]2O
4.0,,EFO_0003854,postmenopausal osteoporosis,CHEMBL5315115,LASOFOXIFENE TARTRATE,ESR1,
4.0,,EFO_1000096,Atrophy,CHEMBL1200430,ESTRADIOL ACETATE,ESR1,CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12
4.0,,EFO_1000096,Atrophy,CHEMBL1201466,"ESTROGENS, CONJUGATED SYNTHETIC A",ESR1,
4.0,,EFO_0004266,primary ovarian insufficiency,CHEMBL1201468,"ESTROGENS, ESTERIFIED",ESR1,
4.0,,EFO_1001271,Atrophic Vaginitis,CHEMBL2105395,OSPEMIFENE,ESR1,OCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1
4.0,,EFO_1000096,Atrophy,CHEMBL1201467,"SYNTHETIC CONJUGATED ESTROGENS, B",ESR1,
4.0,,MONDO_0007254,breast cancer,CHEMBL786,TAMOXIFEN CITRATE,ESR1,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
3.0,Not yet recruiting,EFO_0000279,azoospermia,CHEMBL2355051,CLOMIPHENE,ESR1,CCN(CC)CCOc1ccc(C(=C(Cl)c2ccccc2)c2ccccc2)cc1
3.0,,EFO_0000616,neoplasm,CHEMBL1655,TOREMIFENE,ESR1,CN(C)CCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1
3.0,Unknown status,EFO_0000660,polycystic ovary syndrome,CHEMBL954,ENCLOMIPHENE,ESR1,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
3.0,Completed,EFO_0003882,osteoporosis,CHEMBL46740,BAZEDOXIFENE,ESR1,Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12
3.0,Completed,EFO_0003869,breast neoplasm,CHEMBL226267,ARZOXIFENE,ESR1,COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1
3.0,Completed,EFO_0003882,osteoporosis,CHEMBL328190,LASOFOXIFENE,ESR1,Oc1ccc2c(c1)CC[C@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1
3.0,Completed,EFO_1001271,Atrophic Vaginitis,CHEMBL193482,ESTRIOL,ESR1,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O
3.0,Recruiting,MONDO_0007254,breast cancer,CHEMBL4297509,ELACESTRANT,ESR1,CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1
3.0,Terminated,MONDO_0007254,breast cancer,CHEMBL4475463,AMCENESTRANT,ESR1,O=C(O)c1ccc2c(c1)CCCC(c1ccc(Cl)cc1Cl)=C2c1ccc(O[C@H]2CCN(CCCF)C2)cc1
3.0,"Active, not recruiting",MONDO_0007254,breast cancer,CHEMBL4650316,GIREDESTRANT,ESR1,C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(NC3CN(CCCF)C3)cc2F)N1CC(F)(F)CO
3.0,"Active, not recruiting",MONDO_0007254,breast cancer,CHEMBL4650365,CAMIZESTRANT,ESR1,C[C@@H]1Cc2c(ccc3[nH]ncc23)[C@@H](c2ccc(NC3CN(CCCF)C3)cn2)N1CC(F)(F)F
3.0,Unknown status,MONDO_0004169,premenstrual tension,CHEMBL1405,ESTRONE,ESR1,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O
2.0,Completed,EFO_0000432,breast ductal carcinoma in situ,CHEMBL489,AFIMOXIFENE,ESR1,CC/C(=C(\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
2.0,Completed,EFO_0004234,erectile dysfunction,CHEMBL2107341,FISPEMIFENE,ESR1,OCCOCCOc1ccc(/C(=C(/CCCl)c2ccccc2)c2ccccc2)cc1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL3545211,SR16234,ESR1,CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1
2.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3545017,GTX-758,ESR1,O=C(c1ccc(O)c(F)c1)N(c1ccc(O)cc1)c1ccc(F)cc1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL3545210,SR16234,ESR1,CCN(CC)Cc1ccc(OCC[C@H]2CCC3C4C(CC[C@@]32C)c2ccc(O)cc2C[C@H]4C)c(OC)c1.O=C(O)CC(O)(CC(=O)O)C(=O)O
2.0,Terminated,MONDO_0007254,breast cancer,CHEMBL3581693,BRILANESTRANT,ESR1,CC/C(=C(/c1ccc(/C=C/C(=O)O)cc1)c1ccc2[nH]ncc2c1)c1ccc(F)cc1Cl
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL68055,ACOLBIFENE,ESR1,CC1=C(c2ccc(O)cc2)[C@H](c2ccc(OCCN3CCCCC3)cc2)Oc2cc(O)ccc21
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB8,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB8,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB8,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB8,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL3545252,DOCETAXEL,TUBB8,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000313,carcinoma,CHEMBL428647,PACLITAXEL,TUBB8,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB8,
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB8,
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB8,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB8,
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB8,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB8,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB8,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB8,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB8,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB8,
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB8,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB8,
3.0,Not yet recruiting,EFO_0000181,head and neck squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB8,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Terminated,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB8,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB8,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB8,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB8,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB8,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB8,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB8,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB8,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB8,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB8,
3.0,Completed,MONDO_0002158,fallopian tube cancer,CHEMBL94657,PATUPILONE,TUBB8,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB8,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB8,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB8,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB8,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB8,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB8,
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB8,
2.0,Completed,EFO_0000565,leukemia,CHEMBL39541,DOLASTATIN-10,TUBB8,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB8,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB8,
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB8,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB8,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB8,
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB8,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB8,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB8,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB8,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB8,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB8,
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB8,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB8,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB8,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL96172,EPOTHILONE D,TUBB8,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB8,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB8,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB8,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB8,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB8,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB8,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB8,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB8,
1.0,Completed,MONDO_0004992,cancer,CHEMBL2103852,CROLIBULIN,TUBB8,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB8,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB8,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFAF3,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFAF3,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFAF3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000228,adenocarcinoma,CHEMBL3545252,DOCETAXEL,TUBB,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL428647,PACLITAXEL,TUBB,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB,
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB,
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB,
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB,
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB,
3.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL501867,VINCRISTINE SULFATE,TUBB,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Recruiting,EFO_0000199,oral squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB,
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB,
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB,
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB,
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB,
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB,
2.0,Terminated,MONDO_0008903,lung cancer,CHEMBL96172,EPOTHILONE D,TUBB,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB,
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB,
1.0,Completed,MONDO_0002108,thyroid cancer,CHEMBL2103852,CROLIBULIN,TUBB,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND5,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND5,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND5,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,MT-ND6,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,MT-ND6,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,MT-ND6,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000474,epilepsy,CHEMBL12,DIAZEPAM,GABRG3,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRG3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,Completed,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRG3,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRG3,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL452,CLONAZEPAM,GABRG3,O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1
4.0,,EFO_0000474,epilepsy,CHEMBL655,MIDAZOLAM,GABRG3,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
4.0,Completed,EFO_0004262,panic disorder,CHEMBL661,ALPRAZOLAM,GABRG3,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2
4.0,,EFO_0005230,anxiety,CHEMBL1697737,CLOTIAZEPAM,GABRG3,CCc1cc2c(s1)N(C)C(=O)CN=C2c1ccccc1Cl
4.0,,EFO_0005230,anxiety,CHEMBL451,CHLORDIAZEPOXIDE,GABRG3,CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1
4.0,,EFO_0004698,insomnia,CHEMBL1522,ESZOPICLONE,GABRG3,CN1CCN(C(=O)O[C@H]2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
4.0,,EFO_0004698,insomnia,CHEMBL285674,ESTAZOLAM,GABRG3,Clc1ccc2c(c1)C(c1ccccc1)=NCc1nncn1-2
4.0,,EFO_0004698,insomnia,CHEMBL3989724,FLURAZEPAM HYDROCHLORIDE,GABRG3,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl
4.0,,EFO_0004698,insomnia,CHEMBL646,TRIAZOLAM,GABRG3,Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1Cl)=NC2
4.0,,EFO_0004698,insomnia,CHEMBL967,TEMAZEPAM,GABRG3,CN1C(=O)C(O)N=C(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRG3,COC(F)(F)C(Cl)Cl
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRG3,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRG3,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,EFO_0004698,insomnia,CHEMBL1200472,QUAZEPAM,GABRG3,Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21
4.0,,EFO_0005230,anxiety,CHEMBL70418,CLOBAZAM,GABRG3,CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21
4.0,,EFO_0005230,anxiety,CHEMBL969,PRAZEPAM,GABRG3,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC1CC1
4.0,,EFO_0005230,anxiety,CHEMBL970,HALAZEPAM,GABRG3,O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1CC(F)(F)F
4.0,,EFO_0005230,anxiety,CHEMBL568,OXAZEPAM,GABRG3,O=C1Nc2ccc(Cl)cc2C(c2ccccc2)=NC1O
4.0,,EFO_0005230,anxiety,CHEMBL580,LORAZEPAM,GABRG3,O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O
4.0,,EFO_0006788,anxiety disorder,CHEMBL2096631,CLORAZEPATE DIPOTASSIUM,GABRG3,O=C([O-])C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O.[K+].[K+].[OH-]
4.0,,EFO_0009868,sedation,CHEMBL4594301,REMIMAZOLAM BESYLATE,GABRG3,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1
4.0,,EFO_1001454,amnesia,CHEMBL1200420,MIDAZOLAM HYDROCHLORIDE,GABRG3,Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2.Cl
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRG3,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRG3,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL4297526,REMIMAZOLAM,GABRG3,COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRG3,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRG3,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRG3,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL968,FLURAZEPAM,GABRG3,CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRG3,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Recruiting,EFO_0009686,respiratory failure,CHEMBL1256,ISOFLURANE,GABRG3,FC(F)OC(Cl)C(F)(F)F
2.0,Completed,EFO_0003890,drug dependence,CHEMBL407,FLUMAZENIL,GABRG3,CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2
2.0,Completed,EFO_0004263,partial epilepsy,CHEMBL4297521,PADSEVONIL,GABRG3,COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1
2.0,Completed,EFO_0803321,premature ejaculation,CHEMBL2104745,PAGOCLONE,GABRG3,CC(C)CCC(=O)CC1c2ccccc2C(=O)N1c1ccc2ccc(Cl)nc2n1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRG3,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Terminated,EFO_0004698,insomnia,CHEMBL2103791,ADIPIPLON,GABRG3,CCCc1c(Cn2ccnc2-c2ncccc2F)ncn2nc(C)nc12
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRG3,FC(F)OC(F)C(F)(F)F
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL2107801,RESEQUINIL,GABRG3,COc1cccc(-c2nccc3[nH]c(=O)c(-c4noc(C)n4)cc23)c1
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRG3,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS5,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS5,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS5,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL404849,SULOCTIDIL,CACNA2D1,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1008,BEPRIDIL,CACNA2D1,CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1
4.0,,EFO_0000474,epilepsy,CHEMBL940,GABAPENTIN,CACNA2D1,NCC1(CC(=O)O)CCCCC1
4.0,Completed,EFO_0000474,epilepsy,CHEMBL1059,PREGABALIN,CACNA2D1,CC(C)C[C@H](CN)CC(=O)O
4.0,Completed,EFO_0004270,restless legs syndrome,CHEMBL1628502,GABAPENTIN ENACARBIL,CACNA2D1,CC(OC(=O)NCC1(CC(=O)O)CCCCC1)OC(=O)C(C)C
4.0,,EFO_0010282,gastrointestinal disease,CHEMBL473159,PHLOROGLUCINOL,CACNA2D1,Oc1cc(O)cc(O)c1
4.0,,HP_0000020,Urinary incontinence,CHEMBL363295,TERODILINE,CACNA2D1,CC(CC(c1ccccc1)c1ccccc1)NC(C)(C)C
3.0,Terminated,EFO_0005230,anxiety,CHEMBL2103836,IMAGABALIN,CACNA2D1,CCC[C@@H](C)C[C@H](N)CC(=O)O
3.0,Completed,EFO_0005687,fibromyalgia,CHEMBL3545125,MIROGABALIN,CACNA2D1,CCC1=C[C@@H]2[C@H](C1)C[C@]2(CN)CC(=O)O
2.0,Completed,EFO_0004698,insomnia,CHEMBL593430,ATAGABALIN,CACNA2D1,C[C@H]1CC(CN)(CC(=O)O)C[C@@H]1C
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE,ADRA2C,CC(COc1ccccc1)N(CCCl)Cc1ccccc1.Cl
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1437,NOREPINEPHRINE,ADRA2C,NC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL211456,EPHEDRINE,ADRA2C,CN[C@@H](C)[C@H](O)c1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2311030,ERGOLOID MESYLATES,ADRA2C,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O
4.0,,EFO_0000319,cardiovascular disease,CHEMBL27810,CELIPROLOL,ADRA2C,CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(C(C)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL597,PHENTOLAMINE,ADRA2C,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL753,PHENOXYBENZAMINE,ADRA2C,CC(COc1ccccc1)N(CCCl)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL770,TOLAZOLINE,ADRA2C,c1ccc(CC2=NCCN2)cc1
4.0,,EFO_0000239,adrenal gland pheochromocytoma,CHEMBL1200873,PHENTOLAMINE MESYLATE,ADRA2C,CS(=O)(=O)O.Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL1201234,MEPHENTERMINE,ADRA2C,CNC(C)(C)Cc1ccccc1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL159226,MOXISYLYTE,ADRA2C,CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C
4.0,,EFO_0000319,cardiovascular disease,CHEMBL2103827,DROXIDOPA,ADRA2C,N[C@H](C(=O)O)[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL429,LABETALOL,ADRA2C,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1
4.0,,EFO_0000319,cardiovascular disease,CHEMBL679,EPINEPHRINE,ADRA2C,CNC[C@H](O)c1ccc(O)c(O)c1
4.0,,EFO_0000537,hypertension,CHEMBL862,GUANFACINE,ADRA2C,N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL134,CLONIDINE,ADRA2C,Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL1200323,LABETALOL HYDROCHLORIDE,ADRA2C,CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1.Cl
4.0,,EFO_0000537,hypertension,CHEMBL1705,CLONIDINE HYDROCHLORIDE,ADRA2C,Cl.Clc1cccc(Cl)c1NC1=NCCN1
4.0,,EFO_0000537,hypertension,CHEMBL1200494,GUANFACINE HYDROCHLORIDE,ADRA2C,Cl.N=C(N)NC(=O)Cc1c(Cl)cccc1Cl
4.0,,EFO_0000537,hypertension,CHEMBL2062257,BRIMONIDINE TARTRATE,ADRA2C,Brc1c(NC2=NCCN2)ccc2nccnc12.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0000537,hypertension,CHEMBL3559672,RAUWOLFIA SERPENTINA,ADRA2C,
4.0,,EFO_0000537,hypertension,CHEMBL459,METHYLDOPA,ADRA2C,C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O
4.0,,EFO_0002497,acute hypotension,CHEMBL1434513,NOREPINEPHRINE BITARTRATE,ADRA2C,NC[C@H](O)c1ccc(O)c(O)c1.O.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003890,drug dependence,CHEMBL17860,LOFEXIDINE,ADRA2C,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE,ADRA2C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1.Cl
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL2146102,EPHEDRINE HYDROCHLORIDE,ADRA2C,CN[C@@H](C)[C@H](O)c1ccccc1.Cl
4.0,,EFO_0005751,eye allergy,CHEMBL1266,TETRAHYDROZOLINE,ADRA2C,c1ccc2c(c1)CCCC2C1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL312448,XYLOMETAZOLINE,ADRA2C,Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1
4.0,,EFO_0005751,eye allergy,CHEMBL762,OXYMETAZOLINE,ADRA2C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
4.0,,EFO_0005800,substance withdrawal syndrome,CHEMBL1788132,LOFEXIDINE HYDROCHLORIDE,ADRA2C,CC(Oc1c(Cl)cccc1Cl)C1=NCCN1.Cl
4.0,,EFO_0003843,pain,CHEMBL1256958,EPINEPHRINE BITARTRATE,ADRA2C,CNC[C@H](O)c1ccc(O)c(O)c1.O=C(O)C(O)C(O)C(=O)O
4.0,,EFO_0003956,seasonal allergic rhinitis,CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE,ADRA2C,Cl.c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0004698,insomnia,CHEMBL654,MIRTAZAPINE,ADRA2C,CN1CCN2c3ncccc3Cc3ccccc3C2C1
4.0,,EFO_0005251,hypotension,CHEMBL1523964,EPHEDRINE SULFATE,ADRA2C,CN[C@@H](C)[C@H](O)c1ccccc1.CN[C@@H](C)[C@H](O)c1ccccc1.O=S(=O)(O)O
4.0,,EFO_0005751,eye allergy,CHEMBL761,NAPHAZOLINE,ADRA2C,c1ccc2c(CC3=NCCN3)cccc2c1
4.0,,EFO_0005751,eye allergy,CHEMBL844,BRIMONIDINE,ADRA2C,Brc1c(NC2=NCCN2)ccc2nccnc12
4.0,,HP_0002315,Headache,CHEMBL2448612,ERGOTAMINE TARTRATE,ADRA2C,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21.O=C(O)C(O)C(O)C(=O)O
4.0,,HP_0001257,Spasticity,CHEMBL1200329,TIZANIDINE HYDROCHLORIDE,ADRA2C,Cl.Clc1ccc2nsnc2c1NC1=NCCN1
4.0,,MONDO_0005041,glaucoma,CHEMBL647,APRACLONIDINE,ADRA2C,Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1
4.0,,MONDO_0005041,glaucoma,CHEMBL1201262,DIPIVEFRIN,ADRA2C,CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1
4.0,,MONDO_0005277,migraine disorder,CHEMBL442,ERGOTAMINE,ADRA2C,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
3.0,Recruiting,EFO_0000546,injury,CHEMBL778,DEXMEDETOMIDINE,ADRA2C,Cc1cccc([C@H](C)c2c[nH]cn2)c1C
3.0,Unknown status,EFO_0000678,pterygium,CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE,ADRA2C,Cl.c1ccc2c(c1)CCCC2C1=NCCN1
3.0,Withdrawn,EFO_0000694,severe acute respiratory syndrome,CHEMBL1981592,AVIPTADIL,ADRA2C,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O
3.0,Completed,EFO_0001422,cirrhosis of liver,CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE,ADRA2C,Cc1cccc([C@H](C)c2c[nH]cn2)c1C.Cl
3.0,Completed,EFO_0004698,insomnia,CHEMBL1366933,ESMIRTAZAPINE,ADRA2C,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1
3.0,Completed,EFO_0004698,insomnia,CHEMBL2107339,ESMIRTAZAPINE MALEATE,ADRA2C,CN1CCN2c3ncccc3Cc3ccccc3[C@H]2C1.O=C(O)/C=C\C(=O)O
3.0,Completed,HP_0003419,Low back pain,CHEMBL1079,TIZANIDINE,ADRA2C,Clc1ccc2nsnc2c1NC1=NCCN1
3.0,Withdrawn,MONDO_0002009,major depressive disorder,CHEMBL10316,IDAZOXAN,ADRA2C,c1ccc2c(c1)OCC(C1=NCCN1)O2
2.0,Completed,EFO_0004718,vascular dementia,CHEMBL2364968,ERGOLOID,ADRA2C,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
2.0,Completed,MONDO_0004975,Alzheimer disease,CHEMBL4297312,ORM-12741,ADRA2C,COC[C@@]1(C)CCCN2CCc3c(oc4ccccc34)[C@@H]21
2.0,Completed,MONDO_0005180,Parkinson disease,CHEMBL1255582,FIPAMEZOLE,ADRA2C,CCC1(c2c[nH]cn2)Cc2ccc(F)cc2C1
1.0,Terminated,EFO_0003929,relapsing-remitting multiple sclerosis,CHEMBL420,GUANABENZ,ADRA2C,N=C(N)N/N=C/c1c(Cl)cccc1Cl
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB3,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB3,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA13,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA13,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA13,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
1.0,Completed,MONDO_0004992,cancer,CHEMBL1743089,VESENCUMAB,NRP1,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFAF2,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFAF2,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFAF2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,FAU,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,FAU,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,FAU,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS21,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS21,
2.0,Terminated,MONDO_0016239,cystinosis,CHEMBL4297744,ELX-02,RPS21,
2.0,Withdrawn,EFO_0000365,colorectal adenocarcinoma,CHEMBL4297813,PRI-724,CREBBP,
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRD,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,Completed,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRD,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRD,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRD,COC(F)(F)C(Cl)Cl
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRD,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRD,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRD,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRD,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRD,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRD,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRD,FCOC(C(F)(F)F)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRD,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
3.0,Withdrawn,HP_0000023,Inguinal hernia,CHEMBL1256,ISOFLURANE,GABRD,FC(F)OC(Cl)C(F)(F)F
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRD,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRD,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRD,CC(C)c1cccc([C@H](C)C2CC2)c1O
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFS1,CN(C)C(=N)NC(=N)N
4.0,Not yet recruiting,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFS1,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFS1,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS6,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS6,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS6,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS14,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS14,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS14,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFC2,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFC2,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFC2,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS12,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS12,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS12,
2.0,"Active, not recruiting",EFO_0000712,stroke,CHEMBL4297743,ELEZANUMAB,RGMA,
2.0,Recruiting,MONDO_0043797,spinal cord injury,CHEMBL4650492,UNASNEMAB,RGMA,
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFAF4,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFAF4,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFAF4,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA3,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA3,CN(C)C(=N)NC(=N)N.Cl
1.0,Terminated,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA3,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
1.0,Completed,EFO_0001378,multiple myeloma,CHEMBL1743031,INDATUXIMAB RAVTANSINE,SDC1,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS25,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS25,
2.0,Recruiting,MONDO_0018965,Alport syndrome,CHEMBL4297744,ELX-02,RPS25,
4.0,Recruiting,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFA11,CN(C)C(=N)NC(=N)N
4.0,,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFA11,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFA11,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS11,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS11,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS11,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS7,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS7,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS7,
2.0,Terminated,MONDO_0005180,Parkinson disease,CHEMBL3833330,CINPANEMAB,SNCA,
2.0,"Active, not recruiting",MONDO_0005180,Parkinson disease,CHEMBL4298077,PRASINEZUMAB,SNCA,
4.0,,EFO_0000474,epilepsy,CHEMBL856,PRIMIDONE,GABRB2,CCC1(c2ccccc2)C(=O)NCNC1=O
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRB2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRB2,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRB2,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL450,METHARBITAL,GABRB2,CCC1(CC)C(=O)NC(=O)N(C)C1=O
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRB2,COC(F)(F)C(Cl)Cl
4.0,,EFO_0004698,insomnia,CHEMBL448,PENTOBARBITAL,GABRB2,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O
4.0,,EFO_0006788,anxiety disorder,CHEMBL979,MEPROBAMATE,GABRB2,CCCC(C)(COC(N)=O)COC(N)=O
4.0,Completed,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRB2,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRB2,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRB2,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRB2,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0005277,migraine disorder,CHEMBL454,BUTALBITAL,GABRB2,C=CCC1(CC(C)C)C(=O)NC(=O)NC1=O
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRB2,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRB2,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Not yet recruiting,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRB2,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0005230,anxiety,CHEMBL135400,ZOPICLONE,GABRB2,CN1CCN(C(=O)OC2c3nccnc3C(=O)N2c2ccc(Cl)cn2)CC1
3.0,Terminated,EFO_0005230,anxiety,CHEMBL315795,CLOMETHIAZOLE,GABRB2,Cc1ncsc1CCCl
3.0,Completed,EFO_0006834,septic shock,CHEMBL441,THIOPENTAL,GABRB2,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRB2,FC(F)OC(Cl)C(F)(F)F
3.0,Completed,EFO_0004698,insomnia,CHEMBL312443,GABOXADOL,GABRB2,Oc1noc2c1CCNC2
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRB2,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRB2,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRB2,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRB2,CC(C)c1cccc([C@H](C)C2CC2)c1O
1.0,Completed,EFO_1001454,amnesia,CHEMBL738,THIOPENTAL SODIUM,GABRB2,CCCC(C)C1(CC)C(=O)[N-]C(=S)NC1=O.[Na+]
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,ALCAM,
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN2B,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN2B,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN2B,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN2B,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN2B,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,Recruiting,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN2B,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN2B,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN2B,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,Completed,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN2B,NC12CC3CC(CC(C3)C1)C2
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN2B,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN2B,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL742,KETAMINE,GRIN2B,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN2B,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN2B,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN2B,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN2B,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN2B,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Terminated,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN2B,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN2B,CC1(C)CC(C)(C)CC(C)(N)C1
2.0,Terminated,EFO_0000712,stroke,CHEMBL17350,TRAXOPRODIL,GRIN2B,C[C@@H]([C@@H](O)c1ccc(O)cc1)N1CCC(O)(c2ccccc2)CC1
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL182066,RADIPRODIL,GRIN2B,O=C(Nc1ccc2nc(O)oc2c1)C(=O)N1CCC(Cc2ccc(F)cc2)CC1
2.0,Completed,EFO_0005762,neuropathic pain,CHEMBL3707400,INDANTADOL,GRIN2B,
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN2B,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL2068839,RISLENEMDAZ,GRIN2B,Cc1ccc(COC(=O)N2CC[C@H](CNc3ncccn3)[C@H](F)C2)cc1
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN2B,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL467084,LANICEMINE,GRIN2B,N[C@@H](Cc1ccccn1)c1ccccc1
2.0,Terminated,MONDO_0002050,depressive disorder,CHEMBL3545350,EVT-101,GRIN2B,Cc1nccn1Cc1cc(-c2ccc(F)c(C(F)F)c2)cnn1
4.0,,EFO_0000474,epilepsy,CHEMBL1568698,GANAXOLONE,GABRP,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@](C)(O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0000474,epilepsy,CHEMBL3989949,CENOBAMATE,GABRP,NC(=O)O[C@@H](Cn1ncnn1)c1ccccc1Cl
4.0,,EFO_0000474,epilepsy,CHEMBL220492,TOPIRAMATE,GABRP,CC1(C)O[C@@H]2[C@@H](CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@H]23)O1
4.0,,EFO_0003843,pain,CHEMBL1341,METHOXYFLURANE,GABRP,COC(F)(F)C(Cl)Cl
4.0,,EFO_0007453,postpartum depression,CHEMBL207538,BREXANOLONE,GABRP,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4.0,,EFO_0007453,postpartum depression,CHEMBL4105630,ZURANOLONE,GABRP,C[C@@]1(O)CC[C@H]2[C@H](CC[C@@H]3[C@@H]2CC[C@]2(C)[C@@H](C(=O)Cn4cc(C#N)cn4)CC[C@@H]32)C1
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GABRP,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GABRP,CC(=O)NCCCS(=O)(=O)O
3.0,Recruiting,EFO_0000275,atrial fibrillation,CHEMBL526,PROPOFOL,GABRP,CC(C)c1cccc(C(C)C)c1O
3.0,Withdrawn,EFO_0000537,hypertension,CHEMBL681,ETOMIDATE,GABRP,CCOC(=O)c1cncn1[C@H](C)c1ccccc1
3.0,Completed,EFO_0000694,severe acute respiratory syndrome,CHEMBL1200694,SEVOFLURANE,GABRP,FCOC(C(F)(F)F)C(F)(F)F
3.0,Terminated,EFO_0011061,toxicity,CHEMBL1256,ISOFLURANE,GABRP,FC(F)OC(Cl)C(F)(F)F
3.0,,EFO_0005230,anxiety,CHEMBL2106227,ETIFOXINE,GABRP,CCNC1=Nc2ccc(Cl)cc2C(C)(c2ccccc2)O1
2.0,Recruiting,EFO_0004262,panic disorder,CHEMBL3647536,DARIGABAT,GABRP,CCn1cnc2c(-c3ccc(F)c(-c4ccc(S(=O)(=O)CC)cc4OC)c3)cnnc21
2.0,Completed,EFO_1002048,kidney failure,CHEMBL1200733,DESFLURANE,GABRP,FC(F)OC(F)C(F)(F)F
1.0,Completed,EFO_0003086,kidney disease,CHEMBL4094894,CIPEPOFOL,GABRP,CC(C)c1cccc([C@H](C)C2CC2)c1O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL4298138,REPOTRECTINIB,SDC4,C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN2A,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN2A,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN2A,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,EFO_0007486,sinusitis,CHEMBL1256818,DEXTROMETHORPHAN HYDROBROMIDE,GRIN2A,Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O
4.0,,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN2A,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN2A,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,,HP_0012735,Cough,CHEMBL52440,DEXTROMETHORPHAN,GRIN2A,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3
4.0,,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN2A,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0002009,major depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN2A,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN2A,NC12CC3CC(CC(C3)C1)C2
4.0,Completed,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN2A,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN2A,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN2A,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
3.0,Recruiting,EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN2A,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,Not yet recruiting,EFO_0000546,injury,CHEMBL742,KETAMINE,GRIN2A,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN2A,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN2A,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Terminated,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN2A,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN2A,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN2A,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN2A,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN2A,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,EFO_0003843,pain,CHEMBL3707400,INDANTADOL,GRIN2A,
2.0,Withdrawn,EFO_0003756,autism spectrum disorder,CHEMBL1201461,DEXTROMETHORPHAN POLISTIREX,GRIN2A,
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3989872,APIMOSTINEL,GRIN2A,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL467084,LANICEMINE,GRIN2A,N[C@@H](Cc1ccccn1)c1ccccc1
4.0,,EFO_0000474,epilepsy,CHEMBL1094,FELBAMATE,GRIN2D,NC(=O)OCC(COC(N)=O)c1ccccc1
4.0,,EFO_0000544,infection,CHEMBL1569,AMANTADINE HYDROCHLORIDE,GRIN2D,Cl.NC12CC3CC(CC(C3)C1)C2
4.0,,EFO_0003843,pain,CHEMBL1200395,ORPHENADRINE CITRATE,GRIN2D,Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O
4.0,,HP_0000726,Dementia,CHEMBL1699,MEMANTINE HYDROCHLORIDE,GRIN2D,CC12CC3CC(C)(C1)CC(N)(C3)C2.Cl
4.0,,HP_0000726,Dementia,CHEMBL807,MEMANTINE,GRIN2D,CC12CC3CC(C)(C1)CC(N)(C3)C2
4.0,,MONDO_0002050,depressive disorder,CHEMBL2364609,ESKETAMINE HYDROCHLORIDE,GRIN2D,CN[C@]1(c2ccccc2Cl)CCCCC1=O.Cl
4.0,,MONDO_0002050,depressive disorder,CHEMBL395091,ESKETAMINE,GRIN2D,CN[C@]1(c2ccccc2Cl)CCCCC1=O
4.0,,MONDO_0005180,Parkinson disease,CHEMBL660,AMANTADINE,GRIN2D,NC12CC3CC(CC(C3)C1)C2
4.0,,MONDO_0007079,alcohol dependence,CHEMBL1201293,ACAMPROSATE,GRIN2D,CC(=O)NCCCS(=O)(=O)O
4.0,,MONDO_0007079,alcohol dependence,CHEMBL2068724,ACAMPROSATE CALCIUM,GRIN2D,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2]
4.0,,MONDO_0005180,Parkinson disease,CHEMBL1201023,ORPHENADRINE HYDROCHLORIDE,GRIN2D,Cc1ccccc1C(OCCN(C)C)c1ccccc1.Cl
3.0,"Active, not recruiting",EFO_0000546,injury,CHEMBL1714,KETAMINE HYDROCHLORIDE,GRIN2D,CNC1(c2ccccc2Cl)CCCCC1=O.Cl
3.0,Not yet recruiting,EFO_0000546,injury,CHEMBL742,KETAMINE,GRIN2D,CNC1(c2ccccc2Cl)CCCCC1=O
3.0,"Active, not recruiting",EFO_0001361,pulmonary arterial hypertension,CHEMBL3545351,AV-101,GRIN2D,Nc1cc(Cl)ccc1C(=O)CC(N)C(=O)O
3.0,Completed,EFO_0003843,pain,CHEMBL2107771,RALFINAMIDE,GRIN2D,C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2106798,NERAMEXANE MESYLATE,GRIN2D,CC1(C)CC(C)(C)CC(C)(N)C1.CS(=O)(=O)O
3.0,Completed,HP_0000360,Tinnitus,CHEMBL2110954,NERAMEXANE,GRIN2D,CC1(C)CC(C)(C)CC(C)(N)C1
3.0,Unknown status,HP_0003419,Low back pain,CHEMBL900,ORPHENADRINE,GRIN2D,Cc1ccccc1C(OCCN(C)C)c1ccccc1
3.0,Completed,MONDO_0002009,major depressive disorder,CHEMBL3544917,RAPASTINEL,GRIN2D,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)[C@@H](C)O
2.0,Completed,EFO_0003768,nicotine dependence,CHEMBL1207366,GW468816,GRIN2D,O=C(O)C1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1
2.0,Completed,EFO_0003843,pain,CHEMBL3707400,INDANTADOL,GRIN2D,
2.0,Completed,MONDO_0002050,depressive disorder,CHEMBL467084,LANICEMINE,GRIN2D,N[C@@H](Cc1ccccn1)c1ccccc1
2.0,Withdrawn,MONDO_0005090,schizophrenia,CHEMBL3989872,APIMOSTINEL,GRIN2D,C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@@]1(Cc1ccccc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS15,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS15,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS15,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS19,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS19,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS19,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS29,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS29,
2.0,Terminated,MONDO_0016239,cystinosis,CHEMBL4297744,ELX-02,RPS29,
2.0,Terminated,EFO_0006859,head and neck malignant neoplasia,CHEMBL4297688,ADU-S100,STING1,
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1431,METFORMIN,NDUFB10,CN(C)C(=N)NC(=N)N
4.0,Completed,EFO_0000400,diabetes mellitus,CHEMBL1703,METFORMIN HYDROCHLORIDE,NDUFB10,CN(C)C(=N)NC(=N)N.Cl
1.0,Completed,EFO_0000616,neoplasm,CHEMBL5314386,ME-344,NDUFB10,Cc1c(O)ccc2c1OC[C@@H](c1ccc(O)cc1)[C@H]2c1ccc(O)cc1
3.0,Terminated,EFO_0004194,IGA glomerulonephritis,CHEMBL4298195,NARSOPLIMAB,MASP2,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB2A,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB2A,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000228,adenocarcinoma,CHEMBL3545252,DOCETAXEL,TUBB2A,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000313,carcinoma,CHEMBL428647,PACLITAXEL,TUBB2A,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB2A,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB2A,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB2A,
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB2A,
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB2A,
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB2A,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB2A,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB2A,
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB2A,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB2A,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB2A,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB2A,
4.0,Completed,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB2A,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB2A,
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB2A,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,"Active, not recruiting",EFO_0000178,gastric carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB2A,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB2A,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB2A,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB2A,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB2A,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB2A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB2A,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB2A,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB2A,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB2A,
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB2A,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB2A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB2A,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB2A,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB2A,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB2A,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000565,leukemia,CHEMBL39541,DOLASTATIN-10,TUBB2A,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB2A,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB2A,
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB2A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB2A,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB2A,
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB2A,
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB2A,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB2A,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB2A,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB2A,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB2A,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB2A,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB2A,
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB2A,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB2A,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL96172,EPOTHILONE D,TUBB2A,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB2A,
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB2A,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB2A,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB2A,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB2A,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB2A,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Withdrawn,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB2A,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB2A,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB2A,
1.0,Completed,MONDO_0004992,cancer,CHEMBL2103852,CROLIBULIN,TUBB2A,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB2A,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB2A,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS26,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS26,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS26,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB1,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB1,
4.0,,EFO_0000228,adenocarcinoma,CHEMBL3545252,DOCETAXEL,TUBB1,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB1,
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB1,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB1,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000313,carcinoma,CHEMBL428647,PACLITAXEL,TUBB1,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB1,
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB1,
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB1,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB1,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB1,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB1,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB1,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB1,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB1,
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB1,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB1,
3.0,Not yet recruiting,EFO_0000181,head and neck squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB1,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB1,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB1,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB1,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB1,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB1,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB1,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB1,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Recruiting,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB1,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB1,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB1,
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB1,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB1,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB1,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB1,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB1,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB1,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB1,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB1,
2.0,Completed,EFO_0000565,leukemia,CHEMBL39541,DOLASTATIN-10,TUBB1,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB1,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB1,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB1,
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB1,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB1,
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB1,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB1,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB1,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB1,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB1,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Recruiting,EFO_0003869,breast neoplasm,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB1,
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB1,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB1,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB1,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Terminated,MONDO_0008315,prostate cancer,CHEMBL96172,EPOTHILONE D,TUBB1,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB1,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB1,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB1,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB1,
1.0,Completed,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB1,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB1,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB1,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB1,
1.0,Completed,MONDO_0004992,cancer,CHEMBL2103852,CROLIBULIN,TUBB1,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB1,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB1,
4.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL1742994,BRENTUXIMAB VEDOTIN,TUBB2B,
4.0,,EFO_0000183,Hodgkins lymphoma,CHEMBL378544,VINBLASTINE SULFATE,TUBB2B,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL3545252,DOCETAXEL,TUBB2B,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C.O.O.O
4.0,,EFO_0000305,breast carcinoma,CHEMBL428647,PACLITAXEL,TUBB2B,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1201752,IXABEPILONE,TUBB2B,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)N1
4.0,,EFO_0000305,breast carcinoma,CHEMBL1683544,ERIBULIN MESYLATE,TUBB2B,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C.CS(=O)(=O)O
4.0,,EFO_0000305,breast carcinoma,CHEMBL1743082,TRASTUZUMAB EMTANSINE,TUBB2B,
4.0,,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL3301582,POLATUZUMAB VEDOTIN,TUBB2B,
4.0,,EFO_0000616,neoplasm,CHEMBL553025,VINORELBINE,TUBB2B,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2
4.0,,EFO_0000616,neoplasm,CHEMBL159,VINBLASTINE,TUBB2B,CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL90555,VINCRISTINE,TUBB2B,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
4.0,,EFO_0000616,neoplasm,CHEMBL1201748,CABAZITAXEL,TUBB2B,CO[C@H]1C(=O)[C@]2(C)[C@@H](OC)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
4.0,,EFO_0000616,neoplasm,CHEMBL1683590,ERIBULIN,TUBB2B,C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@@H]3[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]3C[C@H]3O[C@@H](CC[C@@H]1O2)C[C@@H](C)C3=C
4.0,,EFO_0000616,neoplasm,CHEMBL3301589,ENFORTUMAB VEDOTIN,TUBB2B,
4.0,,EFO_0000616,neoplasm,CHEMBL4297841,TISOTUMAB VEDOTIN,TUBB2B,
4.0,,EFO_0000616,neoplasm,CHEMBL4298209,BELANTAMAB MAFODOTIN,TUBB2B,
4.0,,EFO_0004274,gout,CHEMBL107,COLCHICINE,TUBB2B,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2
4.0,,EFO_1001100,peritoneal neoplasm,CHEMBL3545132,MIRVETUXIMAB SORAVTANSINE,TUBB2B,
3.0,Not yet recruiting,EFO_0000181,head and neck squamous cell carcinoma,CHEMBL92,DOCETAXEL ANHYDROUS,TUBB2B,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
3.0,Completed,EFO_0000096,neoplasm of mature B-cells,CHEMBL501867,VINCRISTINE SULFATE,TUBB2B,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O
3.0,Completed,EFO_0000183,Hodgkins lymphoma,CHEMBL538943,VINORELBINE TARTRATE,TUBB2B,CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2.O=C(O)C(O)C(O)C(=O)O.O=C(O)C(O)C(O)C(=O)O
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL2110725,VINFLUNINE,TUBB2B,CC[C@]12C=CCN3CC[C@@]4(c5cc([C@@]6(C(=O)OC)C[C@@H]7C[C@@H](C(C)(F)F)CN(Cc8c6[nH]c6ccccc86)C7)c(OC)cc5N(C)[C@H]4[C@@](O)(C(=O)OC)[C@@H]1OC(C)=O)[C@@H]32
3.0,Completed,EFO_0000294,bladder tumor,CHEMBL4279455,LAROTAXEL,TUBB2B,CC(=O)O[C@H]1C(=O)[C@]23C[C@H]2C[C@H]2OC[C@@]2(OC(C)=O)[C@H]3[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c3ccccc3)C(C)=C1C2(C)C
3.0,,EFO_0000616,neoplasm,CHEMBL2108628,PACLITAXEL POLIGLUMEX,TUBB2B,
3.0,Completed,EFO_0000691,sarcoma,CHEMBL572284,OMBRABULIN,TUBB2B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
3.0,Withdrawn,EFO_0003060,non-small cell lung carcinoma,CHEMBL3990032,TELISOTUZUMAB VEDOTIN,TUBB2B,
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL1096380,PLINABULIN,TUBB2B,CC(C)(C)c1[nH]cnc1/C=c1\[nH]c(=O)/c(=C/c2ccccc2)[nH]c1=O
3.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297441,PACLITAXEL DOCOSAHEXAENOIC ACID,TUBB2B,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@@H]3[C@]4(OC(C)=O)CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](NC(=O)c1ccccc1)c1ccccc1
3.0,"Active, not recruiting",EFO_0003060,non-small cell lung carcinoma,CHEMBL4298098,TUSAMITAMAB RAVTANSINE,TUBB2B,
3.0,Completed,EFO_1001100,peritoneal neoplasm,CHEMBL94657,PATUPILONE,TUBB2B,C/C(=C\c1csc(C)n1)[C@@H]1C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@H](O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1
3.0,Withdrawn,MONDO_0002108,thyroid cancer,CHEMBL1206232,FOSBRETABULIN,TUBB2B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O
2.0,Unknown status,EFO_0000182,hepatocellular carcinoma,CHEMBL4297440,T-900607,TUBB2B,COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL1089636,ANG1005,TUBB2B,CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](OC(=O)CCC(=O)NCCCC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc4ccccc4)C(=O)N[C@@H](CCCCNC(=O)CCC(=O)O[C@@H](C(=O)O[C@H]4C[C@@]5(O)[C@@H](OC(=O)c6ccccc6)[C@@H]6[C@]7(OC(C)=O)CO[C@@H]7C[C@H](O)[C@@]6(C)C(=O)[C@H](OC(C)=O)C(=C4C)C5(C)C)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc4ccc(O)cc4)C(=O)O)[C@@H](C)O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL2304041,SAGOPILONE,TUBB2B,C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O
2.0,Completed,EFO_0000565,leukemia,CHEMBL1743037,LORVOTUZUMAB MERTANSINE,TUBB2B,
2.0,Completed,EFO_0000519,glioblastoma multiforme,CHEMBL492399,VERUBULIN,TUBB2B,COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1
2.0,Terminated,EFO_0000503,gastric adenocarcinoma,CHEMBL4298045,INDUSATUMAB VEDOTIN,TUBB2B,
2.0,Completed,EFO_0000574,lymphoma,CHEMBL39541,DOLASTATIN-10,TUBB2B,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Unknown status,EFO_0000588,mesothelioma,CHEMBL2107759,MILATAXEL,TUBB2B,CCC(=O)O[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)C2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](CC(=O)OC(C)(C)C)c4ccco4)C(C)=C([C@@H](O)C(=O)[C@@]21C)C3(C)C
2.0,Completed,EFO_0000621,neuroblastoma,CHEMBL20684,ABT-751,TUBB2B,COc1ccc(S(=O)(=O)Nc2cccnc2Nc2ccc(O)cc2)cc1
2.0,Completed,EFO_0000616,neoplasm,CHEMBL289351,FOSBRETABULIN DISODIUM,TUBB2B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]
2.0,Withdrawn,EFO_0000616,neoplasm,CHEMBL4297892,ANVATABART OPADOTIN,TUBB2B,
2.0,Completed,EFO_0000637,osteosarcoma,CHEMBL1743028,GLEMBATUMUMAB VEDOTIN,TUBB2B,
2.0,Completed,EFO_0000681,renal cell carcinoma,CHEMBL4594455,AGS-16C3F,TUBB2B,
2.0,Completed,EFO_0000691,sarcoma,CHEMBL3989512,SOBLIDOTIN,TUBB2B,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C
2.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL552212,LEXIBULIN,TUBB2B,CCC[C@H](Nc1nc(-c2ccc(NC(=O)NCC)c(OC)c2)ncc1C)c1cccnc1
2.0,Terminated,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297268,BMS-275183,TUBB2B,COC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](OC(C)=O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C
2.0,Recruiting,EFO_0003968,angiosarcoma,CHEMBL4298101,LADIRATUZUMAB VEDOTIN,TUBB2B,
2.0,Completed,EFO_0003060,non-small cell lung carcinoma,CHEMBL4297296,KOS-1584,TUBB2B,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)/C=C/C1
2.0,Completed,HP_0100543,Cognitive impairment,CHEMBL2103826,DAVUNETIDE,TUBB2B,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)O
2.0,Completed,EFO_1001901,neuroendocrine neoplasm,CHEMBL2105643,FOSBRETABULIN TROMETHAMINE,TUBB2B,COc1ccc(/C=C\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)(O)O.NC(CO)(CO)CO
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL4297636,PLOCABULIN,TUBB2B,C/C=C\C[C@@H](C/C=C\NC(=O)[C@@H](NC(=O)/C=C\C=C/C(C)=C/[C@H](C)[C@@H]1CC=C(OC)C(=O)O1)C(C)(C)C)OC(N)=O
2.0,Completed,MONDO_0005575,colorectal cancer,CHEMBL96172,EPOTHILONE D,TUBB2B,C/C1=C/C[C@@H](/C(C)=C/c2csc(C)n2)OC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC1
2.0,Completed,MONDO_0007254,breast cancer,CHEMBL4297736,PRALUZATAMAB RAVTANSINE,TUBB2B,
2.0,Terminated,MONDO_0008170,ovarian cancer,CHEMBL4297938,LIFASTUZUMAB VEDOTIN,TUBB2B,
1.0,Completed,EFO_0000095,chronic lymphocytic leukemia,CHEMBL3301585,PINATUZUMAB VEDOTIN,TUBB2B,
1.0,Unknown status,EFO_0000616,neoplasm,CHEMBL49642,INDIBULIN,TUBB2B,O=C(Nc1ccncc1)C(=O)c1cn(Cc2ccc(Cl)cc2)c2ccccc12
1.0,Completed,EFO_0000616,neoplasm,CHEMBL4297935,RG-7841,TUBB2B,
1.0,Completed,EFO_0001663,prostate carcinoma,CHEMBL2109574,ASG-5ME,TUBB2B,
1.0,Terminated,EFO_0001378,multiple myeloma,CHEMBL4297859,AZINTUXIZUMAB VEDOTIN,TUBB2B,
1.0,Completed,EFO_0002618,pancreatic carcinoma,CHEMBL3545372,SOFITUZUMAB VEDOTIN,TUBB2B,
1.0,Completed,MONDO_0004992,cancer,CHEMBL2103852,CROLIBULIN,TUBB2B,COc1cc([C@H]2C(C#N)=C(N)Oc3c2ccc(N)c3N)cc(Br)c1OC
1.0,Terminated,MONDO_0004992,cancer,CHEMBL4650293,APRUTUMAB IXADOTIN,TUBB2B,
1.0,Completed,MONDO_0008315,prostate cancer,CHEMBL3833306,VANDORTUZUMAB VEDOTIN,TUBB2B,
4.0,,MONDO_0010679,Duchenne muscular dystrophy,CHEMBL256997,ATALUREN,RPS3,O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1
2.0,Terminated,EFO_0000403,diffuse large B-cell lymphoma,CHEMBL4297789,MT-3724,RPS3,
2.0,Completed,MONDO_0009061,cystic fibrosis,CHEMBL4297744,ELX-02,RPS3,
